id	sid	tid	token	lemma	pos
ajlm-1432	1	1	abstract	abstract	ADJ
ajlm-1432	1	2	introduction	introduction	NOUN
ajlm-1432	1	3	methods	method	NOUN
ajlm-1432	1	4	results	result	VERB
ajlm-1432	1	5	discussion	discussion	NOUN
ajlm-1432	1	6	acknowledgements	acknowledgement	NOUN
ajlm-1432	1	7	references	reference	NOUN
ajlm-1432	1	8	about	about	ADP
ajlm-1432	1	9	the	the	DET
ajlm-1432	1	10	author(s	author(s	NOUN
ajlm-1432	1	11	)	)	PUNCT
ajlm-1432	1	12	victor	victor	PROPN
ajlm-1432	1	13	n.	n.	PROPN
ajlm-1432	1	14	fondoh	fondoh	PROPN
ajlm-1432	1	15	bamenda	bamenda	PROPN
ajlm-1432	1	16	regional	regional	PROPN
ajlm-1432	1	17	hospital	hospital	NOUN
ajlm-1432	1	18	laboratory	laboratory	NOUN
ajlm-1432	1	19	,	,	PUNCT
ajlm-1432	1	20	regional	regional	ADJ
ajlm-1432	1	21	hospital	hospital	NOUN
ajlm-1432	1	22	bamenda	bamenda	NOUN
ajlm-1432	1	23	,	,	PUNCT
ajlm-1432	1	24	cameroon	cameroon	PROPN
ajlm-1432	1	25	department	department	PROPN
ajlm-1432	1	26	of	of	ADP
ajlm-1432	1	27	medical	medical	PROPN
ajlm-1432	1	28	laboratory	laboratory	NOUN
ajlm-1432	1	29	sciences	sciences	PROPN
ajlm-1432	1	30	,	,	PUNCT
ajlm-1432	1	31	school	school	NOUN
ajlm-1432	1	32	of	of	ADP
ajlm-1432	1	33	health	health	NOUN
ajlm-1432	1	34	and	and	CCONJ
ajlm-1432	1	35	medical	medical	ADJ
ajlm-1432	1	36	sciences	science	NOUN
ajlm-1432	1	37	,	,	PUNCT
ajlm-1432	1	38	catholic	catholic	PROPN
ajlm-1432	1	39	university	university	PROPN
ajlm-1432	1	40	of	of	ADP
ajlm-1432	1	41	cameroon	cameroon	PROPN
ajlm-1432	1	42	,	,	PUNCT
ajlm-1432	1	43	bamenda	bamenda	NOUN
ajlm-1432	1	44	,	,	PUNCT
ajlm-1432	1	45	cameroon	cameroon	PROPN
ajlm-1432	1	46	department	department	PROPN
ajlm-1432	1	47	of	of	ADP
ajlm-1432	1	48	health	health	PROPN
ajlm-1432	1	49	economics	economic	NOUN
ajlm-1432	1	50	policy	policy	NOUN
ajlm-1432	1	51	and	and	CCONJ
ajlm-1432	1	52	management	management	NOUN
ajlm-1432	1	53	,	,	PUNCT
ajlm-1432	1	54	faculty	faculty	NOUN
ajlm-1432	1	55	of	of	ADP
ajlm-1432	1	56	business	business	NOUN
ajlm-1432	1	57	management	management	NOUN
ajlm-1432	1	58	,	,	PUNCT
ajlm-1432	1	59	catholic	catholic	PROPN
ajlm-1432	1	60	university	university	PROPN
ajlm-1432	1	61	of	of	ADP
ajlm-1432	1	62	cameroon	cameroon	PROPN
ajlm-1432	1	63	,	,	PUNCT
ajlm-1432	1	64	bamenda	bamenda	NOUN
ajlm-1432	1	65	,	,	PUNCT
ajlm-1432	1	66	cameroon	cameroon	PROPN
ajlm-1432	1	67	nobert	nobert	PROPN
ajlm-1432	1	68	ndzenjempuh	ndzenjempuh	PROPN
ajlm-1432	1	69	department	department	PROPN
ajlm-1432	1	70	of	of	ADP
ajlm-1432	1	71	medical	medical	PROPN
ajlm-1432	1	72	laboratory	laboratory	NOUN
ajlm-1432	1	73	sciences	sciences	PROPN
ajlm-1432	1	74	,	,	PUNCT
ajlm-1432	1	75	school	school	NOUN
ajlm-1432	1	76	of	of	ADP
ajlm-1432	1	77	health	health	NOUN
ajlm-1432	1	78	and	and	CCONJ
ajlm-1432	1	79	medical	medical	ADJ
ajlm-1432	1	80	sciences	science	NOUN
ajlm-1432	1	81	,	,	PUNCT
ajlm-1432	1	82	catholic	catholic	PROPN
ajlm-1432	1	83	university	university	PROPN
ajlm-1432	1	84	of	of	ADP
ajlm-1432	1	85	cameroon	cameroon	PROPN
ajlm-1432	1	86	,	,	PUNCT
ajlm-1432	1	87	bamenda	bamenda	NOUN
ajlm-1432	1	88	,	,	PUNCT
ajlm-1432	1	89	cameroon	cameroon	PROPN
ajlm-1432	1	90	tamunjoh	tamunjoh	PROPN
ajlm-1432	1	91	stella	stella	PROPN
ajlm-1432	1	92	department	department	PROPN
ajlm-1432	1	93	of	of	ADP
ajlm-1432	1	94	medical	medical	PROPN
ajlm-1432	1	95	laboratory	laboratory	NOUN
ajlm-1432	1	96	sciences	sciences	PROPN
ajlm-1432	1	97	,	,	PUNCT
ajlm-1432	1	98	school	school	NOUN
ajlm-1432	1	99	of	of	ADP
ajlm-1432	1	100	health	health	NOUN
ajlm-1432	1	101	and	and	CCONJ
ajlm-1432	1	102	medical	medical	ADJ
ajlm-1432	1	103	sciences	science	NOUN
ajlm-1432	1	104	,	,	PUNCT
ajlm-1432	1	105	catholic	catholic	PROPN
ajlm-1432	1	106	university	university	PROPN
ajlm-1432	1	107	of	of	ADP
ajlm-1432	1	108	cameroon	cameroon	PROPN
ajlm-1432	1	109	,	,	PUNCT
ajlm-1432	1	110	bamenda	bamenda	NOUN
ajlm-1432	1	111	,	,	PUNCT
ajlm-1432	1	112	cameroon	cameroon	PROPN
ajlm-1432	1	113	richard	richard	PROPN
ajlm-1432	1	114	m.	m.	PROPN
ajlm-1432	1	115	fondoh	fondoh	PROPN
ajlm-1432	1	116	north	north	PROPN
ajlm-1432	1	117	-	-	PUNCT
ajlm-1432	1	118	west	west	PROPN
ajlm-1432	1	119	regional	regional	ADJ
ajlm-1432	1	120	fund	fund	NOUN
ajlm-1432	1	121	for	for	ADP
ajlm-1432	1	122	health	health	NOUN
ajlm-1432	1	123	promotion	promotion	NOUN
ajlm-1432	1	124	,	,	PUNCT
ajlm-1432	1	125	bamenda	bamenda	NOUN
ajlm-1432	1	126	,	,	PUNCT
ajlm-1432	1	127	cameroon	cameroon	PROPN
ajlm-1432	1	128	charles	charles	PROPN
ajlm-1432	1	129	n.	n.	PROPN
ajlm-1432	1	130	awasom	awasom	PROPN
ajlm-1432	1	131	department	department	PROPN
ajlm-1432	1	132	of	of	ADP
ajlm-1432	1	133	anatomy	anatomy	NOUN
ajlm-1432	1	134	,	,	PUNCT
ajlm-1432	1	135	school	school	NOUN
ajlm-1432	1	136	of	of	ADP
ajlm-1432	1	137	health	health	NOUN
ajlm-1432	1	138	and	and	CCONJ
ajlm-1432	1	139	medical	medical	ADJ
ajlm-1432	1	140	science	science	NOUN
ajlm-1432	1	141	,	,	PUNCT
ajlm-1432	1	142	catholic	catholic	PROPN
ajlm-1432	1	143	university	university	PROPN
ajlm-1432	1	144	of	of	ADP
ajlm-1432	1	145	cameroon	cameroon	PROPN
ajlm-1432	1	146	,	,	PUNCT
ajlm-1432	1	147	bamenda	bamenda	NOUN
ajlm-1432	1	148	,	,	PUNCT
ajlm-1432	1	149	cameroon	cameroon	PROPN
ajlm-1432	1	150	rebecca	rebecca	PROPN
ajlm-1432	1	151	enow	enow	PROPN
ajlm-1432	1	152	-	-	PUNCT
ajlm-1432	1	153	tanjong	tanjong	PROPN
ajlm-1432	1	154	department	department	PROPN
ajlm-1432	1	155	of	of	ADP
ajlm-1432	1	156	medical	medical	PROPN
ajlm-1432	1	157	laboratory	laboratory	NOUN
ajlm-1432	1	158	sciences	sciences	PROPN
ajlm-1432	1	159	,	,	PUNCT
ajlm-1432	1	160	school	school	NOUN
ajlm-1432	1	161	of	of	ADP
ajlm-1432	1	162	health	health	NOUN
ajlm-1432	1	163	and	and	CCONJ
ajlm-1432	1	164	medical	medical	ADJ
ajlm-1432	1	165	sciences	science	NOUN
ajlm-1432	1	166	,	,	PUNCT
ajlm-1432	1	167	catholic	catholic	PROPN
ajlm-1432	1	168	university	university	PROPN
ajlm-1432	1	169	of	of	ADP
ajlm-1432	1	170	cameroon	cameroon	PROPN
ajlm-1432	1	171	,	,	PUNCT
ajlm-1432	1	172	bamenda	bamenda	NOUN
ajlm-1432	1	173	,	,	PUNCT
ajlm-1432	1	174	cameroon	cameroon	NOUN
ajlm-1432	1	175	egbe	egbe	PROPN
ajlm-1432	1	176	p.	p.	PROPN
ajlm-1432	1	177	egbengu	egbengu	PROPN
ajlm-1432	1	178	department	department	PROPN
ajlm-1432	1	179	of	of	ADP
ajlm-1432	1	180	medicine	medicine	NOUN
ajlm-1432	1	181	and	and	CCONJ
ajlm-1432	1	182	surgery	surgery	NOUN
ajlm-1432	1	183	,	,	PUNCT
ajlm-1432	1	184	school	school	NOUN
ajlm-1432	1	185	of	of	ADP
ajlm-1432	1	186	health	health	NOUN
ajlm-1432	1	187	and	and	CCONJ
ajlm-1432	1	188	medical	medical	ADJ
ajlm-1432	1	189	science	science	NOUN
ajlm-1432	1	190	,	,	PUNCT
ajlm-1432	1	191	catholic	catholic	PROPN
ajlm-1432	1	192	university	university	PROPN
ajlm-1432	1	193	of	of	ADP
ajlm-1432	1	194	cameroon	cameroon	PROPN
ajlm-1432	1	195	,	,	PUNCT
ajlm-1432	1	196	bamenda	bamenda	NOUN
ajlm-1432	1	197	,	,	PUNCT
ajlm-1432	1	198	cameroon	cameroon	PROPN
ajlm-1432	1	199	robert	robert	PROPN
ajlm-1432	1	200	leke	leke	PROPN
ajlm-1432	1	201	department	department	PROPN
ajlm-1432	1	202	of	of	ADP
ajlm-1432	1	203	medicine	medicine	NOUN
ajlm-1432	1	204	and	and	CCONJ
ajlm-1432	1	205	surgery	surgery	NOUN
ajlm-1432	1	206	,	,	PUNCT
ajlm-1432	1	207	school	school	NOUN
ajlm-1432	1	208	of	of	ADP
ajlm-1432	1	209	health	health	NOUN
ajlm-1432	1	210	and	and	CCONJ
ajlm-1432	1	211	medical	medical	ADJ
ajlm-1432	1	212	science	science	NOUN
ajlm-1432	1	213	,	,	PUNCT
ajlm-1432	1	214	catholic	catholic	PROPN
ajlm-1432	1	215	university	university	PROPN
ajlm-1432	1	216	of	of	ADP
ajlm-1432	1	217	cameroon	cameroon	PROPN
ajlm-1432	1	218	,	,	PUNCT
ajlm-1432	1	219	bamenda	bamenda	NOUN
ajlm-1432	1	220	,	,	PUNCT
ajlm-1432	1	221	cameroon	cameroon	PROPN
ajlm-1432	1	222	njini	njini	PROPN
ajlm-1432	1	223	f.n	f.n	PROPN
ajlm-1432	1	224	.	.	PROPN
ajlm-1432	1	225	rose	rise	VERB
ajlm-1432	1	226	regional	regional	ADJ
ajlm-1432	1	227	hospital	hospital	NOUN
ajlm-1432	1	228	bamenda	bamenda	NOUN
ajlm-1432	1	229	,	,	PUNCT
ajlm-1432	1	230	bamenda	bamenda	NOUN
ajlm-1432	1	231	,	,	PUNCT
ajlm-1432	1	232	cameroon	cameroon	PROPN
ajlm-1432	1	233	denis	denis	PROPN
ajlm-1432	1	234	nsame	nsame	PROPN
ajlm-1432	1	235	regional	regional	ADJ
ajlm-1432	1	236	hospital	hospital	NOUN
ajlm-1432	1	237	bamenda	bamenda	NOUN
ajlm-1432	1	238	,	,	PUNCT
ajlm-1432	1	239	bamenda	bamenda	NOUN
ajlm-1432	1	240	,	,	PUNCT
ajlm-1432	1	241	cameroon	cameroon	PROPN
ajlm-1432	1	242	citation	citation	PROPN
ajlm-1432	1	243	fondoh	fondoh	PROPN
ajlm-1432	1	244	vn	vn	PROPN
ajlm-1432	1	245	,	,	PUNCT
ajlm-1432	1	246	ndzenjempuh	ndzenjempuh	NOUN
ajlm-1432	1	247	n	n	CCONJ
ajlm-1432	1	248	,	,	PUNCT
ajlm-1432	1	249	stella	stella	PROPN
ajlm-1432	1	250	t	t	PROPN
ajlm-1432	1	251	,	,	PUNCT
ajlm-1432	1	252	et	et	PROPN
ajlm-1432	1	253	al	al	PROPN
ajlm-1432	1	254	.	.	PUNCT
ajlm-1432	2	1	prevalence	prevalence	NOUN
ajlm-1432	2	2	of	of	ADP
ajlm-1432	2	3	alpha	alpha	NOUN
ajlm-1432	2	4	and	and	CCONJ
ajlm-1432	2	5	beta	beta	ADJ
ajlm-1432	2	6	haemolysin	haemolysin	NOUN
ajlm-1432	2	7	among	among	ADP
ajlm-1432	2	8	blood	blood	NOUN
ajlm-1432	2	9	group	group	NOUN
ajlm-1432	2	10	o	o	NOUN
ajlm-1432	2	11	donors	donor	NOUN
ajlm-1432	2	12	in	in	ADP
ajlm-1432	2	13	bamenda	bamenda	NOUN
ajlm-1432	2	14	,	,	PUNCT
ajlm-1432	2	15	cameroon	cameroon	PROPN
ajlm-1432	2	16	.	.	PUNCT
ajlm-1432	3	1	afr	afr	PROPN
ajlm-1432	3	2	j	j	PROPN
ajlm-1432	3	3	lab	lab	PROPN
ajlm-1432	3	4	med	med	PROPN
ajlm-1432	3	5	.	.	PUNCT
ajlm-1432	4	1	2022;11(1	2022;11(1	NUM
ajlm-1432	4	2	)	)	PUNCT
ajlm-1432	4	3	,	,	PUNCT
ajlm-1432	5	1	a1432	a1432	PROPN
ajlm-1432	5	2	.	.	PUNCT
ajlm-1432	5	3	https://doi.org/10.4102/ajlm.v11i1.1432	https://doi.org/10.4102/ajlm.v11i1.1432	NUM
ajlm-1432	5	4	original	original	ADJ
ajlm-1432	5	5	research	research	NOUN
ajlm-1432	5	6	prevalence	prevalence	NOUN
ajlm-1432	5	7	of	of	ADP
ajlm-1432	5	8	alpha	alpha	NOUN
ajlm-1432	5	9	and	and	CCONJ
ajlm-1432	5	10	beta	beta	ADJ
ajlm-1432	5	11	haemolysin	haemolysin	NOUN
ajlm-1432	5	12	among	among	ADP
ajlm-1432	5	13	blood	blood	NOUN
ajlm-1432	5	14	group	group	NOUN
ajlm-1432	5	15	o	o	NOUN
ajlm-1432	5	16	donors	donor	NOUN
ajlm-1432	5	17	in	in	ADP
ajlm-1432	5	18	bamenda	bamenda	NOUN
ajlm-1432	5	19	,	,	PUNCT
ajlm-1432	5	20	cameroon	cameroon	PROPN
ajlm-1432	5	21	victor	victor	PROPN
ajlm-1432	5	22	n.	n.	PROPN
ajlm-1432	5	23	fondoh	fondoh	PROPN
ajlm-1432	5	24	,	,	PUNCT
ajlm-1432	5	25	nobert	nobert	ADJ
ajlm-1432	5	26	ndzenjempuh	ndzenjempuh	NOUN
ajlm-1432	5	27	,	,	PUNCT
ajlm-1432	5	28	tamunjoh	tamunjoh	PROPN
ajlm-1432	5	29	stella	stella	PROPN
ajlm-1432	5	30	,	,	PUNCT
ajlm-1432	5	31	richard	richard	PROPN
ajlm-1432	5	32	m.	m.	PROPN
ajlm-1432	5	33	fondoh	fondoh	PROPN
ajlm-1432	5	34	,	,	PUNCT
ajlm-1432	5	35	charles	charles	PROPN
ajlm-1432	5	36	n.	n.	PROPN
ajlm-1432	5	37	awasom	awasom	PROPN
ajlm-1432	5	38	,	,	PUNCT
ajlm-1432	5	39	rebecca	rebecca	PROPN
ajlm-1432	5	40	enow	enow	PROPN
ajlm-1432	5	41	-	-	PUNCT
ajlm-1432	5	42	tanjong	tanjong	PROPN
ajlm-1432	5	43	,	,	PUNCT
ajlm-1432	5	44	egbe	egbe	PROPN
ajlm-1432	5	45	p.	p.	PROPN
ajlm-1432	5	46	egbengu	egbengu	PROPN
ajlm-1432	5	47	,	,	PUNCT
ajlm-1432	5	48	robert	robert	PROPN
ajlm-1432	5	49	leke	leke	PROPN
ajlm-1432	5	50	,	,	PUNCT
ajlm-1432	5	51	njini	njini	PROPN
ajlm-1432	5	52	f.n	f.n	PROPN
ajlm-1432	5	53	.	.	PROPN
ajlm-1432	5	54	rose	rise	VERB
ajlm-1432	5	55	,	,	PUNCT
ajlm-1432	5	56	denis	denis	PROPN
ajlm-1432	5	57	nsame	nsame	PROPN
ajlm-1432	5	58	received	receive	VERB
ajlm-1432	5	59	:	:	PUNCT
ajlm-1432	5	60	25	25	NUM
ajlm-1432	5	61	oct	oct	PROPN
ajlm-1432	5	62	.	.	PROPN
ajlm-1432	5	63	2020	2020	NUM
ajlm-1432	5	64	;	;	PUNCT
ajlm-1432	5	65	accepted	accept	VERB
ajlm-1432	5	66	:	:	PUNCT
ajlm-1432	5	67	03	03	NUM
ajlm-1432	5	68	feb	feb	X
ajlm-1432	5	69	.	.	PROPN
ajlm-1432	5	70	2022	2022	NUM
ajlm-1432	5	71	;	;	PUNCT
ajlm-1432	5	72	published	publish	VERB
ajlm-1432	5	73	:	:	PUNCT
ajlm-1432	5	74	19	19	NUM
ajlm-1432	5	75	apr	apr	NOUN
ajlm-1432	5	76	.	.	PUNCT
ajlm-1432	6	1	2022	2022	NUM
ajlm-1432	6	2	copyright	copyright	NOUN
ajlm-1432	6	3	:	:	PUNCT
ajlm-1432	6	4	©	©	PROPN
ajlm-1432	6	5	2022	2022	NUM
ajlm-1432	6	6	.	.	PUNCT
ajlm-1432	7	1	the	the	DET
ajlm-1432	7	2	author(s	author(s	PROPN
ajlm-1432	7	3	)	)	PUNCT
ajlm-1432	7	4	.	.	PUNCT
ajlm-1432	8	1	licensee	licensee	NOUN
ajlm-1432	8	2	:	:	PUNCT
ajlm-1432	8	3	aosis	aosis	NOUN
ajlm-1432	8	4	.	.	PUNCT
ajlm-1432	9	1	this	this	PRON
ajlm-1432	9	2	is	be	AUX
ajlm-1432	9	3	an	an	DET
ajlm-1432	9	4	open	open	ADJ
ajlm-1432	9	5	access	access	NOUN
ajlm-1432	9	6	article	article	NOUN
ajlm-1432	9	7	distributed	distribute	VERB
ajlm-1432	9	8	under	under	ADP
ajlm-1432	9	9	the	the	DET
ajlm-1432	9	10	terms	term	NOUN
ajlm-1432	9	11	of	of	ADP
ajlm-1432	9	12	the	the	DET
ajlm-1432	9	13	creative	creative	ADJ
ajlm-1432	9	14	commons	common	NOUN
ajlm-1432	9	15	attribution	attribution	NOUN
ajlm-1432	9	16	license	license	NOUN
ajlm-1432	9	17	,	,	PUNCT
ajlm-1432	9	18	which	which	PRON
ajlm-1432	9	19	permits	permit	VERB
ajlm-1432	9	20	unrestricted	unrestricted	ADJ
ajlm-1432	9	21	use	use	NOUN
ajlm-1432	9	22	,	,	PUNCT
ajlm-1432	9	23	distribution	distribution	NOUN
ajlm-1432	9	24	,	,	PUNCT
ajlm-1432	9	25	and	and	CCONJ
ajlm-1432	9	26	reproduction	reproduction	NOUN
ajlm-1432	9	27	in	in	ADP
ajlm-1432	9	28	any	any	DET
ajlm-1432	9	29	medium	medium	NOUN
ajlm-1432	9	30	,	,	PUNCT
ajlm-1432	9	31	provided	provide	VERB
ajlm-1432	9	32	the	the	DET
ajlm-1432	9	33	original	original	ADJ
ajlm-1432	9	34	work	work	NOUN
ajlm-1432	9	35	is	be	AUX
ajlm-1432	9	36	properly	properly	ADV
ajlm-1432	9	37	cited	cite	VERB
ajlm-1432	9	38	.	.	PUNCT
ajlm-1432	10	1	abstract	abstract	ADJ
ajlm-1432	10	2	background	background	NOUN
ajlm-1432	10	3	:	:	PUNCT
ajlm-1432	10	4	the	the	DET
ajlm-1432	10	5	occurrence	occurrence	NOUN
ajlm-1432	10	6	of	of	ADP
ajlm-1432	10	7	high	high	ADJ
ajlm-1432	10	8	titres	titre	NOUN
ajlm-1432	10	9	of	of	ADP
ajlm-1432	10	10	alpha	alpha	NOUN
ajlm-1432	10	11	(	(	PUNCT
ajlm-1432	10	12	anti	anti	ADJ
ajlm-1432	10	13	-	-	ADJ
ajlm-1432	10	14	a	a	NOUN
ajlm-1432	10	15	)	)	PUNCT
ajlm-1432	10	16	and	and	CCONJ
ajlm-1432	10	17	beta	beta	ADJ
ajlm-1432	10	18	(	(	PUNCT
ajlm-1432	10	19	anti	anti	ADJ
ajlm-1432	10	20	-	-	ADJ
ajlm-1432	10	21	b	b	ADJ
ajlm-1432	10	22	)	)	PUNCT
ajlm-1432	10	23	haemolysin	haemolysin	NOUN
ajlm-1432	10	24	immunoglobulin	immunoglobulin	PROPN
ajlm-1432	10	25	g	g	PROPN
ajlm-1432	10	26	antibodies	antibodie	VERB
ajlm-1432	10	27	in	in	ADP
ajlm-1432	10	28	blood	blood	NOUN
ajlm-1432	10	29	causes	cause	VERB
ajlm-1432	10	30	haemolysis	haemolysis	NOUN
ajlm-1432	10	31	during	during	ADP
ajlm-1432	10	32	blood	blood	NOUN
ajlm-1432	10	33	transfusion	transfusion	NOUN
ajlm-1432	10	34	from	from	ADP
ajlm-1432	10	35	a	a	DET
ajlm-1432	10	36	group	group	NOUN
ajlm-1432	10	37	o	o	NOUN
ajlm-1432	10	38	donor	donor	NOUN
ajlm-1432	10	39	,	,	PUNCT
ajlm-1432	10	40	commonly	commonly	ADV
ajlm-1432	10	41	and	and	CCONJ
ajlm-1432	10	42	inappropriately	inappropriately	ADV
ajlm-1432	10	43	known	know	VERB
ajlm-1432	10	44	as	as	ADP
ajlm-1432	10	45	the	the	DET
ajlm-1432	10	46	‘	'	PUNCT
ajlm-1432	10	47	universal	universal	ADJ
ajlm-1432	10	48	blood	blood	NOUN
ajlm-1432	10	49	donor	donor	NOUN
ajlm-1432	10	50	’	'	PUNCT
ajlm-1432	10	51	,	,	PUNCT
ajlm-1432	10	52	to	to	ADP
ajlm-1432	10	53	a	a	DET
ajlm-1432	10	54	group	group	NOUN
ajlm-1432	10	55	a	a	PRON
ajlm-1432	10	56	,	,	PUNCT
ajlm-1432	10	57	b	b	NOUN
ajlm-1432	10	58	or	or	CCONJ
ajlm-1432	10	59	ab	ab	PROPN
ajlm-1432	10	60	recipient	recipient	NOUN
ajlm-1432	10	61	.	.	PUNCT
ajlm-1432	11	1	surprisingly	surprisingly	ADV
ajlm-1432	11	2	,	,	PUNCT
ajlm-1432	11	3	haemolysin	haemolysin	NOUN
ajlm-1432	11	4	testing	testing	NOUN
ajlm-1432	11	5	is	be	AUX
ajlm-1432	11	6	not	not	PART
ajlm-1432	11	7	routinely	routinely	ADV
ajlm-1432	11	8	done	do	VERB
ajlm-1432	11	9	during	during	ADP
ajlm-1432	11	10	blood	blood	NOUN
ajlm-1432	11	11	transfusion	transfusion	NOUN
ajlm-1432	11	12	services	service	NOUN
ajlm-1432	11	13	in	in	ADP
ajlm-1432	11	14	bamenda	bamenda	NOUN
ajlm-1432	11	15	,	,	PUNCT
ajlm-1432	11	16	cameroon	cameroon	PROPN
ajlm-1432	11	17	.	.	PUNCT
ajlm-1432	12	1	objective	objective	NOUN
ajlm-1432	12	2	:	:	PUNCT
ajlm-1432	12	3	this	this	DET
ajlm-1432	12	4	study	study	NOUN
ajlm-1432	12	5	aimed	aim	VERB
ajlm-1432	12	6	to	to	PART
ajlm-1432	12	7	determine	determine	VERB
ajlm-1432	12	8	the	the	DET
ajlm-1432	12	9	prevalence	prevalence	NOUN
ajlm-1432	12	10	of	of	ADP
ajlm-1432	12	11	haemolysin	haemolysin	NOUN
ajlm-1432	12	12	among	among	ADP
ajlm-1432	12	13	blood	blood	NOUN
ajlm-1432	12	14	group	group	NOUN
ajlm-1432	12	15	‘	'	PUNCT
ajlm-1432	12	16	o	o	NOUN
ajlm-1432	12	17	’	'	PUNCT
ajlm-1432	12	18	donors	donor	NOUN
ajlm-1432	12	19	at	at	ADP
ajlm-1432	12	20	the	the	DET
ajlm-1432	12	21	regional	regional	ADJ
ajlm-1432	12	22	hospital	hospital	NOUN
ajlm-1432	12	23	bamenda	bamenda	NOUN
ajlm-1432	12	24	blood	blood	NOUN
ajlm-1432	12	25	bank	bank	PROPN
ajlm-1432	12	26	,	,	PUNCT
ajlm-1432	12	27	bamenda	bamenda	NOUN
ajlm-1432	12	28	,	,	PUNCT
ajlm-1432	12	29	cameroon	cameroon	PROPN
ajlm-1432	12	30	.	.	PUNCT
ajlm-1432	13	1	methods	method	NOUN
ajlm-1432	13	2	:	:	PUNCT
ajlm-1432	13	3	this	this	PRON
ajlm-1432	13	4	was	be	AUX
ajlm-1432	13	5	a	a	DET
ajlm-1432	13	6	cross	cross	ADJ
ajlm-1432	13	7	-	-	ADJ
ajlm-1432	13	8	sectional	sectional	ADJ
ajlm-1432	13	9	descriptive	descriptive	ADJ
ajlm-1432	13	10	study	study	NOUN
ajlm-1432	13	11	carried	carry	VERB
ajlm-1432	13	12	out	out	ADP
ajlm-1432	13	13	between	between	ADP
ajlm-1432	13	14	june	june	PROPN
ajlm-1432	13	15	and	and	CCONJ
ajlm-1432	13	16	september	september	PROPN
ajlm-1432	13	17	2020	2020	NUM
ajlm-1432	13	18	at	at	ADP
ajlm-1432	13	19	the	the	DET
ajlm-1432	13	20	regional	regional	ADJ
ajlm-1432	13	21	hospital	hospital	NOUN
ajlm-1432	13	22	bamenda	bamenda	NOUN
ajlm-1432	13	23	blood	blood	NOUN
ajlm-1432	13	24	bank	bank	PROPN
ajlm-1432	13	25	,	,	PUNCT
ajlm-1432	13	26	bamenda	bamenda	NOUN
ajlm-1432	13	27	,	,	PUNCT
ajlm-1432	13	28	cameroon	cameroon	NOUN
ajlm-1432	13	29	.	.	PUNCT
ajlm-1432	14	1	blood	blood	NOUN
ajlm-1432	14	2	group	group	NOUN
ajlm-1432	14	3	o	o	NOUN
ajlm-1432	14	4	donors	donor	NOUN
ajlm-1432	14	5	who	who	PRON
ajlm-1432	14	6	were	be	AUX
ajlm-1432	14	7	free	free	ADJ
ajlm-1432	14	8	from	from	ADP
ajlm-1432	14	9	transfusion	transfusion	NOUN
ajlm-1432	14	10	-	-	PUNCT
ajlm-1432	14	11	transmissible	transmissible	ADJ
ajlm-1432	14	12	infections	infection	NOUN
ajlm-1432	14	13	were	be	AUX
ajlm-1432	14	14	selected	select	VERB
ajlm-1432	14	15	systematically	systematically	ADV
ajlm-1432	14	16	and	and	CCONJ
ajlm-1432	14	17	serially	serially	ADV
ajlm-1432	14	18	and	and	CCONJ
ajlm-1432	14	19	their	their	PRON
ajlm-1432	14	20	serum	serum	NOUN
ajlm-1432	14	21	tested	test	VERB
ajlm-1432	14	22	for	for	ADP
ajlm-1432	14	23	the	the	DET
ajlm-1432	14	24	presence	presence	NOUN
ajlm-1432	14	25	of	of	ADP
ajlm-1432	14	26	haemolysin	haemolysin	NOUN
ajlm-1432	14	27	.	.	PUNCT
ajlm-1432	15	1	haemolysin	haemolysin	PROPN
ajlm-1432	15	2	titres	titre	NOUN
ajlm-1432	15	3	were	be	AUX
ajlm-1432	15	4	determined	determine	VERB
ajlm-1432	15	5	,	,	PUNCT
ajlm-1432	15	6	and	and	CCONJ
ajlm-1432	15	7	titres	titre	NOUN
ajlm-1432	15	8	≥	≥	NUM
ajlm-1432	15	9	8	8	NUM
ajlm-1432	15	10	were	be	AUX
ajlm-1432	15	11	considered	consider	VERB
ajlm-1432	15	12	significant	significant	ADJ
ajlm-1432	15	13	.	.	PUNCT
ajlm-1432	16	1	the	the	DET
ajlm-1432	16	2	associations	association	NOUN
ajlm-1432	16	3	between	between	ADP
ajlm-1432	16	4	haemolysin	haemolysin	NOUN
ajlm-1432	16	5	prevalence	prevalence	NOUN
ajlm-1432	16	6	and	and	CCONJ
ajlm-1432	16	7	age	age	NOUN
ajlm-1432	16	8	group	group	NOUN
ajlm-1432	16	9	,	,	PUNCT
ajlm-1432	16	10	gender	gender	NOUN
ajlm-1432	16	11	and	and	CCONJ
ajlm-1432	16	12	rhesus	rhesus	NOUN
ajlm-1432	16	13	d	d	NOUN
ajlm-1432	16	14	blood	blood	NOUN
ajlm-1432	16	15	group	group	NOUN
ajlm-1432	16	16	were	be	AUX
ajlm-1432	16	17	determined	determine	VERB
ajlm-1432	16	18	using	use	VERB
ajlm-1432	16	19	the	the	DET
ajlm-1432	16	20	chi	chi	ADJ
ajlm-1432	16	21	-	-	PUNCT
ajlm-1432	16	22	square	square	ADJ
ajlm-1432	16	23	test	test	NOUN
ajlm-1432	16	24	.	.	PUNCT
ajlm-1432	17	1	results	result	NOUN
ajlm-1432	17	2	:	:	PUNCT
ajlm-1432	17	3	the	the	DET
ajlm-1432	17	4	prevalence	prevalence	NOUN
ajlm-1432	17	5	of	of	ADP
ajlm-1432	17	6	haemolysin	haemolysin	NOUN
ajlm-1432	17	7	among	among	ADP
ajlm-1432	17	8	the	the	DET
ajlm-1432	17	9	480	480	NUM
ajlm-1432	17	10	study	study	NOUN
ajlm-1432	17	11	participants	participant	NOUN
ajlm-1432	17	12	was	be	AUX
ajlm-1432	17	13	52.1	52.1	NUM
ajlm-1432	17	14	%	%	NOUN
ajlm-1432	17	15	and	and	CCONJ
ajlm-1432	17	16	significant	significant	ADJ
ajlm-1432	17	17	haemolysin	haemolysin	NOUN
ajlm-1432	17	18	titres	titre	NOUN
ajlm-1432	17	19	were	be	AUX
ajlm-1432	17	20	detected	detect	VERB
ajlm-1432	17	21	in	in	ADP
ajlm-1432	17	22	18.5	18.5	NUM
ajlm-1432	17	23	%	%	NOUN
ajlm-1432	17	24	.	.	PUNCT
ajlm-1432	18	1	there	there	PRON
ajlm-1432	18	2	was	be	VERB
ajlm-1432	18	3	no	no	DET
ajlm-1432	18	4	association	association	NOUN
ajlm-1432	18	5	between	between	ADP
ajlm-1432	18	6	haemolysin	haemolysin	NOUN
ajlm-1432	18	7	and	and	CCONJ
ajlm-1432	18	8	gender	gender	NOUN
ajlm-1432	18	9	,	,	PUNCT
ajlm-1432	18	10	age	age	NOUN
ajlm-1432	18	11	group	group	NOUN
ajlm-1432	18	12	or	or	CCONJ
ajlm-1432	18	13	the	the	DET
ajlm-1432	18	14	rhesus	rhesus	NOUN
ajlm-1432	18	15	d	d	NOUN
ajlm-1432	18	16	blood	blood	NOUN
ajlm-1432	18	17	group	group	NOUN
ajlm-1432	18	18	.	.	PUNCT
ajlm-1432	19	1	conclusion	conclusion	NOUN
ajlm-1432	19	2	:	:	PUNCT
ajlm-1432	19	3	the	the	DET
ajlm-1432	19	4	prevalence	prevalence	NOUN
ajlm-1432	19	5	of	of	ADP
ajlm-1432	19	6	significant	significant	ADJ
ajlm-1432	19	7	titres	titre	NOUN
ajlm-1432	19	8	of	of	ADP
ajlm-1432	19	9	haemolysin	haemolysin	NOUN
ajlm-1432	19	10	among	among	ADP
ajlm-1432	19	11	participants	participant	NOUN
ajlm-1432	19	12	in	in	ADP
ajlm-1432	19	13	this	this	DET
ajlm-1432	19	14	study	study	NOUN
ajlm-1432	19	15	was	be	AUX
ajlm-1432	19	16	high	high	ADJ
ajlm-1432	19	17	.	.	PUNCT
ajlm-1432	20	1	there	there	PRON
ajlm-1432	20	2	is	be	VERB
ajlm-1432	20	3	the	the	DET
ajlm-1432	20	4	need	need	NOUN
ajlm-1432	20	5	to	to	PART
ajlm-1432	20	6	test	test	VERB
ajlm-1432	20	7	for	for	ADP
ajlm-1432	20	8	haemolysin	haemolysin	NOUN
ajlm-1432	20	9	in	in	ADP
ajlm-1432	20	10	blood	blood	NOUN
ajlm-1432	20	11	group	group	NOUN
ajlm-1432	20	12	o	o	NOUN
ajlm-1432	20	13	donors	donor	NOUN
ajlm-1432	20	14	to	to	PART
ajlm-1432	20	15	prevent	prevent	VERB
ajlm-1432	20	16	the	the	DET
ajlm-1432	20	17	potential	potential	ADJ
ajlm-1432	20	18	risk	risk	NOUN
ajlm-1432	20	19	to	to	ADP
ajlm-1432	20	20	blood	blood	NOUN
ajlm-1432	20	21	group	group	NOUN
ajlm-1432	20	22	a	a	PROPN
ajlm-1432	20	23	,	,	PUNCT
ajlm-1432	20	24	b	b	NOUN
ajlm-1432	20	25	,	,	PUNCT
ajlm-1432	20	26	and	and	CCONJ
ajlm-1432	20	27	ab	ab	PROPN
ajlm-1432	20	28	recipients	recipient	NOUN
ajlm-1432	20	29	and	and	CCONJ
ajlm-1432	20	30	to	to	PART
ajlm-1432	20	31	provide	provide	VERB
ajlm-1432	20	32	safer	safe	ADJ
ajlm-1432	20	33	blood	blood	NOUN
ajlm-1432	20	34	for	for	ADP
ajlm-1432	20	35	transfusion	transfusion	NOUN
ajlm-1432	20	36	.	.	PUNCT
ajlm-1432	21	1	keywords	keyword	NOUN
ajlm-1432	21	2	:	:	PUNCT
ajlm-1432	21	3	prevalence	prevalence	NOUN
ajlm-1432	21	4	;	;	PUNCT
ajlm-1432	21	5	haemolysin	haemolysin	NOUN
ajlm-1432	21	6	;	;	PUNCT
ajlm-1432	21	7	immunoglobulin	immunoglobulin	NOUN
ajlm-1432	21	8	;	;	PUNCT
ajlm-1432	21	9	blood	blood	NOUN
ajlm-1432	21	10	group	group	NOUN
ajlm-1432	21	11	o	o	NOUN
ajlm-1432	21	12	;	;	PUNCT
ajlm-1432	21	13	donors	donor	NOUN
ajlm-1432	21	14	;	;	PUNCT
ajlm-1432	21	15	bamenda	bamenda	NOUN
ajlm-1432	21	16	;	;	PUNCT
ajlm-1432	21	17	cameroon	cameroon	PROPN
ajlm-1432	21	18	.	.	PUNCT
ajlm-1432	22	1	introduction	introduction	NOUN
ajlm-1432	22	2	the	the	DET
ajlm-1432	22	3	occurrence	occurrence	NOUN
ajlm-1432	22	4	of	of	ADP
ajlm-1432	22	5	alpha	alpha	NOUN
ajlm-1432	22	6	(	(	PUNCT
ajlm-1432	22	7	anti	anti	ADJ
ajlm-1432	22	8	-	-	ADJ
ajlm-1432	22	9	a	a	NOUN
ajlm-1432	22	10	)	)	PUNCT
ajlm-1432	22	11	and	and	CCONJ
ajlm-1432	22	12	beta	beta	ADJ
ajlm-1432	22	13	(	(	PUNCT
ajlm-1432	22	14	anti	anti	ADJ
ajlm-1432	22	15	-	-	ADJ
ajlm-1432	22	16	b	b	ADJ
ajlm-1432	22	17	)	)	PUNCT
ajlm-1432	22	18	immunoglobulin	immunoglobulin	NOUN
ajlm-1432	22	19	m	m	PROPN
ajlm-1432	22	20	antibodies	antibodie	VERB
ajlm-1432	22	21	in	in	ADP
ajlm-1432	22	22	the	the	DET
ajlm-1432	22	23	absence	absence	NOUN
ajlm-1432	22	24	of	of	ADP
ajlm-1432	22	25	corresponding	correspond	VERB
ajlm-1432	22	26	red	red	ADJ
ajlm-1432	22	27	blood	blood	NOUN
ajlm-1432	22	28	cell	cell	NOUN
ajlm-1432	22	29	antigens	antigen	NOUN
ajlm-1432	22	30	is	be	AUX
ajlm-1432	22	31	a	a	DET
ajlm-1432	22	32	significant	significant	ADJ
ajlm-1432	22	33	feature	feature	NOUN
ajlm-1432	22	34	of	of	ADP
ajlm-1432	22	35	the	the	DET
ajlm-1432	22	36	abo	abo	NOUN
ajlm-1432	22	37	blood	blood	NOUN
ajlm-1432	22	38	group	group	NOUN
ajlm-1432	22	39	system	system	NOUN
ajlm-1432	22	40	in	in	ADP
ajlm-1432	22	41	individuals.1	individuals.1	NOUN
ajlm-1432	22	42	when	when	SCONJ
ajlm-1432	22	43	blood	blood	NOUN
ajlm-1432	22	44	transfusion	transfusion	NOUN
ajlm-1432	22	45	is	be	AUX
ajlm-1432	22	46	done	do	VERB
ajlm-1432	22	47	without	without	ADP
ajlm-1432	22	48	consideration	consideration	NOUN
ajlm-1432	22	49	for	for	ADP
ajlm-1432	22	50	abo	abo	NOUN
ajlm-1432	22	51	compatibility	compatibility	NOUN
ajlm-1432	22	52	,	,	PUNCT
ajlm-1432	22	53	these	these	PRON
ajlm-1432	22	54	naturally	naturally	ADV
ajlm-1432	22	55	occurring	occur	VERB
ajlm-1432	22	56	antibodies	antibody	NOUN
ajlm-1432	22	57	are	be	AUX
ajlm-1432	22	58	a	a	DET
ajlm-1432	22	59	potential	potential	ADJ
ajlm-1432	22	60	cause	cause	NOUN
ajlm-1432	22	61	of	of	ADP
ajlm-1432	22	62	dangerous	dangerous	ADJ
ajlm-1432	22	63	haemolysis	haemolysis	NOUN
ajlm-1432	22	64	in	in	ADP
ajlm-1432	22	65	recipients.2	recipients.2	NOUN
ajlm-1432	22	66	although	although	SCONJ
ajlm-1432	22	67	these	these	DET
ajlm-1432	22	68	antibodies	antibody	NOUN
ajlm-1432	22	69	react	react	VERB
ajlm-1432	22	70	optimally	optimally	ADV
ajlm-1432	22	71	at	at	ADP
ajlm-1432	22	72	4	4	NUM
ajlm-1432	22	73	°	°	NOUN
ajlm-1432	22	74	c	c	NOUN
ajlm-1432	22	75	,	,	PUNCT
ajlm-1432	22	76	they	they	PRON
ajlm-1432	22	77	may	may	AUX
ajlm-1432	22	78	also	also	ADV
ajlm-1432	22	79	cause	cause	VERB
ajlm-1432	22	80	haemolysis	haemolysis	NOUN
ajlm-1432	22	81	at	at	ADP
ajlm-1432	22	82	37	37	NUM
ajlm-1432	22	83	°	°	NOUN
ajlm-1432	22	84	c	c	NOUN
ajlm-1432	22	85	.	.	PUNCT
ajlm-1432	23	1	also	also	ADV
ajlm-1432	23	2	,	,	PUNCT
ajlm-1432	23	3	some	some	DET
ajlm-1432	23	4	blood	blood	NOUN
ajlm-1432	23	5	group	group	NOUN
ajlm-1432	23	6	o	o	NOUN
ajlm-1432	23	7	,	,	PUNCT
ajlm-1432	23	8	and	and	CCONJ
ajlm-1432	23	9	sometimes	sometimes	ADV
ajlm-1432	23	10	blood	blood	NOUN
ajlm-1432	23	11	group	group	NOUN
ajlm-1432	23	12	a2	a2	PROPN
ajlm-1432	23	13	,	,	PUNCT
ajlm-1432	23	14	individuals	individual	NOUN
ajlm-1432	23	15	may	may	AUX
ajlm-1432	23	16	develop	develop	VERB
ajlm-1432	23	17	alpha	alpha	NOUN
ajlm-1432	23	18	and	and	CCONJ
ajlm-1432	23	19	beta	beta	ADJ
ajlm-1432	23	20	antibodies	antibody	NOUN
ajlm-1432	23	21	of	of	ADP
ajlm-1432	23	22	the	the	DET
ajlm-1432	23	23	immunoglobulin	immunoglobulin	NOUN
ajlm-1432	23	24	g	g	PROPN
ajlm-1432	23	25	class	class	NOUN
ajlm-1432	23	26	that	that	PRON
ajlm-1432	23	27	react	react	VERB
ajlm-1432	23	28	optimally	optimally	ADV
ajlm-1432	23	29	at	at	ADP
ajlm-1432	23	30	37	37	NUM
ajlm-1432	23	31	°	°	NOUN
ajlm-1432	23	32	c	c	NOUN
ajlm-1432	23	33	.	.	PUNCT
ajlm-1432	24	1	these	these	DET
ajlm-1432	24	2	antibodies	antibody	NOUN
ajlm-1432	24	3	are	be	AUX
ajlm-1432	24	4	commonly	commonly	ADV
ajlm-1432	24	5	referred	refer	VERB
ajlm-1432	24	6	to	to	ADP
ajlm-1432	24	7	as	as	ADP
ajlm-1432	24	8	haemolysins	haemolysin	NOUN
ajlm-1432	24	9	and	and	CCONJ
ajlm-1432	24	10	are	be	AUX
ajlm-1432	24	11	more	more	ADV
ajlm-1432	24	12	dangerous	dangerous	ADJ
ajlm-1432	24	13	compared	compare	VERB
ajlm-1432	24	14	to	to	ADP
ajlm-1432	24	15	naturally	naturally	ADV
ajlm-1432	24	16	occurring	occur	VERB
ajlm-1432	24	17	haemolysins.2	haemolysins.2	PROPN
ajlm-1432	24	18	in	in	ADP
ajlm-1432	24	19	cases	case	NOUN
ajlm-1432	24	20	of	of	ADP
ajlm-1432	24	21	non	non	ADJ
ajlm-1432	24	22	-	-	ADJ
ajlm-1432	24	23	iso	iso	ADJ
ajlm-1432	24	24	group	group	NOUN
ajlm-1432	24	25	-	-	PUNCT
ajlm-1432	24	26	compatible	compatible	ADJ
ajlm-1432	24	27	abo	abo	NOUN
ajlm-1432	24	28	transfusion	transfusion	NOUN
ajlm-1432	24	29	,	,	PUNCT
ajlm-1432	24	30	these	these	DET
ajlm-1432	24	31	antibodies	antibody	NOUN
ajlm-1432	24	32	can	can	AUX
ajlm-1432	24	33	trigger	trigger	VERB
ajlm-1432	24	34	the	the	DET
ajlm-1432	24	35	complete	complete	ADJ
ajlm-1432	24	36	complement	complement	NOUN
ajlm-1432	24	37	cascade	cascade	NOUN
ajlm-1432	24	38	,	,	PUNCT
ajlm-1432	24	39	leading	lead	VERB
ajlm-1432	24	40	to	to	ADP
ajlm-1432	24	41	haemolytic	haemolytic	ADJ
ajlm-1432	24	42	reactions.2	reactions.2	ADJ
ajlm-1432	24	43	several	several	ADJ
ajlm-1432	24	44	studies	study	NOUN
ajlm-1432	24	45	have	have	AUX
ajlm-1432	24	46	reported	report	VERB
ajlm-1432	24	47	complications	complication	NOUN
ajlm-1432	24	48	in	in	ADP
ajlm-1432	24	49	patients	patient	NOUN
ajlm-1432	24	50	who	who	PRON
ajlm-1432	24	51	were	be	AUX
ajlm-1432	24	52	transfused	transfuse	VERB
ajlm-1432	24	53	with	with	ADP
ajlm-1432	24	54	non	non	ADJ
ajlm-1432	24	55	-	-	ADJ
ajlm-1432	24	56	identical	identical	ADJ
ajlm-1432	24	57	blood	blood	NOUN
ajlm-1432	24	58	groups	group	NOUN
ajlm-1432	24	59	,	,	PUNCT
ajlm-1432	24	60	including	include	VERB
ajlm-1432	24	61	disseminated	disseminate	VERB
ajlm-1432	24	62	intravascular	intravascular	ADJ
ajlm-1432	24	63	coagulation,3,4	coagulation,3,4	ADJ
ajlm-1432	24	64	hepatic	hepatic	ADJ
ajlm-1432	24	65	and	and	CCONJ
ajlm-1432	24	66	renal	renal	ADJ
ajlm-1432	24	67	failure	failure	NOUN
ajlm-1432	24	68	leading	lead	VERB
ajlm-1432	24	69	to	to	ADP
ajlm-1432	24	70	death,3,5	death,3,5	NOUN
ajlm-1432	24	71	paleness	paleness	NOUN
ajlm-1432	24	72	,	,	PUNCT
ajlm-1432	24	73	jaundice	jaundice	NOUN
ajlm-1432	24	74	,	,	PUNCT
ajlm-1432	24	75	fever	fever	NOUN
ajlm-1432	24	76	,	,	PUNCT
ajlm-1432	24	77	ecchymosis	ecchymosis	NOUN
ajlm-1432	24	78	and	and	CCONJ
ajlm-1432	24	79	generalised	generalise	VERB
ajlm-1432	24	80	exfoliation	exfoliation	NOUN
ajlm-1432	24	81	of	of	ADP
ajlm-1432	24	82	the	the	DET
ajlm-1432	24	83	skin,6	skin,6	ADJ
ajlm-1432	24	84	significant	significant	ADJ
ajlm-1432	24	85	reduction	reduction	NOUN
ajlm-1432	24	86	in	in	ADP
ajlm-1432	24	87	packed	packed	ADJ
ajlm-1432	24	88	cell	cell	NOUN
ajlm-1432	24	89	volume,7	volume,7	ADJ
ajlm-1432	24	90	hyperbilirubinaemia,8	hyperbilirubinaemia,8	NOUN
ajlm-1432	24	91	varying	vary	VERB
ajlm-1432	24	92	degrees	degree	NOUN
ajlm-1432	24	93	of	of	ADP
ajlm-1432	24	94	haemoglobinaemia	haemoglobinaemia	NOUN
ajlm-1432	24	95	,	,	PUNCT
ajlm-1432	24	96	and	and	CCONJ
ajlm-1432	24	97	intravascular	intravascular	ADJ
ajlm-1432	24	98	agglutination.9	agglutination.9	NOUN
ajlm-1432	24	99	several	several	ADJ
ajlm-1432	24	100	studies	study	NOUN
ajlm-1432	24	101	have	have	AUX
ajlm-1432	24	102	advocated	advocate	VERB
ajlm-1432	24	103	that	that	SCONJ
ajlm-1432	24	104	the	the	DET
ajlm-1432	24	105	transfusion	transfusion	NOUN
ajlm-1432	24	106	of	of	ADP
ajlm-1432	24	107	group	group	NOUN
ajlm-1432	24	108	o	o	NOUN
ajlm-1432	24	109	blood	blood	NOUN
ajlm-1432	24	110	to	to	ADP
ajlm-1432	24	111	a	a	DET
ajlm-1432	24	112	,	,	PUNCT
ajlm-1432	24	113	b	b	NOUN
ajlm-1432	24	114	,	,	PUNCT
ajlm-1432	24	115	or	or	CCONJ
ajlm-1432	24	116	ab	ab	PROPN
ajlm-1432	24	117	recipients	recipient	NOUN
ajlm-1432	24	118	be	be	AUX
ajlm-1432	24	119	discontinued	discontinue	VERB
ajlm-1432	24	120	due	due	ADP
ajlm-1432	24	121	to	to	ADP
ajlm-1432	24	122	the	the	DET
ajlm-1432	24	123	high	high	ADJ
ajlm-1432	24	124	prevalence	prevalence	NOUN
ajlm-1432	24	125	of	of	ADP
ajlm-1432	24	126	alpha	alpha	NOUN
ajlm-1432	24	127	and	and	CCONJ
ajlm-1432	24	128	beta	beta	ADJ
ajlm-1432	24	129	haemolysins	haemolysin	NOUN
ajlm-1432	24	130	among	among	ADP
ajlm-1432	24	131	blood	blood	NOUN
ajlm-1432	24	132	group	group	NOUN
ajlm-1432	24	133	o	o	PROPN
ajlm-1432	24	134	donors.10,11,12	donors.10,11,12	PROPN
ajlm-1432	24	135	despite	despite	SCONJ
ajlm-1432	24	136	this	this	DET
ajlm-1432	24	137	concern	concern	NOUN
ajlm-1432	24	138	,	,	PUNCT
ajlm-1432	24	139	the	the	DET
ajlm-1432	24	140	practice	practice	NOUN
ajlm-1432	24	141	is	be	AUX
ajlm-1432	24	142	yet	yet	ADV
ajlm-1432	24	143	to	to	PART
ajlm-1432	24	144	be	be	AUX
ajlm-1432	24	145	discontinued	discontinue	VERB
ajlm-1432	24	146	.	.	PUNCT
ajlm-1432	25	1	several	several	ADJ
ajlm-1432	25	2	studies	study	NOUN
ajlm-1432	25	3	have	have	AUX
ajlm-1432	25	4	postulated	postulate	VERB
ajlm-1432	25	5	that	that	SCONJ
ajlm-1432	25	6	these	these	DET
ajlm-1432	25	7	alpha	alpha	NOUN
ajlm-1432	25	8	and	and	CCONJ
ajlm-1432	25	9	beta	beta	ADJ
ajlm-1432	25	10	antibodies	antibody	NOUN
ajlm-1432	25	11	originated	originate	VERB
ajlm-1432	25	12	as	as	ADP
ajlm-1432	25	13	products	product	NOUN
ajlm-1432	25	14	of	of	ADP
ajlm-1432	25	15	immunisation	immunisation	NOUN
ajlm-1432	25	16	from	from	ADP
ajlm-1432	25	17	allogenic	allogenic	ADJ
ajlm-1432	25	18	stimulation	stimulation	NOUN
ajlm-1432	25	19	(	(	PUNCT
ajlm-1432	25	20	due	due	ADP
ajlm-1432	25	21	to	to	PART
ajlm-1432	25	22	transfer	transfer	VERB
ajlm-1432	25	23	of	of	ADP
ajlm-1432	25	24	antigen	antigen	NOUN
ajlm-1432	25	25	by	by	ADP
ajlm-1432	25	26	red	red	ADJ
ajlm-1432	25	27	cells	cell	NOUN
ajlm-1432	25	28	from	from	ADP
ajlm-1432	25	29	pregnancy	pregnancy	NOUN
ajlm-1432	25	30	with	with	ADP
ajlm-1432	25	31	an	an	DET
ajlm-1432	25	32	abo	abo	NOUN
ajlm-1432	25	33	-	-	PUNCT
ajlm-1432	25	34	incompatible	incompatible	ADJ
ajlm-1432	25	35	foetus	foetus	NOUN
ajlm-1432	25	36	,	,	PUNCT
ajlm-1432	25	37	incompatible	incompatible	ADJ
ajlm-1432	25	38	blood	blood	NOUN
ajlm-1432	25	39	transfusion	transfusion	NOUN
ajlm-1432	25	40	,	,	PUNCT
ajlm-1432	25	41	tissue	tissue	NOUN
ajlm-1432	25	42	transplant	transplant	NOUN
ajlm-1432	25	43	,	,	PUNCT
ajlm-1432	25	44	etc	etc	X
ajlm-1432	25	45	.	.	X
ajlm-1432	25	46	)	)	PUNCT
ajlm-1432	25	47	and	and	CCONJ
ajlm-1432	25	48	heterogeneous	heterogeneous	ADJ
ajlm-1432	25	49	stimulation	stimulation	NOUN
ajlm-1432	25	50	(	(	PUNCT
ajlm-1432	25	51	due	due	ADP
ajlm-1432	25	52	to	to	ADP
ajlm-1432	25	53	vaccination	vaccination	NOUN
ajlm-1432	25	54	,	,	PUNCT
ajlm-1432	25	55	serotherapy	serotherapy	NOUN
ajlm-1432	25	56	,	,	PUNCT
ajlm-1432	25	57	and	and	CCONJ
ajlm-1432	25	58	inoculation	inoculation	NOUN
ajlm-1432	25	59	from	from	ADP
ajlm-1432	25	60	vectors	vector	NOUN
ajlm-1432	25	61	such	such	ADJ
ajlm-1432	25	62	as	as	ADP
ajlm-1432	25	63	blood	blood	NOUN
ajlm-1432	25	64	-	-	PUNCT
ajlm-1432	25	65	sucking	suck	VERB
ajlm-1432	25	66	insects	insect	NOUN
ajlm-1432	25	67	and	and	CCONJ
ajlm-1432	25	68	certain	certain	ADJ
ajlm-1432	25	69	pharmaceutical	pharmaceutical	ADJ
ajlm-1432	25	70	preparations	preparation	NOUN
ajlm-1432	25	71	contaminated	contaminate	VERB
ajlm-1432	25	72	with	with	ADP
ajlm-1432	25	73	alphaand	alphaand	NOUN
ajlm-1432	25	74	beta	beta	NOUN
ajlm-1432	25	75	-	-	PUNCT
ajlm-1432	25	76	like	like	ADJ
ajlm-1432	25	77	antigens	antigen	NOUN
ajlm-1432	25	78	,	,	PUNCT
ajlm-1432	25	79	etc.).13,14,15	etc.).13,14,15	X
ajlm-1432	25	80	due	due	ADP
ajlm-1432	25	81	to	to	ADP
ajlm-1432	25	82	the	the	DET
ajlm-1432	25	83	high	high	ADJ
ajlm-1432	25	84	demand	demand	NOUN
ajlm-1432	25	85	for	for	ADP
ajlm-1432	25	86	and	and	CCONJ
ajlm-1432	25	87	shortage	shortage	NOUN
ajlm-1432	25	88	of	of	ADP
ajlm-1432	25	89	allogenic	allogenic	ADJ
ajlm-1432	25	90	blood	blood	NOUN
ajlm-1432	25	91	in	in	ADP
ajlm-1432	25	92	most	most	ADJ
ajlm-1432	25	93	developing	develop	VERB
ajlm-1432	25	94	countries	country	NOUN
ajlm-1432	25	95	,	,	PUNCT
ajlm-1432	25	96	including	include	VERB
ajlm-1432	25	97	cameroon	cameroon	NOUN
ajlm-1432	25	98	,	,	PUNCT
ajlm-1432	25	99	as	as	ADV
ajlm-1432	25	100	well	well	ADV
ajlm-1432	25	101	as	as	ADP
ajlm-1432	25	102	the	the	DET
ajlm-1432	25	103	relative	relative	ADJ
ajlm-1432	25	104	difficulty	difficulty	NOUN
ajlm-1432	25	105	in	in	ADP
ajlm-1432	25	106	getting	get	VERB
ajlm-1432	25	107	abo	abo	NOUN
ajlm-1432	25	108	group	group	NOUN
ajlm-1432	25	109	-	-	PUNCT
ajlm-1432	25	110	compatible	compatible	ADJ
ajlm-1432	25	111	blood	blood	NOUN
ajlm-1432	25	112	during	during	ADP
ajlm-1432	25	113	emergencies	emergency	NOUN
ajlm-1432	25	114	,	,	PUNCT
ajlm-1432	25	115	blood	blood	NOUN
ajlm-1432	25	116	group	group	NOUN
ajlm-1432	25	117	o	o	PROPN
ajlm-1432	25	118	,	,	PUNCT
ajlm-1432	25	119	which	which	PRON
ajlm-1432	25	120	is	be	AUX
ajlm-1432	25	121	often	often	ADV
ajlm-1432	25	122	inappropriately	inappropriately	ADV
ajlm-1432	25	123	referred	refer	VERB
ajlm-1432	25	124	to	to	ADP
ajlm-1432	25	125	as	as	ADP
ajlm-1432	25	126	the	the	DET
ajlm-1432	25	127	‘	'	PUNCT
ajlm-1432	25	128	universal	universal	ADJ
ajlm-1432	25	129	blood	blood	NOUN
ajlm-1432	25	130	donor	donor	NOUN
ajlm-1432	25	131	’	'	PUNCT
ajlm-1432	25	132	,	,	PUNCT
ajlm-1432	25	133	has	have	AUX
ajlm-1432	25	134	been	be	AUX
ajlm-1432	25	135	increasingly	increasingly	ADV
ajlm-1432	25	136	transfused	transfuse	VERB
ajlm-1432	25	137	to	to	ADP
ajlm-1432	25	138	non	non	ADJ
ajlm-1432	25	139	-	-	NOUN
ajlm-1432	25	140	group	group	ADJ
ajlm-1432	25	141	o	o	PROPN
ajlm-1432	25	142	recipients.16	recipients.16	PROPN
ajlm-1432	25	143	besides	besides	SCONJ
ajlm-1432	25	144	,	,	PUNCT
ajlm-1432	25	145	there	there	PRON
ajlm-1432	25	146	is	be	VERB
ajlm-1432	25	147	evidence	evidence	NOUN
ajlm-1432	25	148	that	that	SCONJ
ajlm-1432	25	149	blood	blood	NOUN
ajlm-1432	25	150	group	group	NOUN
ajlm-1432	25	151	o	o	NOUN
ajlm-1432	25	152	is	be	AUX
ajlm-1432	25	153	the	the	DET
ajlm-1432	25	154	most	most	ADV
ajlm-1432	25	155	abundant	abundant	ADJ
ajlm-1432	25	156	group	group	NOUN
ajlm-1432	25	157	in	in	ADP
ajlm-1432	25	158	the	the	DET
ajlm-1432	25	159	abo	abo	NOUN
ajlm-1432	25	160	blood	blood	NOUN
ajlm-1432	25	161	system	system	NOUN
ajlm-1432	25	162	,	,	PUNCT
ajlm-1432	25	163	with	with	ADP
ajlm-1432	25	164	a	a	DET
ajlm-1432	25	165	prevalence	prevalence	NOUN
ajlm-1432	25	166	of	of	ADP
ajlm-1432	25	167	51.1	51.1	NUM
ajlm-1432	25	168	%	%	NOUN
ajlm-1432	25	169	reported	report	VERB
ajlm-1432	25	170	in	in	ADP
ajlm-1432	25	171	a	a	DET
ajlm-1432	25	172	study	study	NOUN
ajlm-1432	25	173	in	in	ADP
ajlm-1432	25	174	cameroon.17	cameroon.17	PROPN
ajlm-1432	25	175	blood	blood	NOUN
ajlm-1432	25	176	transfusion	transfusion	NOUN
ajlm-1432	25	177	is	be	AUX
ajlm-1432	25	178	an	an	DET
ajlm-1432	25	179	essential	essential	ADJ
ajlm-1432	25	180	medical	medical	ADJ
ajlm-1432	25	181	practice	practice	NOUN
ajlm-1432	25	182	that	that	SCONJ
ajlm-1432	25	183	replenishes	replenishe	NOUN
ajlm-1432	25	184	lost	lose	VERB
ajlm-1432	25	185	blood	blood	NOUN
ajlm-1432	25	186	or	or	CCONJ
ajlm-1432	25	187	blood	blood	NOUN
ajlm-1432	25	188	products	product	NOUN
ajlm-1432	25	189	in	in	ADP
ajlm-1432	25	190	the	the	DET
ajlm-1432	25	191	recipient	recipient	NOUN
ajlm-1432	25	192	.	.	PUNCT
ajlm-1432	26	1	the	the	DET
ajlm-1432	26	2	transfused	transfused	ADJ
ajlm-1432	26	3	blood	blood	NOUN
ajlm-1432	26	4	should	should	AUX
ajlm-1432	26	5	be	be	AUX
ajlm-1432	26	6	as	as	ADV
ajlm-1432	26	7	safe	safe	ADJ
ajlm-1432	26	8	as	as	ADP
ajlm-1432	26	9	possible	possible	ADJ
ajlm-1432	26	10	to	to	PART
ajlm-1432	26	11	ensure	ensure	VERB
ajlm-1432	26	12	maximum	maximum	ADJ
ajlm-1432	26	13	benefit	benefit	NOUN
ajlm-1432	26	14	to	to	ADP
ajlm-1432	26	15	the	the	DET
ajlm-1432	26	16	recipients	recipient	NOUN
ajlm-1432	26	17	.	.	PUNCT
ajlm-1432	27	1	thus	thus	ADV
ajlm-1432	27	2	,	,	PUNCT
ajlm-1432	27	3	there	there	PRON
ajlm-1432	27	4	is	be	VERB
ajlm-1432	27	5	the	the	DET
ajlm-1432	27	6	need	need	NOUN
ajlm-1432	27	7	to	to	PART
ajlm-1432	27	8	strictly	strictly	ADV
ajlm-1432	27	9	adhere	adhere	VERB
ajlm-1432	27	10	to	to	ADP
ajlm-1432	27	11	standard	standard	ADJ
ajlm-1432	27	12	screening	screen	VERB
ajlm-1432	27	13	protocols	protocol	NOUN
ajlm-1432	27	14	to	to	PART
ajlm-1432	27	15	achieve	achieve	VERB
ajlm-1432	27	16	safe	safe	ADJ
ajlm-1432	27	17	blood	blood	NOUN
ajlm-1432	27	18	transfusion	transfusion	NOUN
ajlm-1432	27	19	.	.	PUNCT
ajlm-1432	28	1	unfortunately	unfortunately	ADV
ajlm-1432	28	2	,	,	PUNCT
ajlm-1432	28	3	this	this	DET
ajlm-1432	28	4	practice	practice	NOUN
ajlm-1432	28	5	is	be	AUX
ajlm-1432	28	6	limited	limit	VERB
ajlm-1432	28	7	in	in	ADP
ajlm-1432	28	8	the	the	DET
ajlm-1432	28	9	developing	develop	VERB
ajlm-1432	28	10	world	world	NOUN
ajlm-1432	28	11	due	due	ADP
ajlm-1432	28	12	to	to	ADP
ajlm-1432	28	13	inefficient	inefficient	ADJ
ajlm-1432	28	14	blood	blood	NOUN
ajlm-1432	28	15	banking	banking	NOUN
ajlm-1432	28	16	systems	system	NOUN
ajlm-1432	28	17	and	and	CCONJ
ajlm-1432	28	18	scarcity	scarcity	NOUN
ajlm-1432	28	19	of	of	ADP
ajlm-1432	28	20	screening	screen	VERB
ajlm-1432	28	21	facilities	facility	NOUN
ajlm-1432	28	22	.	.	PUNCT
ajlm-1432	29	1	besides	besides	SCONJ
ajlm-1432	29	2	,	,	PUNCT
ajlm-1432	29	3	the	the	DET
ajlm-1432	29	4	standard	standard	ADJ
ajlm-1432	29	5	protocol	protocol	NOUN
ajlm-1432	29	6	for	for	ADP
ajlm-1432	29	7	compatibility	compatibility	NOUN
ajlm-1432	29	8	testing	testing	NOUN
ajlm-1432	29	9	to	to	PART
ajlm-1432	29	10	ensure	ensure	VERB
ajlm-1432	29	11	safe	safe	ADJ
ajlm-1432	29	12	blood	blood	NOUN
ajlm-1432	29	13	has	have	AUX
ajlm-1432	29	14	been	be	AUX
ajlm-1432	29	15	omitted	omit	VERB
ajlm-1432	29	16	or	or	CCONJ
ajlm-1432	29	17	abbreviated	abbreviate	VERB
ajlm-1432	29	18	by	by	ADP
ajlm-1432	29	19	many	many	ADJ
ajlm-1432	29	20	screening	screening	NOUN
ajlm-1432	29	21	services	service	NOUN
ajlm-1432	29	22	.	.	PUNCT
ajlm-1432	30	1	this	this	DET
ajlm-1432	30	2	standard	standard	ADJ
ajlm-1432	30	3	compatibility	compatibility	NOUN
ajlm-1432	30	4	testing	testing	NOUN
ajlm-1432	30	5	protocol18	protocol18	NOUN
ajlm-1432	30	6	requires	require	VERB
ajlm-1432	30	7	that	that	SCONJ
ajlm-1432	30	8	all	all	DET
ajlm-1432	30	9	group	group	NOUN
ajlm-1432	30	10	o	o	NOUN
ajlm-1432	30	11	blood	blood	NOUN
ajlm-1432	30	12	intended	intend	VERB
ajlm-1432	30	13	for	for	ADP
ajlm-1432	30	14	transfusion	transfusion	NOUN
ajlm-1432	30	15	to	to	ADP
ajlm-1432	30	16	group	group	PROPN
ajlm-1432	30	17	a	a	PROPN
ajlm-1432	30	18	,	,	PUNCT
ajlm-1432	30	19	b	b	NOUN
ajlm-1432	30	20	,	,	PUNCT
ajlm-1432	30	21	or	or	CCONJ
ajlm-1432	30	22	ab	ab	PROPN
ajlm-1432	30	23	recipients	recipient	NOUN
ajlm-1432	30	24	should	should	AUX
ajlm-1432	30	25	be	be	AUX
ajlm-1432	30	26	screened	screen	VERB
ajlm-1432	30	27	for	for	ADP
ajlm-1432	30	28	the	the	DET
ajlm-1432	30	29	presence	presence	NOUN
ajlm-1432	30	30	of	of	ADP
ajlm-1432	30	31	high	high	ADJ
ajlm-1432	30	32	titres	titre	NOUN
ajlm-1432	30	33	of	of	ADP
ajlm-1432	30	34	alpha	alpha	NOUN
ajlm-1432	30	35	and	and	CCONJ
ajlm-1432	30	36	beta	beta	NOUN
ajlm-1432	30	37	haemolysins	haemolysin	NOUN
ajlm-1432	30	38	and	and	CCONJ
ajlm-1432	30	39	that	that	SCONJ
ajlm-1432	30	40	only	only	ADV
ajlm-1432	30	41	haemolysin	haemolysin	NOUN
ajlm-1432	30	42	-	-	PUNCT
ajlm-1432	30	43	free	free	ADJ
ajlm-1432	30	44	blood	blood	NOUN
ajlm-1432	30	45	should	should	AUX
ajlm-1432	30	46	be	be	AUX
ajlm-1432	30	47	reserved	reserve	VERB
ajlm-1432	30	48	for	for	ADP
ajlm-1432	30	49	blood	blood	NOUN
ajlm-1432	30	50	group	group	NOUN
ajlm-1432	30	51	a	a	PROPN
ajlm-1432	30	52	,	,	PUNCT
ajlm-1432	30	53	b	b	NOUN
ajlm-1432	30	54	,	,	PUNCT
ajlm-1432	30	55	or	or	CCONJ
ajlm-1432	30	56	ab	ab	PROPN
ajlm-1432	30	57	recipients	recipient	NOUN
ajlm-1432	30	58	,	,	PUNCT
ajlm-1432	30	59	while	while	SCONJ
ajlm-1432	30	60	haemolysin	haemolysin	NOUN
ajlm-1432	30	61	-	-	PUNCT
ajlm-1432	30	62	positive	positive	ADJ
ajlm-1432	30	63	blood	blood	NOUN
ajlm-1432	30	64	should	should	AUX
ajlm-1432	30	65	be	be	AUX
ajlm-1432	30	66	reserved	reserve	VERB
ajlm-1432	30	67	for	for	ADP
ajlm-1432	30	68	group	group	NOUN
ajlm-1432	30	69	o	o	NOUN
ajlm-1432	30	70	recipients	recipient	NOUN
ajlm-1432	30	71	only.13	only.13	VERB
ajlm-1432	30	72	several	several	ADJ
ajlm-1432	30	73	countries	country	NOUN
ajlm-1432	30	74	,	,	PUNCT
ajlm-1432	30	75	including	include	VERB
ajlm-1432	30	76	côte	côte	PROPN
ajlm-1432	30	77	d’ivoire	d’ivoire	NOUN
ajlm-1432	30	78	,	,	PUNCT
ajlm-1432	30	79	have	have	AUX
ajlm-1432	30	80	included	include	VERB
ajlm-1432	30	81	a	a	DET
ajlm-1432	30	82	haemolysin	haemolysin	NOUN
ajlm-1432	30	83	test	test	NOUN
ajlm-1432	30	84	as	as	ADP
ajlm-1432	30	85	part	part	NOUN
ajlm-1432	30	86	of	of	ADP
ajlm-1432	30	87	the	the	DET
ajlm-1432	30	88	standard	standard	ADJ
ajlm-1432	30	89	protocol	protocol	NOUN
ajlm-1432	30	90	in	in	ADP
ajlm-1432	30	91	their	their	PRON
ajlm-1432	30	92	national	national	ADJ
ajlm-1432	30	93	blood	blood	NOUN
ajlm-1432	30	94	transfusion	transfusion	NOUN
ajlm-1432	30	95	programmes.18	programmes.18	ADV
ajlm-1432	30	96	surprisingly	surprisingly	ADV
ajlm-1432	30	97	,	,	PUNCT
ajlm-1432	30	98	this	this	DET
ajlm-1432	30	99	practice	practice	NOUN
ajlm-1432	30	100	is	be	AUX
ajlm-1432	30	101	yet	yet	ADV
ajlm-1432	30	102	to	to	PART
ajlm-1432	30	103	be	be	AUX
ajlm-1432	30	104	implemented	implement	VERB
ajlm-1432	30	105	in	in	ADP
ajlm-1432	30	106	blood	blood	NOUN
ajlm-1432	30	107	bank	bank	NOUN
ajlm-1432	30	108	facilities	facility	NOUN
ajlm-1432	30	109	in	in	ADP
ajlm-1432	30	110	bamenda	bamenda	NOUN
ajlm-1432	30	111	or	or	CCONJ
ajlm-1432	30	112	cameroon	cameroon	NOUN
ajlm-1432	30	113	in	in	ADP
ajlm-1432	30	114	general	general	ADJ
ajlm-1432	30	115	.	.	PUNCT
ajlm-1432	31	1	hence	hence	ADV
ajlm-1432	31	2	,	,	PUNCT
ajlm-1432	31	3	this	this	DET
ajlm-1432	31	4	study	study	NOUN
ajlm-1432	31	5	aimed	aim	VERB
ajlm-1432	31	6	to	to	PART
ajlm-1432	31	7	determine	determine	VERB
ajlm-1432	31	8	and	and	CCONJ
ajlm-1432	31	9	demonstrate	demonstrate	VERB
ajlm-1432	31	10	the	the	DET
ajlm-1432	31	11	presence	presence	NOUN
ajlm-1432	31	12	of	of	ADP
ajlm-1432	31	13	significant	significant	ADJ
ajlm-1432	31	14	titres	titre	NOUN
ajlm-1432	31	15	of	of	ADP
ajlm-1432	31	16	alpha	alpha	NOUN
ajlm-1432	31	17	and	and	CCONJ
ajlm-1432	31	18	beta	beta	NOUN
ajlm-1432	31	19	haemolysins	haemolysin	NOUN
ajlm-1432	31	20	among	among	ADP
ajlm-1432	31	21	blood	blood	NOUN
ajlm-1432	31	22	group	group	NOUN
ajlm-1432	31	23	o	o	NOUN
ajlm-1432	31	24	donors	donor	NOUN
ajlm-1432	31	25	at	at	ADP
ajlm-1432	31	26	the	the	DET
ajlm-1432	31	27	regional	regional	ADJ
ajlm-1432	31	28	hospital	hospital	NOUN
ajlm-1432	31	29	bamenda	bamenda	NOUN
ajlm-1432	31	30	blood	blood	NOUN
ajlm-1432	31	31	bank	bank	PROPN
ajlm-1432	31	32	(	(	PUNCT
ajlm-1432	31	33	rhbbb	rhbbb	NOUN
ajlm-1432	31	34	)	)	PUNCT
ajlm-1432	31	35	,	,	PUNCT
ajlm-1432	31	36	bamenda	bamenda	NOUN
ajlm-1432	31	37	,	,	PUNCT
ajlm-1432	31	38	cameroon	cameroon	NOUN
ajlm-1432	31	39	,	,	PUNCT
ajlm-1432	31	40	to	to	PART
ajlm-1432	31	41	guide	guide	VERB
ajlm-1432	31	42	the	the	DET
ajlm-1432	31	43	implementation	implementation	NOUN
ajlm-1432	31	44	of	of	ADP
ajlm-1432	31	45	a	a	DET
ajlm-1432	31	46	policy	policy	NOUN
ajlm-1432	31	47	to	to	PART
ajlm-1432	31	48	include	include	VERB
ajlm-1432	31	49	haemolysin	haemolysin	NOUN
ajlm-1432	31	50	testing	testing	NOUN
ajlm-1432	31	51	in	in	ADP
ajlm-1432	31	52	the	the	DET
ajlm-1432	31	53	protocol	protocol	NOUN
ajlm-1432	31	54	for	for	ADP
ajlm-1432	31	55	compatibility	compatibility	NOUN
ajlm-1432	31	56	testing	testing	NOUN
ajlm-1432	31	57	in	in	ADP
ajlm-1432	31	58	cameroon	cameroon	NOUN
ajlm-1432	31	59	.	.	PUNCT
ajlm-1432	32	1	methods	method	NOUN
ajlm-1432	32	2	ethical	ethical	ADJ
ajlm-1432	32	3	considerations	consideration	NOUN
ajlm-1432	32	4	administrative	administrative	ADJ
ajlm-1432	32	5	authorisation	authorisation	NOUN
ajlm-1432	32	6	to	to	PART
ajlm-1432	32	7	carry	carry	VERB
ajlm-1432	32	8	out	out	ADP
ajlm-1432	32	9	this	this	DET
ajlm-1432	32	10	work	work	NOUN
ajlm-1432	32	11	was	be	AUX
ajlm-1432	32	12	provided	provide	VERB
ajlm-1432	32	13	by	by	ADP
ajlm-1432	32	14	the	the	DET
ajlm-1432	32	15	catholic	catholic	PROPN
ajlm-1432	32	16	university	university	PROPN
ajlm-1432	32	17	of	of	ADP
ajlm-1432	32	18	cameroon	cameroon	PROPN
ajlm-1432	32	19	,	,	PUNCT
ajlm-1432	32	20	bamenda	bamenda	NOUN
ajlm-1432	32	21	,	,	PUNCT
ajlm-1432	32	22	north	north	NOUN
ajlm-1432	32	23	-	-	PUNCT
ajlm-1432	32	24	west	west	NOUN
ajlm-1432	32	25	regional	regional	ADJ
ajlm-1432	32	26	delegation	delegation	NOUN
ajlm-1432	32	27	of	of	ADP
ajlm-1432	32	28	public	public	ADJ
ajlm-1432	32	29	health	health	NOUN
ajlm-1432	32	30	,	,	PUNCT
ajlm-1432	32	31	bamenda	bamenda	NOUN
ajlm-1432	32	32	,	,	PUNCT
ajlm-1432	32	33	and	and	CCONJ
ajlm-1432	32	34	regional	regional	ADJ
ajlm-1432	32	35	hospital	hospital	NOUN
ajlm-1432	32	36	bamenda	bamenda	NOUN
ajlm-1432	32	37	.	.	PUNCT
ajlm-1432	33	1	ethical	ethical	ADJ
ajlm-1432	33	2	clearance	clearance	NOUN
ajlm-1432	33	3	was	be	AUX
ajlm-1432	33	4	provided	provide	VERB
ajlm-1432	33	5	by	by	ADP
ajlm-1432	33	6	the	the	DET
ajlm-1432	33	7	institutional	institutional	ADJ
ajlm-1432	33	8	review	review	PROPN
ajlm-1432	33	9	board	board	NOUN
ajlm-1432	33	10	of	of	ADP
ajlm-1432	33	11	the	the	DET
ajlm-1432	33	12	regional	regional	ADJ
ajlm-1432	33	13	hospital	hospital	NOUN
ajlm-1432	33	14	bamenda	bamenda	NOUN
ajlm-1432	33	15	(	(	PUNCT
ajlm-1432	33	16	irb	irb	VERB
ajlm-1432	33	17	number	number	NOUN
ajlm-1432	33	18	:	:	PUNCT
ajlm-1432	33	19	211	211	NUM
ajlm-1432	33	20	/	/	SYM
ajlm-1432	33	21	app	app	PROPN
ajlm-1432	33	22	/	/	SYM
ajlm-1432	33	23	rdph	rdph	ADJ
ajlm-1432	33	24	/	/	SYM
ajlm-1432	33	25	rhb	rhb	PROPN
ajlm-1432	33	26	/	/	SYM
ajlm-1432	33	27	irb	irb	PROPN
ajlm-1432	33	28	)	)	PUNCT
ajlm-1432	33	29	.	.	PUNCT
ajlm-1432	34	1	participants	participant	NOUN
ajlm-1432	34	2	provided	provide	VERB
ajlm-1432	34	3	written	write	VERB
ajlm-1432	34	4	informed	inform	VERB
ajlm-1432	34	5	consent	consent	NOUN
ajlm-1432	34	6	and	and	CCONJ
ajlm-1432	34	7	were	be	AUX
ajlm-1432	34	8	free	free	ADJ
ajlm-1432	34	9	to	to	PART
ajlm-1432	34	10	withdraw	withdraw	VERB
ajlm-1432	34	11	from	from	ADP
ajlm-1432	34	12	the	the	DET
ajlm-1432	34	13	study	study	NOUN
ajlm-1432	34	14	at	at	ADP
ajlm-1432	34	15	any	any	DET
ajlm-1432	34	16	time	time	NOUN
ajlm-1432	34	17	.	.	PUNCT
ajlm-1432	35	1	the	the	DET
ajlm-1432	35	2	participants	participant	NOUN
ajlm-1432	35	3	’	'	PUNCT
ajlm-1432	35	4	data	datum	NOUN
ajlm-1432	35	5	were	be	AUX
ajlm-1432	35	6	coded	code	VERB
ajlm-1432	35	7	by	by	ADP
ajlm-1432	35	8	assigning	assign	VERB
ajlm-1432	35	9	numbers	number	NOUN
ajlm-1432	35	10	to	to	PART
ajlm-1432	35	11	identify	identify	VERB
ajlm-1432	35	12	the	the	DET
ajlm-1432	35	13	participants	participant	NOUN
ajlm-1432	35	14	instead	instead	ADV
ajlm-1432	35	15	of	of	ADP
ajlm-1432	35	16	names	name	NOUN
ajlm-1432	35	17	.	.	PUNCT
ajlm-1432	36	1	the	the	DET
ajlm-1432	36	2	anonymity	anonymity	NOUN
ajlm-1432	36	3	of	of	ADP
ajlm-1432	36	4	participants	participant	NOUN
ajlm-1432	36	5	and	and	CCONJ
ajlm-1432	36	6	their	their	PRON
ajlm-1432	36	7	data	datum	NOUN
ajlm-1432	36	8	were	be	AUX
ajlm-1432	36	9	ensured	ensure	VERB
ajlm-1432	36	10	by	by	ADP
ajlm-1432	36	11	storing	store	VERB
ajlm-1432	36	12	the	the	DET
ajlm-1432	36	13	data	datum	NOUN
ajlm-1432	36	14	on	on	ADP
ajlm-1432	36	15	password	password	NOUN
ajlm-1432	36	16	-	-	PUNCT
ajlm-1432	36	17	protected	protect	VERB
ajlm-1432	36	18	computers	computer	NOUN
ajlm-1432	36	19	and	and	CCONJ
ajlm-1432	36	20	in	in	ADP
ajlm-1432	36	21	locked	locked	ADJ
ajlm-1432	36	22	file	file	NOUN
ajlm-1432	36	23	cabinets	cabinet	NOUN
ajlm-1432	36	24	accessible	accessible	ADJ
ajlm-1432	36	25	only	only	ADV
ajlm-1432	36	26	to	to	ADP
ajlm-1432	36	27	the	the	DET
ajlm-1432	36	28	study	study	NOUN
ajlm-1432	36	29	staff	staff	NOUN
ajlm-1432	36	30	and	and	CCONJ
ajlm-1432	36	31	researchers	researcher	NOUN
ajlm-1432	36	32	.	.	PUNCT
ajlm-1432	37	1	study	study	NOUN
ajlm-1432	37	2	area	area	NOUN
ajlm-1432	37	3	this	this	DET
ajlm-1432	37	4	research	research	NOUN
ajlm-1432	37	5	was	be	AUX
ajlm-1432	37	6	carried	carry	VERB
ajlm-1432	37	7	out	out	ADP
ajlm-1432	37	8	in	in	ADP
ajlm-1432	37	9	bamenda	bamenda	NOUN
ajlm-1432	37	10	at	at	ADP
ajlm-1432	37	11	the	the	DET
ajlm-1432	37	12	rhbbb	rhbbb	NOUN
ajlm-1432	37	13	,	,	PUNCT
ajlm-1432	37	14	bamenda	bamenda	NOUN
ajlm-1432	37	15	,	,	PUNCT
ajlm-1432	37	16	a	a	DET
ajlm-1432	37	17	unit	unit	NOUN
ajlm-1432	37	18	at	at	ADP
ajlm-1432	37	19	the	the	DET
ajlm-1432	37	20	regional	regional	ADJ
ajlm-1432	37	21	hospital	hospital	NOUN
ajlm-1432	37	22	bamenda	bamenda	NOUN
ajlm-1432	37	23	.	.	PUNCT
ajlm-1432	38	1	the	the	DET
ajlm-1432	38	2	rhbbb	rhbbb	NOUN
ajlm-1432	38	3	receives	receive	VERB
ajlm-1432	38	4	approximately	approximately	ADV
ajlm-1432	38	5	5400	5400	NUM
ajlm-1432	38	6	blood	blood	NOUN
ajlm-1432	38	7	donors	donor	NOUN
ajlm-1432	38	8	and	and	CCONJ
ajlm-1432	38	9	issues	issue	NOUN
ajlm-1432	38	10	about	about	ADP
ajlm-1432	38	11	4200	4200	NUM
ajlm-1432	38	12	safe	safe	ADJ
ajlm-1432	38	13	pints	pint	NOUN
ajlm-1432	38	14	of	of	ADP
ajlm-1432	38	15	blood	blood	NOUN
ajlm-1432	38	16	yearly	yearly	ADV
ajlm-1432	38	17	.	.	PUNCT
ajlm-1432	39	1	it	it	PRON
ajlm-1432	39	2	has	have	VERB
ajlm-1432	39	3	a	a	DET
ajlm-1432	39	4	standard	standard	ADJ
ajlm-1432	39	5	blood	blood	NOUN
ajlm-1432	39	6	transfusion	transfusion	NOUN
ajlm-1432	39	7	service	service	NOUN
ajlm-1432	39	8	and	and	CCONJ
ajlm-1432	39	9	is	be	AUX
ajlm-1432	39	10	enrolled	enrol	VERB
ajlm-1432	39	11	in	in	ADP
ajlm-1432	39	12	a	a	DET
ajlm-1432	39	13	certification	certification	NOUN
ajlm-1432	39	14	programme	programme	NOUN
ajlm-1432	39	15	with	with	ADP
ajlm-1432	39	16	the	the	DET
ajlm-1432	39	17	safe	safe	ADJ
ajlm-1432	39	18	blood	blood	NOUN
ajlm-1432	39	19	for	for	ADP
ajlm-1432	39	20	africa	africa	PROPN
ajlm-1432	39	21	foundation	foundation	PROPN
ajlm-1432	39	22	.	.	PUNCT
ajlm-1432	40	1	it	it	PRON
ajlm-1432	40	2	is	be	AUX
ajlm-1432	40	3	also	also	ADV
ajlm-1432	40	4	the	the	DET
ajlm-1432	40	5	largest	large	ADJ
ajlm-1432	40	6	blood	blood	NOUN
ajlm-1432	40	7	transfusion	transfusion	NOUN
ajlm-1432	40	8	centre	centre	NOUN
ajlm-1432	40	9	in	in	ADP
ajlm-1432	40	10	the	the	DET
ajlm-1432	40	11	north	north	NOUN
ajlm-1432	40	12	-	-	PUNCT
ajlm-1432	40	13	west	west	NOUN
ajlm-1432	40	14	region	region	NOUN
ajlm-1432	40	15	and	and	CCONJ
ajlm-1432	40	16	provides	provide	VERB
ajlm-1432	40	17	transfusion	transfusion	NOUN
ajlm-1432	40	18	services	service	NOUN
ajlm-1432	40	19	to	to	ADP
ajlm-1432	40	20	the	the	DET
ajlm-1432	40	21	region	region	NOUN
ajlm-1432	40	22	and	and	CCONJ
ajlm-1432	40	23	beyond	beyond	ADP
ajlm-1432	40	24	.	.	PUNCT
ajlm-1432	41	1	research	research	NOUN
ajlm-1432	41	2	design	design	NOUN
ajlm-1432	41	3	this	this	PRON
ajlm-1432	41	4	was	be	AUX
ajlm-1432	41	5	a	a	DET
ajlm-1432	41	6	descriptive	descriptive	ADJ
ajlm-1432	41	7	,	,	PUNCT
ajlm-1432	41	8	cross	cross	ADJ
ajlm-1432	41	9	-	-	ADJ
ajlm-1432	41	10	sectional	sectional	ADJ
ajlm-1432	41	11	study	study	NOUN
ajlm-1432	41	12	conducted	conduct	VERB
ajlm-1432	41	13	between	between	ADP
ajlm-1432	41	14	june	june	PROPN
ajlm-1432	41	15	2020	2020	NUM
ajlm-1432	41	16	and	and	CCONJ
ajlm-1432	41	17	september	september	PROPN
ajlm-1432	41	18	2020	2020	NUM
ajlm-1432	41	19	at	at	ADP
ajlm-1432	41	20	the	the	DET
ajlm-1432	41	21	rhbbb	rhbbb	NOUN
ajlm-1432	41	22	.	.	PUNCT
ajlm-1432	42	1	the	the	DET
ajlm-1432	42	2	sample	sample	NOUN
ajlm-1432	42	3	size	size	NOUN
ajlm-1432	42	4	was	be	AUX
ajlm-1432	42	5	calculated	calculate	VERB
ajlm-1432	42	6	based	base	VERB
ajlm-1432	42	7	on	on	ADP
ajlm-1432	42	8	a	a	DET
ajlm-1432	42	9	previous	previous	ADJ
ajlm-1432	42	10	study	study	NOUN
ajlm-1432	42	11	conducted	conduct	VERB
ajlm-1432	42	12	in	in	ADP
ajlm-1432	42	13	2011	2011	NUM
ajlm-1432	42	14	in	in	ADP
ajlm-1432	42	15	eastern	eastern	ADJ
ajlm-1432	42	16	nigeria16	nigeria16	NOUN
ajlm-1432	42	17	that	that	PRON
ajlm-1432	42	18	reported	report	VERB
ajlm-1432	42	19	an	an	DET
ajlm-1432	42	20	overall	overall	ADJ
ajlm-1432	42	21	haemolysin	haemolysin	NOUN
ajlm-1432	42	22	prevalence	prevalence	NOUN
ajlm-1432	42	23	of	of	ADP
ajlm-1432	42	24	55.4	55.4	NUM
ajlm-1432	42	25	%	%	NOUN
ajlm-1432	42	26	.	.	PUNCT
ajlm-1432	43	1	a	a	DET
ajlm-1432	43	2	minimum	minimum	NOUN
ajlm-1432	43	3	of	of	ADP
ajlm-1432	43	4	385	385	NUM
ajlm-1432	43	5	participants	participant	NOUN
ajlm-1432	43	6	was	be	AUX
ajlm-1432	43	7	required	require	VERB
ajlm-1432	43	8	for	for	ADP
ajlm-1432	43	9	this	this	DET
ajlm-1432	43	10	study	study	NOUN
ajlm-1432	43	11	.	.	PUNCT
ajlm-1432	44	1	blood	blood	NOUN
ajlm-1432	44	2	donors	donor	NOUN
ajlm-1432	44	3	arriving	arrive	VERB
ajlm-1432	44	4	at	at	ADP
ajlm-1432	44	5	the	the	DET
ajlm-1432	44	6	reception	reception	NOUN
ajlm-1432	44	7	area	area	NOUN
ajlm-1432	44	8	of	of	ADP
ajlm-1432	44	9	the	the	DET
ajlm-1432	44	10	rhbbb	rhbbb	NOUN
ajlm-1432	44	11	undergo	undergo	VERB
ajlm-1432	44	12	routine	routine	ADJ
ajlm-1432	44	13	screening	screening	NOUN
ajlm-1432	44	14	to	to	PART
ajlm-1432	44	15	determine	determine	VERB
ajlm-1432	44	16	physical	physical	ADJ
ajlm-1432	44	17	fitness	fitness	NOUN
ajlm-1432	44	18	to	to	PART
ajlm-1432	44	19	donate	donate	VERB
ajlm-1432	44	20	blood	blood	NOUN
ajlm-1432	44	21	using	use	VERB
ajlm-1432	44	22	a	a	DET
ajlm-1432	44	23	standard	standard	ADJ
ajlm-1432	44	24	questionnaire	questionnaire	NOUN
ajlm-1432	44	25	validated	validate	VERB
ajlm-1432	44	26	and	and	CCONJ
ajlm-1432	44	27	provided	provide	VERB
ajlm-1432	44	28	by	by	ADP
ajlm-1432	44	29	the	the	DET
ajlm-1432	44	30	rhbbb	rhbbb	ADJ
ajlm-1432	44	31	quality	quality	NOUN
ajlm-1432	44	32	team	team	NOUN
ajlm-1432	44	33	.	.	PUNCT
ajlm-1432	45	1	this	this	DET
ajlm-1432	45	2	routine	routine	ADJ
ajlm-1432	45	3	screening	screening	NOUN
ajlm-1432	45	4	selects	select	VERB
ajlm-1432	45	5	individuals	individual	NOUN
ajlm-1432	45	6	who	who	PRON
ajlm-1432	45	7	had	have	AUX
ajlm-1432	45	8	not	not	PART
ajlm-1432	45	9	donated	donate	VERB
ajlm-1432	45	10	blood	blood	NOUN
ajlm-1432	45	11	and	and	CCONJ
ajlm-1432	45	12	had	have	VERB
ajlm-1432	45	13	no	no	DET
ajlm-1432	45	14	history	history	NOUN
ajlm-1432	45	15	of	of	ADP
ajlm-1432	45	16	sexually	sexually	ADV
ajlm-1432	45	17	transmitted	transmit	VERB
ajlm-1432	45	18	diseases	disease	NOUN
ajlm-1432	45	19	in	in	ADP
ajlm-1432	45	20	the	the	DET
ajlm-1432	45	21	three	three	NUM
ajlm-1432	45	22	months	month	NOUN
ajlm-1432	45	23	preceding	precede	VERB
ajlm-1432	45	24	the	the	DET
ajlm-1432	45	25	blood	blood	NOUN
ajlm-1432	45	26	donation	donation	NOUN
ajlm-1432	45	27	,	,	PUNCT
ajlm-1432	45	28	were	be	AUX
ajlm-1432	45	29	free	free	ADJ
ajlm-1432	45	30	from	from	ADP
ajlm-1432	45	31	non	non	ADJ
ajlm-1432	45	32	-	-	ADJ
ajlm-1432	45	33	communicable	communicable	ADJ
ajlm-1432	45	34	diseases	disease	NOUN
ajlm-1432	45	35	such	such	ADJ
ajlm-1432	45	36	as	as	ADP
ajlm-1432	45	37	diabetes	diabetes	NOUN
ajlm-1432	45	38	and	and	CCONJ
ajlm-1432	45	39	hypertension	hypertension	NOUN
ajlm-1432	45	40	,	,	PUNCT
ajlm-1432	45	41	had	have	AUX
ajlm-1432	45	42	not	not	PART
ajlm-1432	45	43	been	be	AUX
ajlm-1432	45	44	vaccinated	vaccinate	VERB
ajlm-1432	45	45	in	in	ADP
ajlm-1432	45	46	the	the	DET
ajlm-1432	45	47	last	last	ADJ
ajlm-1432	45	48	four	four	NUM
ajlm-1432	45	49	months	month	NOUN
ajlm-1432	45	50	,	,	PUNCT
ajlm-1432	45	51	had	have	AUX
ajlm-1432	45	52	not	not	PART
ajlm-1432	45	53	taken	take	VERB
ajlm-1432	45	54	medication	medication	NOUN
ajlm-1432	45	55	for	for	ADP
ajlm-1432	45	56	at	at	ADV
ajlm-1432	45	57	least	least	ADV
ajlm-1432	45	58	one	one	NUM
ajlm-1432	45	59	week	week	NOUN
ajlm-1432	45	60	,	,	PUNCT
ajlm-1432	45	61	and	and	CCONJ
ajlm-1432	45	62	had	have	AUX
ajlm-1432	45	63	not	not	PART
ajlm-1432	45	64	smoked	smoke	VERB
ajlm-1432	45	65	on	on	ADP
ajlm-1432	45	66	the	the	DET
ajlm-1432	45	67	day	day	NOUN
ajlm-1432	45	68	of	of	ADP
ajlm-1432	45	69	the	the	DET
ajlm-1432	45	70	donation	donation	NOUN
ajlm-1432	45	71	or	or	CCONJ
ajlm-1432	45	72	taken	take	VERB
ajlm-1432	45	73	alcohol	alcohol	NOUN
ajlm-1432	45	74	in	in	ADP
ajlm-1432	45	75	the	the	DET
ajlm-1432	45	76	last	last	ADJ
ajlm-1432	45	77	24	24	NUM
ajlm-1432	45	78	h.	h.	NOUN
ajlm-1432	45	79	women	woman	NOUN
ajlm-1432	45	80	who	who	PRON
ajlm-1432	45	81	were	be	AUX
ajlm-1432	45	82	pregnant	pregnant	ADJ
ajlm-1432	45	83	,	,	PUNCT
ajlm-1432	45	84	breastfeeding	breastfeeding	NOUN
ajlm-1432	45	85	,	,	PUNCT
ajlm-1432	45	86	or	or	CCONJ
ajlm-1432	45	87	menstruating	menstruate	VERB
ajlm-1432	45	88	or	or	CCONJ
ajlm-1432	45	89	expecting	expect	VERB
ajlm-1432	45	90	their	their	PRON
ajlm-1432	45	91	menses	mense	NOUN
ajlm-1432	45	92	within	within	ADP
ajlm-1432	45	93	one	one	NUM
ajlm-1432	45	94	week	week	NOUN
ajlm-1432	45	95	were	be	AUX
ajlm-1432	45	96	excluded	exclude	VERB
ajlm-1432	45	97	.	.	PUNCT
ajlm-1432	46	1	in	in	ADP
ajlm-1432	46	2	addition	addition	NOUN
ajlm-1432	46	3	,	,	PUNCT
ajlm-1432	46	4	only	only	ADV
ajlm-1432	46	5	donors	donor	NOUN
ajlm-1432	46	6	who	who	PRON
ajlm-1432	46	7	weighed	weigh	VERB
ajlm-1432	46	8	greater	great	ADJ
ajlm-1432	46	9	than	than	ADP
ajlm-1432	46	10	50	50	NUM
ajlm-1432	46	11	kg	kg	NOUN
ajlm-1432	46	12	,	,	PUNCT
ajlm-1432	46	13	were	be	AUX
ajlm-1432	46	14	between	between	ADP
ajlm-1432	46	15	the	the	DET
ajlm-1432	46	16	ages	age	NOUN
ajlm-1432	46	17	of	of	ADP
ajlm-1432	46	18	18	18	NUM
ajlm-1432	46	19	and	and	CCONJ
ajlm-1432	46	20	60	60	NUM
ajlm-1432	46	21	years	year	NOUN
ajlm-1432	46	22	(	(	PUNCT
ajlm-1432	46	23	women	woman	NOUN
ajlm-1432	46	24	)	)	PUNCT
ajlm-1432	46	25	or	or	CCONJ
ajlm-1432	46	26	18	18	NUM
ajlm-1432	46	27	and	and	CCONJ
ajlm-1432	46	28	65	65	NUM
ajlm-1432	46	29	years	year	NOUN
ajlm-1432	46	30	(	(	PUNCT
ajlm-1432	46	31	men	man	NOUN
ajlm-1432	46	32	)	)	PUNCT
ajlm-1432	46	33	and	and	CCONJ
ajlm-1432	46	34	had	have	VERB
ajlm-1432	46	35	blood	blood	NOUN
ajlm-1432	46	36	pressures	pressure	NOUN
ajlm-1432	46	37	between	between	ADP
ajlm-1432	46	38	100	100	NUM
ajlm-1432	46	39	mmhg	mmhg	NOUN
ajlm-1432	46	40	and	and	CCONJ
ajlm-1432	46	41	140	140	NUM
ajlm-1432	46	42	mmhg	mmhg	NOUN
ajlm-1432	46	43	over	over	ADP
ajlm-1432	46	44	60	60	NUM
ajlm-1432	46	45	mmhg	mmhg	NOUN
ajlm-1432	46	46	–	–	PUNCT
ajlm-1432	46	47	100	100	NUM
ajlm-1432	46	48	mmhg	mmhg	NOUN
ajlm-1432	46	49	and	and	CCONJ
ajlm-1432	46	50	temperatures	temperature	NOUN
ajlm-1432	46	51	between	between	ADP
ajlm-1432	46	52	36	36	NUM
ajlm-1432	46	53	°	°	NOUN
ajlm-1432	46	54	c	c	NOUN
ajlm-1432	46	55	and	and	CCONJ
ajlm-1432	46	56	37.5	37.5	NUM
ajlm-1432	46	57	°	°	NUM
ajlm-1432	46	58	c	c	NOUN
ajlm-1432	46	59	were	be	AUX
ajlm-1432	46	60	endorsed	endorse	VERB
ajlm-1432	46	61	as	as	ADP
ajlm-1432	46	62	fit	fit	ADJ
ajlm-1432	46	63	for	for	ADP
ajlm-1432	46	64	blood	blood	NOUN
ajlm-1432	46	65	donation	donation	NOUN
ajlm-1432	46	66	.	.	PUNCT
ajlm-1432	47	1	as	as	ADP
ajlm-1432	47	2	part	part	NOUN
ajlm-1432	47	3	of	of	ADP
ajlm-1432	47	4	the	the	DET
ajlm-1432	47	5	routine	routine	ADJ
ajlm-1432	47	6	protocol	protocol	NOUN
ajlm-1432	47	7	for	for	ADP
ajlm-1432	47	8	screening	screen	VERB
ajlm-1432	47	9	donors	donor	NOUN
ajlm-1432	47	10	to	to	PART
ajlm-1432	47	11	obtain	obtain	VERB
ajlm-1432	47	12	safe	safe	ADJ
ajlm-1432	47	13	blood	blood	NOUN
ajlm-1432	47	14	in	in	ADP
ajlm-1432	47	15	the	the	DET
ajlm-1432	47	16	blood	blood	NOUN
ajlm-1432	47	17	bank	bank	NOUN
ajlm-1432	47	18	,	,	PUNCT
ajlm-1432	47	19	abo	abo	NOUN
ajlm-1432	47	20	and	and	CCONJ
ajlm-1432	47	21	rhesus	rhesus	NOUN
ajlm-1432	47	22	d	d	NOUN
ajlm-1432	47	23	blood	blood	NOUN
ajlm-1432	47	24	group	group	NOUN
ajlm-1432	47	25	tests	test	NOUN
ajlm-1432	47	26	and	and	CCONJ
ajlm-1432	47	27	transfusion	transfusion	NOUN
ajlm-1432	47	28	transmittable	transmittable	ADJ
ajlm-1432	47	29	infection	infection	NOUN
ajlm-1432	47	30	(	(	PUNCT
ajlm-1432	47	31	tti	tti	PROPN
ajlm-1432	47	32	)	)	PUNCT
ajlm-1432	47	33	tests	test	NOUN
ajlm-1432	47	34	were	be	AUX
ajlm-1432	47	35	done	do	VERB
ajlm-1432	47	36	on	on	ADP
ajlm-1432	47	37	samples	sample	NOUN
ajlm-1432	47	38	from	from	ADP
ajlm-1432	47	39	all	all	DET
ajlm-1432	47	40	donors	donor	NOUN
ajlm-1432	47	41	.	.	PUNCT
ajlm-1432	48	1	abo	abo	VERB
ajlm-1432	48	2	and	and	CCONJ
ajlm-1432	48	3	rhesus	rhesus	NOUN
ajlm-1432	48	4	blood	blood	NOUN
ajlm-1432	48	5	groups	group	NOUN
ajlm-1432	48	6	were	be	AUX
ajlm-1432	48	7	determined	determine	VERB
ajlm-1432	48	8	using	use	VERB
ajlm-1432	48	9	the	the	DET
ajlm-1432	48	10	procedure	procedure	NOUN
ajlm-1432	48	11	described	describe	VERB
ajlm-1432	48	12	by	by	ADP
ajlm-1432	48	13	dacie	dacie	NOUN
ajlm-1432	48	14	and	and	CCONJ
ajlm-1432	48	15	lewis19	lewis19	VERB
ajlm-1432	48	16	using	use	VERB
ajlm-1432	48	17	the	the	DET
ajlm-1432	48	18	blood	blood	NOUN
ajlm-1432	48	19	in	in	ADP
ajlm-1432	48	20	the	the	DET
ajlm-1432	48	21	ethylenediaminetetraacetic	ethylenediaminetetraacetic	ADJ
ajlm-1432	48	22	acid	acid	NOUN
ajlm-1432	48	23	tube	tube	NOUN
ajlm-1432	48	24	.	.	PUNCT
ajlm-1432	49	1	the	the	DET
ajlm-1432	49	2	tti	tti	PROPN
ajlm-1432	49	3	test	test	NOUN
ajlm-1432	49	4	was	be	AUX
ajlm-1432	49	5	done	do	VERB
ajlm-1432	49	6	using	use	VERB
ajlm-1432	49	7	the	the	DET
ajlm-1432	49	8	blood	blood	NOUN
ajlm-1432	49	9	in	in	ADP
ajlm-1432	49	10	the	the	DET
ajlm-1432	49	11	plain	plain	ADJ
ajlm-1432	49	12	tube	tube	NOUN
ajlm-1432	49	13	.	.	PUNCT
ajlm-1432	50	1	tti	tti	PROPN
ajlm-1432	50	2	testing	testing	NOUN
ajlm-1432	50	3	included	include	VERB
ajlm-1432	50	4	the	the	DET
ajlm-1432	50	5	following	following	NOUN
ajlm-1432	50	6	:	:	PUNCT
ajlm-1432	50	7	hiv	hiv	PROPN
ajlm-1432	50	8	test	test	NOUN
ajlm-1432	50	9	using	use	VERB
ajlm-1432	50	10	the	the	DET
ajlm-1432	50	11	hiv-1/2	hiv-1/2	PROPN
ajlm-1432	50	12	ag	ag	PROPN
ajlm-1432	50	13	/	/	SYM
ajlm-1432	50	14	ab	ab	PROPN
ajlm-1432	50	15	combo	combo	PROPN
ajlm-1432	50	16	determine	determine	NOUN
ajlm-1432	50	17	(	(	PUNCT
ajlm-1432	50	18	alere	alere	PROPN
ajlm-1432	50	19	medical	medical	PROPN
ajlm-1432	50	20	co.	co.	PROPN
ajlm-1432	50	21	,	,	PUNCT
ajlm-1432	50	22	ltd	ltd	PROPN
ajlm-1432	50	23	,	,	PUNCT
ajlm-1432	50	24	matsuhidai	matsuhidai	PROPN
ajlm-1432	50	25	,	,	PUNCT
ajlm-1432	50	26	matsudo	matsudo	NOUN
ajlm-1432	50	27	-	-	PUNCT
ajlm-1432	50	28	shi	shi	PROPN
ajlm-1432	50	29	,	,	PUNCT
ajlm-1432	50	30	chiba	chiba	PROPN
ajlm-1432	50	31	-	-	PUNCT
ajlm-1432	50	32	ken	ken	PROPN
ajlm-1432	50	33	,	,	PUNCT
ajlm-1432	50	34	japan	japan	PROPN
ajlm-1432	50	35	)	)	PUNCT
ajlm-1432	50	36	as	as	ADP
ajlm-1432	50	37	the	the	DET
ajlm-1432	50	38	first	first	ADJ
ajlm-1432	50	39	-	-	PUNCT
ajlm-1432	50	40	line	line	NOUN
ajlm-1432	50	41	test	test	NOUN
ajlm-1432	50	42	and	and	CCONJ
ajlm-1432	50	43	oraquick	oraquick	NOUN
ajlm-1432	50	44	(	(	PUNCT
ajlm-1432	50	45	orasure	orasure	NOUN
ajlm-1432	50	46	technologies	technology	NOUN
ajlm-1432	50	47	,	,	PUNCT
ajlm-1432	50	48	inc	inc	PROPN
ajlm-1432	50	49	.	.	PROPN
ajlm-1432	50	50	,	,	PUNCT
ajlm-1432	50	51	bethlehem	bethlehem	PROPN
ajlm-1432	50	52	,	,	PUNCT
ajlm-1432	50	53	pennsylvania	pennsylvania	PROPN
ajlm-1432	50	54	,	,	PUNCT
ajlm-1432	50	55	united	united	PROPN
ajlm-1432	50	56	states	states	PROPN
ajlm-1432	50	57	)	)	PUNCT
ajlm-1432	50	58	as	as	ADP
ajlm-1432	50	59	the	the	DET
ajlm-1432	50	60	second	second	ADJ
ajlm-1432	50	61	-	-	PUNCT
ajlm-1432	50	62	line	line	NOUN
ajlm-1432	50	63	test	test	NOUN
ajlm-1432	50	64	;	;	PUNCT
ajlm-1432	50	65	hepatitis	hepatitis	PROPN
ajlm-1432	50	66	b	b	PROPN
ajlm-1432	50	67	and	and	CCONJ
ajlm-1432	50	68	hepatitis	hepatitis	PROPN
ajlm-1432	50	69	c	c	PROPN
ajlm-1432	50	70	virus	virus	NOUN
ajlm-1432	50	71	tests	test	NOUN
ajlm-1432	50	72	using	use	VERB
ajlm-1432	50	73	the	the	DET
ajlm-1432	50	74	diaspot	diaspot	NOUN
ajlm-1432	50	75	diagnostic	diagnostic	ADJ
ajlm-1432	50	76	kit	kit	NOUN
ajlm-1432	50	77	(	(	PUNCT
ajlm-1432	50	78	diaspot	diaspot	NOUN
ajlm-1432	50	79	diagnostics	diagnostic	NOUN
ajlm-1432	50	80	,	,	PUNCT
ajlm-1432	50	81	jawa	jawa	PROPN
ajlm-1432	50	82	barat	barat	PROPN
ajlm-1432	50	83	,	,	PUNCT
ajlm-1432	50	84	indonesia	indonesia	PROPN
ajlm-1432	50	85	)	)	PUNCT
ajlm-1432	50	86	;	;	PUNCT
ajlm-1432	51	1	syphilis	syphili	NOUN
ajlm-1432	51	2	test	test	NOUN
ajlm-1432	51	3	using	use	VERB
ajlm-1432	51	4	the	the	DET
ajlm-1432	51	5	rapid	rapid	ADJ
ajlm-1432	51	6	plasma	plasma	NOUN
ajlm-1432	51	7	reagin	reagin	NOUN
ajlm-1432	51	8	(	(	PUNCT
ajlm-1432	51	9	rpr)-carbon	rpr)-carbon	ADJ
ajlm-1432	51	10	slide	slide	NOUN
ajlm-1432	51	11	agglutination	agglutination	NOUN
ajlm-1432	51	12	assay	assay	PROPN
ajlm-1432	51	13	(	(	PUNCT
ajlm-1432	51	14	cypress	cypress	NOUN
ajlm-1432	51	15	diagnostics	diagnostic	NOUN
ajlm-1432	51	16	,	,	PUNCT
ajlm-1432	51	17	langdorp	langdorp	PROPN
ajlm-1432	51	18	,	,	PUNCT
ajlm-1432	51	19	belgium	belgium	NOUN
ajlm-1432	51	20	)	)	PUNCT
ajlm-1432	51	21	and	and	CCONJ
ajlm-1432	51	22	treponema	treponema	VERB
ajlm-1432	51	23	pallidum	pallidum	NOUN
ajlm-1432	51	24	haemagglutination	haemagglutination	NOUN
ajlm-1432	51	25	assay	assay	NOUN
ajlm-1432	51	26	(	(	PUNCT
ajlm-1432	51	27	omega	omega	NOUN
ajlm-1432	51	28	diagnostic	diagnostic	PROPN
ajlm-1432	51	29	,	,	PUNCT
ajlm-1432	51	30	alva	alva	PROPN
ajlm-1432	51	31	,	,	PUNCT
ajlm-1432	51	32	scotland	scotland	PROPN
ajlm-1432	51	33	,	,	PUNCT
ajlm-1432	51	34	united	united	ADJ
ajlm-1432	51	35	kingdom	kingdom	PROPN
ajlm-1432	51	36	)	)	PUNCT
ajlm-1432	51	37	;	;	PUNCT
ajlm-1432	51	38	and	and	CCONJ
ajlm-1432	51	39	malaria	malaria	NOUN
ajlm-1432	51	40	test	test	NOUN
ajlm-1432	51	41	using	use	VERB
ajlm-1432	51	42	the	the	DET
ajlm-1432	51	43	carestartth	carestartth	ADJ
ajlm-1432	51	44	malaria	malaria	NOUN
ajlm-1432	51	45	pf	pf	PROPN
ajlm-1432	51	46	/	/	SYM
ajlm-1432	51	47	pan	pan	PROPN
ajlm-1432	51	48	(	(	PUNCT
ajlm-1432	51	49	hrp2	hrp2	PROPN
ajlm-1432	51	50	/	/	SYM
ajlm-1432	51	51	pldh)ag	pldh)ag	ADV
ajlm-1432	51	52	combo	combo	NOUN
ajlm-1432	51	53	rdt	rdt	PROPN
ajlm-1432	51	54	(	(	PUNCT
ajlm-1432	51	55	accessbio	accessbio	PROPN
ajlm-1432	51	56	,	,	PUNCT
ajlm-1432	51	57	somerset	somerset	PROPN
ajlm-1432	51	58	,	,	PUNCT
ajlm-1432	51	59	new	new	PROPN
ajlm-1432	51	60	jersey	jersey	PROPN
ajlm-1432	51	61	,	,	PUNCT
ajlm-1432	51	62	united	united	PROPN
ajlm-1432	51	63	states	states	PROPN
ajlm-1432	51	64	)	)	PUNCT
ajlm-1432	51	65	.	.	PUNCT
ajlm-1432	52	1	as	as	ADP
ajlm-1432	52	2	part	part	NOUN
ajlm-1432	52	3	of	of	ADP
ajlm-1432	52	4	the	the	DET
ajlm-1432	52	5	donation	donation	NOUN
ajlm-1432	52	6	process	process	NOUN
ajlm-1432	52	7	,	,	PUNCT
ajlm-1432	52	8	blood	blood	NOUN
ajlm-1432	52	9	samples	sample	NOUN
ajlm-1432	52	10	were	be	AUX
ajlm-1432	52	11	collected	collect	VERB
ajlm-1432	52	12	into	into	ADP
ajlm-1432	52	13	two	two	NUM
ajlm-1432	52	14	tubes	tube	NOUN
ajlm-1432	52	15	–	–	PUNCT
ajlm-1432	52	16	one	one	NUM
ajlm-1432	52	17	in	in	ADP
ajlm-1432	52	18	a	a	DET
ajlm-1432	52	19	plain	plain	ADJ
ajlm-1432	52	20	tube	tube	NOUN
ajlm-1432	52	21	and	and	CCONJ
ajlm-1432	52	22	the	the	DET
ajlm-1432	52	23	other	other	ADJ
ajlm-1432	52	24	in	in	ADP
ajlm-1432	52	25	an	an	DET
ajlm-1432	52	26	ethylenediaminetetraacetic	ethylenediaminetetraacetic	ADJ
ajlm-1432	52	27	acid	acid	NOUN
ajlm-1432	52	28	tube	tube	NOUN
ajlm-1432	52	29	from	from	ADP
ajlm-1432	52	30	donors	donor	NOUN
ajlm-1432	52	31	already	already	ADV
ajlm-1432	52	32	screened	screen	VERB
ajlm-1432	52	33	using	use	VERB
ajlm-1432	52	34	the	the	DET
ajlm-1432	52	35	questionnaire	questionnaire	NOUN
ajlm-1432	52	36	as	as	ADP
ajlm-1432	52	37	fit	fit	ADJ
ajlm-1432	52	38	for	for	ADP
ajlm-1432	52	39	blood	blood	NOUN
ajlm-1432	52	40	donation	donation	NOUN
ajlm-1432	52	41	.	.	PUNCT
ajlm-1432	53	1	the	the	DET
ajlm-1432	53	2	screened	screen	VERB
ajlm-1432	53	3	donors	donor	NOUN
ajlm-1432	53	4	were	be	AUX
ajlm-1432	53	5	systematically	systematically	ADV
ajlm-1432	53	6	and	and	CCONJ
ajlm-1432	53	7	serially	serially	ADV
ajlm-1432	53	8	contacted	contact	VERB
ajlm-1432	53	9	to	to	PART
ajlm-1432	53	10	participate	participate	VERB
ajlm-1432	53	11	in	in	ADP
ajlm-1432	53	12	the	the	DET
ajlm-1432	53	13	study	study	NOUN
ajlm-1432	53	14	.	.	PUNCT
ajlm-1432	54	1	only	only	ADV
ajlm-1432	54	2	donors	donor	NOUN
ajlm-1432	54	3	who	who	PRON
ajlm-1432	54	4	were	be	AUX
ajlm-1432	54	5	blood	blood	NOUN
ajlm-1432	54	6	group	group	NOUN
ajlm-1432	54	7	o	o	NOUN
ajlm-1432	54	8	,	,	PUNCT
ajlm-1432	54	9	free	free	ADJ
ajlm-1432	54	10	from	from	ADP
ajlm-1432	54	11	all	all	DET
ajlm-1432	54	12	the	the	DET
ajlm-1432	54	13	ttis	ttis	NOUN
ajlm-1432	54	14	,	,	PUNCT
ajlm-1432	54	15	and	and	CCONJ
ajlm-1432	54	16	who	who	PRON
ajlm-1432	54	17	consented	consent	VERB
ajlm-1432	54	18	to	to	PART
ajlm-1432	54	19	be	be	AUX
ajlm-1432	54	20	part	part	NOUN
ajlm-1432	54	21	of	of	ADP
ajlm-1432	54	22	the	the	DET
ajlm-1432	54	23	study	study	NOUN
ajlm-1432	54	24	were	be	AUX
ajlm-1432	54	25	included	include	VERB
ajlm-1432	54	26	.	.	PUNCT
ajlm-1432	55	1	a	a	DET
ajlm-1432	55	2	standard	standard	ADJ
ajlm-1432	55	3	data	data	NOUN
ajlm-1432	55	4	collection	collection	NOUN
ajlm-1432	55	5	format	format	NOUN
ajlm-1432	55	6	was	be	AUX
ajlm-1432	55	7	used	use	VERB
ajlm-1432	55	8	to	to	PART
ajlm-1432	55	9	collect	collect	VERB
ajlm-1432	55	10	information	information	NOUN
ajlm-1432	55	11	on	on	ADP
ajlm-1432	55	12	the	the	DET
ajlm-1432	55	13	age	age	NOUN
ajlm-1432	55	14	,	,	PUNCT
ajlm-1432	55	15	blood	blood	NOUN
ajlm-1432	55	16	groups	group	NOUN
ajlm-1432	55	17	and	and	CCONJ
ajlm-1432	55	18	gender	gender	NOUN
ajlm-1432	55	19	of	of	ADP
ajlm-1432	55	20	the	the	DET
ajlm-1432	55	21	study	study	NOUN
ajlm-1432	55	22	participants	participant	NOUN
ajlm-1432	55	23	.	.	PUNCT
ajlm-1432	56	1	haemolysin	haemolysin	PROPN
ajlm-1432	56	2	test	test	PROPN
ajlm-1432	56	3	and	and	CCONJ
ajlm-1432	56	4	titration	titration	NOUN
ajlm-1432	56	5	blood	blood	NOUN
ajlm-1432	56	6	specimens	specimen	NOUN
ajlm-1432	56	7	collected	collect	VERB
ajlm-1432	56	8	in	in	ADP
ajlm-1432	56	9	the	the	DET
ajlm-1432	56	10	plain	plain	ADJ
ajlm-1432	56	11	tubes	tube	NOUN
ajlm-1432	56	12	(	(	PUNCT
ajlm-1432	56	13	used	use	VERB
ajlm-1432	56	14	for	for	ADP
ajlm-1432	56	15	tti	tti	PROPN
ajlm-1432	56	16	screening	screening	NOUN
ajlm-1432	56	17	)	)	PUNCT
ajlm-1432	56	18	were	be	AUX
ajlm-1432	56	19	used	use	VERB
ajlm-1432	56	20	to	to	PART
ajlm-1432	56	21	determine	determine	VERB
ajlm-1432	56	22	haemolysin	haemolysin	NOUN
ajlm-1432	56	23	titres	titre	NOUN
ajlm-1432	56	24	within	within	ADP
ajlm-1432	56	25	24	24	NUM
ajlm-1432	56	26	h	h	NOUN
ajlm-1432	56	27	of	of	ADP
ajlm-1432	56	28	specimen	speciman	NOUN
ajlm-1432	56	29	collection	collection	NOUN
ajlm-1432	56	30	.	.	PUNCT
ajlm-1432	57	1	briefly	briefly	ADV
ajlm-1432	57	2	,	,	PUNCT
ajlm-1432	57	3	the	the	DET
ajlm-1432	57	4	sample	sample	NOUN
ajlm-1432	57	5	was	be	AUX
ajlm-1432	57	6	allowed	allow	VERB
ajlm-1432	57	7	to	to	PART
ajlm-1432	57	8	clot	clot	VERB
ajlm-1432	57	9	for	for	ADP
ajlm-1432	57	10	about	about	ADV
ajlm-1432	57	11	45	45	NUM
ajlm-1432	57	12	min	min	NOUN
ajlm-1432	57	13	and	and	CCONJ
ajlm-1432	57	14	then	then	ADV
ajlm-1432	57	15	centrifuged	centrifuge	VERB
ajlm-1432	57	16	to	to	PART
ajlm-1432	57	17	separate	separate	VERB
ajlm-1432	57	18	the	the	DET
ajlm-1432	57	19	serum	serum	NOUN
ajlm-1432	57	20	.	.	PUNCT
ajlm-1432	58	1	the	the	DET
ajlm-1432	58	2	serum	serum	NOUN
ajlm-1432	58	3	was	be	AUX
ajlm-1432	58	4	then	then	ADV
ajlm-1432	58	5	tested	test	VERB
ajlm-1432	58	6	for	for	ADP
ajlm-1432	58	7	the	the	DET
ajlm-1432	58	8	presence	presence	NOUN
ajlm-1432	58	9	of	of	ADP
ajlm-1432	58	10	haemolysins.11,16	haemolysins.11,16	NOUN
ajlm-1432	58	11	zero	zero	NUM
ajlm-1432	58	12	point	point	NOUN
ajlm-1432	58	13	5	5	NUM
ajlm-1432	58	14	mililetres	mililetre	NOUN
ajlm-1432	58	15	of	of	ADP
ajlm-1432	58	16	the	the	DET
ajlm-1432	58	17	serum	serum	NOUN
ajlm-1432	58	18	was	be	AUX
ajlm-1432	58	19	placed	place	VERB
ajlm-1432	58	20	in	in	ADP
ajlm-1432	58	21	three	three	NUM
ajlm-1432	58	22	test	test	NOUN
ajlm-1432	58	23	tubes	tube	NOUN
ajlm-1432	58	24	labelled	label	VERB
ajlm-1432	58	25	‘	'	PUNCT
ajlm-1432	58	26	a	a	PRON
ajlm-1432	58	27	’	'	PUNCT
ajlm-1432	58	28	,	,	PUNCT
ajlm-1432	58	29	‘	'	PUNCT
ajlm-1432	58	30	b	b	X
ajlm-1432	58	31	’	'	PUNCT
ajlm-1432	58	32	and	and	CCONJ
ajlm-1432	58	33	‘	'	PUNCT
ajlm-1432	58	34	o	o	NOUN
ajlm-1432	58	35	’	'	PUNCT
ajlm-1432	58	36	,	,	PUNCT
ajlm-1432	58	37	and	and	CCONJ
ajlm-1432	58	38	0.5	0.5	NUM
ajlm-1432	58	39	ml	ml	NOUN
ajlm-1432	58	40	of	of	ADP
ajlm-1432	58	41	5	5	NUM
ajlm-1432	58	42	%	%	NOUN
ajlm-1432	58	43	blood	blood	NOUN
ajlm-1432	58	44	group	group	NOUN
ajlm-1432	58	45	a	a	PROPN
ajlm-1432	58	46	,	,	PUNCT
ajlm-1432	58	47	b	b	NOUN
ajlm-1432	58	48	,	,	PUNCT
ajlm-1432	58	49	or	or	CCONJ
ajlm-1432	58	50	o	o	NOUN
ajlm-1432	58	51	washed	wash	VERB
ajlm-1432	58	52	red	red	ADJ
ajlm-1432	58	53	cells	cell	NOUN
ajlm-1432	58	54	suspended	suspend	VERB
ajlm-1432	58	55	in	in	ADP
ajlm-1432	58	56	physiological	physiological	ADJ
ajlm-1432	58	57	saline	saline	NOUN
ajlm-1432	58	58	was	be	AUX
ajlm-1432	58	59	added	add	VERB
ajlm-1432	58	60	to	to	ADP
ajlm-1432	58	61	each	each	DET
ajlm-1432	58	62	tube	tube	NOUN
ajlm-1432	58	63	.	.	PUNCT
ajlm-1432	59	1	the	the	DET
ajlm-1432	59	2	blood	blood	NOUN
ajlm-1432	59	3	group	group	NOUN
ajlm-1432	59	4	o	o	PROPN
ajlm-1432	59	5	red	red	ADJ
ajlm-1432	59	6	cells	cell	NOUN
ajlm-1432	59	7	were	be	AUX
ajlm-1432	59	8	used	use	VERB
ajlm-1432	59	9	as	as	ADP
ajlm-1432	59	10	a	a	DET
ajlm-1432	59	11	negative	negative	ADJ
ajlm-1432	59	12	control	control	NOUN
ajlm-1432	59	13	.	.	PUNCT
ajlm-1432	60	1	the	the	DET
ajlm-1432	60	2	setup	setup	NOUN
ajlm-1432	60	3	was	be	AUX
ajlm-1432	60	4	incubated	incubate	VERB
ajlm-1432	60	5	at	at	ADP
ajlm-1432	60	6	37	37	NUM
ajlm-1432	60	7	°	°	NOUN
ajlm-1432	60	8	c	c	NOUN
ajlm-1432	60	9	for	for	ADP
ajlm-1432	60	10	2	2	NUM
ajlm-1432	60	11	h	h	NOUN
ajlm-1432	60	12	and	and	CCONJ
ajlm-1432	60	13	centrifuged	centrifuge	VERB
ajlm-1432	60	14	afterwards	afterwards	ADV
ajlm-1432	60	15	.	.	PUNCT
ajlm-1432	61	1	the	the	DET
ajlm-1432	61	2	supernatant	supernatant	NOUN
ajlm-1432	61	3	was	be	AUX
ajlm-1432	61	4	then	then	ADV
ajlm-1432	61	5	examined	examine	VERB
ajlm-1432	61	6	macroscopically	macroscopically	ADV
ajlm-1432	61	7	(	(	PUNCT
ajlm-1432	61	8	in	in	ADP
ajlm-1432	61	9	bright	bright	ADJ
ajlm-1432	61	10	light	light	NOUN
ajlm-1432	61	11	)	)	PUNCT
ajlm-1432	61	12	and	and	CCONJ
ajlm-1432	61	13	microscopically	microscopically	ADV
ajlm-1432	61	14	for	for	ADP
ajlm-1432	61	15	the	the	DET
ajlm-1432	61	16	presence	presence	NOUN
ajlm-1432	61	17	of	of	ADP
ajlm-1432	61	18	haemolysins	haemolysin	NOUN
ajlm-1432	61	19	.	.	PUNCT
ajlm-1432	62	1	the	the	DET
ajlm-1432	62	2	degree	degree	NOUN
ajlm-1432	62	3	of	of	ADP
ajlm-1432	62	4	haemolysis	haemolysis	NOUN
ajlm-1432	62	5	was	be	AUX
ajlm-1432	62	6	graded	grade	VERB
ajlm-1432	62	7	as	as	ADP
ajlm-1432	62	8	1	1	NUM
ajlm-1432	62	9	+	+	NUM
ajlm-1432	62	10	for	for	ADP
ajlm-1432	62	11	traces	trace	NOUN
ajlm-1432	62	12	of	of	ADP
ajlm-1432	62	13	haemolysis	haemolysis	NOUN
ajlm-1432	62	14	,	,	PUNCT
ajlm-1432	62	15	2	2	NUM
ajlm-1432	62	16	+	+	X
ajlm-1432	62	17	for	for	ADP
ajlm-1432	62	18	partial	partial	ADJ
ajlm-1432	62	19	(	(	PUNCT
ajlm-1432	62	20	greater	great	ADJ
ajlm-1432	62	21	than	than	ADP
ajlm-1432	62	22	50	50	NUM
ajlm-1432	62	23	%	%	NOUN
ajlm-1432	62	24	but	but	CCONJ
ajlm-1432	62	25	not	not	PART
ajlm-1432	62	26	complete	complete	ADJ
ajlm-1432	62	27	)	)	PUNCT
ajlm-1432	62	28	haemolysis	haemolysis	NOUN
ajlm-1432	62	29	,	,	PUNCT
ajlm-1432	62	30	3	3	NUM
ajlm-1432	62	31	+	+	NOUN
ajlm-1432	62	32	for	for	ADP
ajlm-1432	62	33	complete	complete	ADJ
ajlm-1432	62	34	haemolysis	haemolysis	NOUN
ajlm-1432	62	35	,	,	PUNCT
ajlm-1432	62	36	and	and	CCONJ
ajlm-1432	62	37	negative	negative	ADJ
ajlm-1432	62	38	when	when	SCONJ
ajlm-1432	62	39	no	no	DET
ajlm-1432	62	40	haemolysis	haemolysis	NOUN
ajlm-1432	62	41	was	be	AUX
ajlm-1432	62	42	observed.11,20,21,22	observed.11,20,21,22	ADJ
ajlm-1432	62	43	all	all	DET
ajlm-1432	62	44	sera	sera	NOUN
ajlm-1432	62	45	positive	positive	ADJ
ajlm-1432	62	46	for	for	ADP
ajlm-1432	62	47	haemolysis	haemolysis	NOUN
ajlm-1432	62	48	were	be	AUX
ajlm-1432	62	49	titrated	titrate	VERB
ajlm-1432	62	50	to	to	PART
ajlm-1432	62	51	quantify	quantify	VERB
ajlm-1432	62	52	the	the	DET
ajlm-1432	62	53	degree	degree	NOUN
ajlm-1432	62	54	of	of	ADP
ajlm-1432	62	55	haemolysis.11,20,21	haemolysis.11,20,21	ADV
ajlm-1432	62	56	0.5	0.5	NUM
ajlm-1432	62	57	ml	ml	NOUN
ajlm-1432	62	58	of	of	ADP
ajlm-1432	62	59	the	the	DET
ajlm-1432	62	60	sera	sera	NOUN
ajlm-1432	62	61	was	be	AUX
ajlm-1432	62	62	diluted	dilute	VERB
ajlm-1432	62	63	twofold	twofold	ADV
ajlm-1432	62	64	with	with	ADP
ajlm-1432	62	65	physiological	physiological	ADJ
ajlm-1432	62	66	saline	saline	NOUN
ajlm-1432	62	67	to	to	ADP
ajlm-1432	62	68	a	a	DET
ajlm-1432	62	69	titre	titre	NOUN
ajlm-1432	62	70	of	of	ADP
ajlm-1432	62	71	526	526	NUM
ajlm-1432	62	72	,	,	PUNCT
ajlm-1432	62	73	and	and	CCONJ
ajlm-1432	62	74	0.5	0.5	NUM
ajlm-1432	62	75	ml	ml	NOUN
ajlm-1432	62	76	of	of	ADP
ajlm-1432	62	77	5	5	NUM
ajlm-1432	62	78	%	%	NOUN
ajlm-1432	62	79	washed	wash	VERB
ajlm-1432	62	80	red	red	ADJ
ajlm-1432	62	81	cells	cell	NOUN
ajlm-1432	62	82	of	of	ADP
ajlm-1432	62	83	the	the	DET
ajlm-1432	62	84	respective	respective	ADJ
ajlm-1432	62	85	positive	positive	ADJ
ajlm-1432	62	86	sera	sera	NOUN
ajlm-1432	62	87	was	be	AUX
ajlm-1432	62	88	added	add	VERB
ajlm-1432	62	89	.	.	PUNCT
ajlm-1432	63	1	the	the	DET
ajlm-1432	63	2	setup	setup	NOUN
ajlm-1432	63	3	was	be	AUX
ajlm-1432	63	4	incubated	incubate	VERB
ajlm-1432	63	5	for	for	ADP
ajlm-1432	63	6	2	2	NUM
ajlm-1432	63	7	h	h	NOUN
ajlm-1432	63	8	and	and	CCONJ
ajlm-1432	63	9	observed	observe	VERB
ajlm-1432	63	10	for	for	ADP
ajlm-1432	63	11	haemolysis	haemolysis	NOUN
ajlm-1432	63	12	macroscopically	macroscopically	ADV
ajlm-1432	63	13	and	and	CCONJ
ajlm-1432	63	14	microscopically	microscopically	ADV
ajlm-1432	63	15	.	.	PUNCT
ajlm-1432	64	1	the	the	DET
ajlm-1432	64	2	reciprocal	reciprocal	NOUN
ajlm-1432	64	3	of	of	ADP
ajlm-1432	64	4	the	the	DET
ajlm-1432	64	5	serum	serum	NOUN
ajlm-1432	64	6	dilution	dilution	NOUN
ajlm-1432	64	7	in	in	ADP
ajlm-1432	64	8	the	the	DET
ajlm-1432	64	9	last	last	ADJ
ajlm-1432	64	10	tube	tube	NOUN
ajlm-1432	64	11	with	with	ADP
ajlm-1432	64	12	haemolysis	haemolysis	NOUN
ajlm-1432	64	13	was	be	AUX
ajlm-1432	64	14	considered	consider	VERB
ajlm-1432	64	15	as	as	SCONJ
ajlm-1432	64	16	the	the	DET
ajlm-1432	64	17	titre.11,20,21	titre.11,20,21	NOUN
ajlm-1432	64	18	statistical	statistical	ADJ
ajlm-1432	64	19	analysis	analysis	NOUN
ajlm-1432	64	20	collected	collect	VERB
ajlm-1432	64	21	data	datum	NOUN
ajlm-1432	64	22	were	be	AUX
ajlm-1432	64	23	entered	enter	VERB
ajlm-1432	64	24	into	into	ADP
ajlm-1432	64	25	microsoft	microsoft	PROPN
ajlm-1432	64	26	excel	excel	PROPN
ajlm-1432	64	27	2010	2010	NUM
ajlm-1432	64	28	(	(	PUNCT
ajlm-1432	64	29	microsoft	microsoft	PROPN
ajlm-1432	64	30	corporation	corporation	PROPN
ajlm-1432	64	31	,	,	PUNCT
ajlm-1432	64	32	redmond	redmond	PROPN
ajlm-1432	64	33	,	,	PUNCT
ajlm-1432	64	34	washington	washington	PROPN
ajlm-1432	64	35	,	,	PUNCT
ajlm-1432	64	36	united	united	PROPN
ajlm-1432	64	37	states	states	PROPN
ajlm-1432	64	38	)	)	PUNCT
ajlm-1432	64	39	and	and	CCONJ
ajlm-1432	64	40	double	double	ADV
ajlm-1432	64	41	-	-	PUNCT
ajlm-1432	64	42	checked	check	VERB
ajlm-1432	64	43	for	for	ADP
ajlm-1432	64	44	errors	error	NOUN
ajlm-1432	64	45	by	by	ADP
ajlm-1432	64	46	a	a	DET
ajlm-1432	64	47	second	second	ADJ
ajlm-1432	64	48	person	person	NOUN
ajlm-1432	64	49	.	.	PUNCT
ajlm-1432	65	1	all	all	DET
ajlm-1432	65	2	analyses	analysis	NOUN
ajlm-1432	65	3	were	be	AUX
ajlm-1432	65	4	done	do	VERB
ajlm-1432	65	5	using	use	VERB
ajlm-1432	65	6	statistical	statistical	ADJ
ajlm-1432	65	7	package	package	NOUN
ajlm-1432	65	8	for	for	ADP
ajlm-1432	65	9	social	social	ADJ
ajlm-1432	65	10	sciences	science	NOUN
ajlm-1432	65	11	version	version	NOUN
ajlm-1432	65	12	20	20	NUM
ajlm-1432	65	13	(	(	PUNCT
ajlm-1432	65	14	ibm	ibm	PROPN
ajlm-1432	65	15	corp	corp	PROPN
ajlm-1432	65	16	.	.	PROPN
ajlm-1432	65	17	,	,	PUNCT
ajlm-1432	65	18	chicago	chicago	PROPN
ajlm-1432	65	19	,	,	PUNCT
ajlm-1432	65	20	illinois	illinois	PROPN
ajlm-1432	65	21	,	,	PUNCT
ajlm-1432	65	22	united	united	PROPN
ajlm-1432	65	23	states	states	PROPN
ajlm-1432	65	24	)	)	PUNCT
ajlm-1432	65	25	.	.	PUNCT
ajlm-1432	66	1	haemolysin	haemolysin	PROPN
ajlm-1432	66	2	prevalence	prevalence	NOUN
ajlm-1432	66	3	was	be	AUX
ajlm-1432	66	4	determined	determine	VERB
ajlm-1432	66	5	as	as	ADP
ajlm-1432	66	6	the	the	DET
ajlm-1432	66	7	proportion	proportion	NOUN
ajlm-1432	66	8	of	of	ADP
ajlm-1432	66	9	participants	participant	NOUN
ajlm-1432	66	10	whose	whose	DET
ajlm-1432	66	11	blood	blood	NOUN
ajlm-1432	66	12	samples	sample	NOUN
ajlm-1432	66	13	were	be	AUX
ajlm-1432	66	14	positive	positive	ADJ
ajlm-1432	66	15	for	for	ADP
ajlm-1432	66	16	haemolysin	haemolysin	NOUN
ajlm-1432	66	17	(	(	PUNCT
ajlm-1432	66	18	alpha	alpha	NOUN
ajlm-1432	66	19	,	,	PUNCT
ajlm-1432	66	20	beta	beta	NOUN
ajlm-1432	66	21	or	or	CCONJ
ajlm-1432	66	22	both	both	CCONJ
ajlm-1432	66	23	alpha	alpha	NOUN
ajlm-1432	66	24	and	and	CCONJ
ajlm-1432	66	25	beta	beta	NOUN
ajlm-1432	66	26	haemolysin	haemolysin	NOUN
ajlm-1432	66	27	)	)	PUNCT
ajlm-1432	66	28	.	.	PUNCT
ajlm-1432	67	1	haemolysin	haemolysin	PROPN
ajlm-1432	67	2	titres	titre	NOUN
ajlm-1432	67	3	equal	equal	ADJ
ajlm-1432	67	4	to	to	ADP
ajlm-1432	67	5	or	or	CCONJ
ajlm-1432	67	6	greater	great	ADJ
ajlm-1432	67	7	than	than	ADP
ajlm-1432	67	8	8	8	NUM
ajlm-1432	67	9	were	be	AUX
ajlm-1432	67	10	considered	consider	VERB
ajlm-1432	67	11	significant	significant	ADJ
ajlm-1432	67	12	.	.	PUNCT
ajlm-1432	68	1	the	the	DET
ajlm-1432	68	2	prevalence	prevalence	NOUN
ajlm-1432	68	3	of	of	ADP
ajlm-1432	68	4	significant	significant	ADJ
ajlm-1432	68	5	titres	titre	NOUN
ajlm-1432	68	6	was	be	AUX
ajlm-1432	68	7	also	also	ADV
ajlm-1432	68	8	determined	determined	ADJ
ajlm-1432	68	9	as	as	ADP
ajlm-1432	68	10	the	the	DET
ajlm-1432	68	11	proportion	proportion	NOUN
ajlm-1432	68	12	of	of	ADP
ajlm-1432	68	13	participants	participant	NOUN
ajlm-1432	68	14	with	with	ADP
ajlm-1432	68	15	significant	significant	ADJ
ajlm-1432	68	16	haemolysin	haemolysin	NOUN
ajlm-1432	68	17	titres	titre	NOUN
ajlm-1432	68	18	.	.	PUNCT
ajlm-1432	69	1	associations	association	NOUN
ajlm-1432	69	2	between	between	ADP
ajlm-1432	69	3	haemolysin	haemolysin	NOUN
ajlm-1432	69	4	prevalence	prevalence	NOUN
ajlm-1432	69	5	and	and	CCONJ
ajlm-1432	69	6	age	age	NOUN
ajlm-1432	69	7	group	group	NOUN
ajlm-1432	69	8	,	,	PUNCT
ajlm-1432	69	9	gender	gender	NOUN
ajlm-1432	69	10	and	and	CCONJ
ajlm-1432	69	11	rhesus	rhesus	NOUN
ajlm-1432	69	12	d	d	NOUN
ajlm-1432	69	13	blood	blood	NOUN
ajlm-1432	69	14	group	group	NOUN
ajlm-1432	69	15	were	be	AUX
ajlm-1432	69	16	determined	determine	VERB
ajlm-1432	69	17	using	use	VERB
ajlm-1432	69	18	chi	chi	ADJ
ajlm-1432	69	19	-	-	PUNCT
ajlm-1432	69	20	square	square	ADJ
ajlm-1432	69	21	test	test	NOUN
ajlm-1432	69	22	,	,	PUNCT
ajlm-1432	69	23	and	and	CCONJ
ajlm-1432	69	24	p	p	X
ajlm-1432	69	25	-	-	PUNCT
ajlm-1432	69	26	values	value	NOUN
ajlm-1432	69	27	<	<	X
ajlm-1432	69	28	0.05	0.05	NUM
ajlm-1432	69	29	were	be	AUX
ajlm-1432	69	30	considered	consider	VERB
ajlm-1432	69	31	as	as	ADP
ajlm-1432	69	32	statistically	statistically	ADV
ajlm-1432	69	33	significant	significant	ADJ
ajlm-1432	69	34	.	.	PUNCT
ajlm-1432	70	1	results	result	NOUN
ajlm-1432	70	2	in	in	ADP
ajlm-1432	70	3	total	total	ADJ
ajlm-1432	70	4	,	,	PUNCT
ajlm-1432	70	5	1161	1161	NUM
ajlm-1432	70	6	blood	blood	NOUN
ajlm-1432	70	7	donors	donor	NOUN
ajlm-1432	70	8	presented	present	VERB
ajlm-1432	70	9	to	to	ADP
ajlm-1432	70	10	the	the	DET
ajlm-1432	70	11	rhbbb	rhbbb	NOUN
ajlm-1432	70	12	for	for	ADP
ajlm-1432	70	13	blood	blood	NOUN
ajlm-1432	70	14	donation	donation	NOUN
ajlm-1432	70	15	between	between	ADP
ajlm-1432	70	16	june	june	PROPN
ajlm-1432	70	17	2020	2020	NUM
ajlm-1432	70	18	and	and	CCONJ
ajlm-1432	70	19	september	september	PROPN
ajlm-1432	70	20	2020	2020	NUM
ajlm-1432	70	21	,	,	PUNCT
ajlm-1432	70	22	820	820	NUM
ajlm-1432	70	23	of	of	ADP
ajlm-1432	70	24	whom	whom	PRON
ajlm-1432	70	25	were	be	AUX
ajlm-1432	70	26	screened	screen	VERB
ajlm-1432	70	27	for	for	ADP
ajlm-1432	70	28	physical	physical	ADJ
ajlm-1432	70	29	fitness	fitness	NOUN
ajlm-1432	70	30	.	.	PUNCT
ajlm-1432	71	1	of	of	ADP
ajlm-1432	71	2	the	the	DET
ajlm-1432	71	3	820	820	NUM
ajlm-1432	71	4	donors	donor	NOUN
ajlm-1432	71	5	,	,	PUNCT
ajlm-1432	71	6	812	812	NUM
ajlm-1432	71	7	were	be	AUX
ajlm-1432	71	8	classified	classify	VERB
ajlm-1432	71	9	as	as	ADP
ajlm-1432	71	10	physically	physically	ADV
ajlm-1432	71	11	fit	fit	ADJ
ajlm-1432	71	12	based	base	VERB
ajlm-1432	71	13	on	on	ADP
ajlm-1432	71	14	the	the	DET
ajlm-1432	71	15	applied	apply	VERB
ajlm-1432	71	16	standard	standard	ADJ
ajlm-1432	71	17	questionnaire	questionnaire	NOUN
ajlm-1432	71	18	prepared	prepare	VERB
ajlm-1432	71	19	by	by	ADP
ajlm-1432	71	20	the	the	DET
ajlm-1432	71	21	rhbbb	rhbbb	NOUN
ajlm-1432	71	22	,	,	PUNCT
ajlm-1432	71	23	and	and	CCONJ
ajlm-1432	71	24	all	all	DET
ajlm-1432	71	25	the	the	DET
ajlm-1432	71	26	812	812	NUM
ajlm-1432	71	27	donors	donor	NOUN
ajlm-1432	71	28	consented	consent	VERB
ajlm-1432	71	29	to	to	PART
ajlm-1432	71	30	participate	participate	VERB
ajlm-1432	71	31	in	in	ADP
ajlm-1432	71	32	the	the	DET
ajlm-1432	71	33	study	study	NOUN
ajlm-1432	71	34	.	.	PUNCT
ajlm-1432	72	1	out	out	ADP
ajlm-1432	72	2	of	of	ADP
ajlm-1432	72	3	the	the	DET
ajlm-1432	72	4	screened	screened	ADJ
ajlm-1432	72	5	812	812	NUM
ajlm-1432	72	6	donors	donor	NOUN
ajlm-1432	72	7	,	,	PUNCT
ajlm-1432	72	8	493	493	NUM
ajlm-1432	72	9	were	be	AUX
ajlm-1432	72	10	blood	blood	NOUN
ajlm-1432	72	11	group	group	NOUN
ajlm-1432	72	12	o	o	PROPN
ajlm-1432	72	13	,	,	PUNCT
ajlm-1432	72	14	480	480	NUM
ajlm-1432	72	15	of	of	ADP
ajlm-1432	72	16	whom	whom	PRON
ajlm-1432	72	17	were	be	AUX
ajlm-1432	72	18	free	free	ADJ
ajlm-1432	72	19	from	from	ADP
ajlm-1432	72	20	ttis	ttis	PROPN
ajlm-1432	72	21	and	and	CCONJ
ajlm-1432	72	22	were	be	AUX
ajlm-1432	72	23	included	include	VERB
ajlm-1432	72	24	to	to	PART
ajlm-1432	72	25	participate	participate	VERB
ajlm-1432	72	26	in	in	ADP
ajlm-1432	72	27	the	the	DET
ajlm-1432	72	28	study	study	NOUN
ajlm-1432	72	29	(	(	PUNCT
ajlm-1432	72	30	figure	figure	NOUN
ajlm-1432	72	31	1	1	NUM
ajlm-1432	72	32	)	)	PUNCT
ajlm-1432	72	33	.	.	PUNCT
ajlm-1432	73	1	figure	figure	VERB
ajlm-1432	73	2	1	1	NUM
ajlm-1432	73	3	:	:	PUNCT
ajlm-1432	73	4	selection	selection	NOUN
ajlm-1432	73	5	of	of	ADP
ajlm-1432	73	6	study	study	NOUN
ajlm-1432	73	7	participants	participant	NOUN
ajlm-1432	73	8	among	among	ADP
ajlm-1432	73	9	blood	blood	NOUN
ajlm-1432	73	10	group	group	NOUN
ajlm-1432	73	11	o	o	NOUN
ajlm-1432	73	12	donors	donor	NOUN
ajlm-1432	73	13	at	at	ADP
ajlm-1432	73	14	the	the	DET
ajlm-1432	73	15	rhbbb	rhbbb	NOUN
ajlm-1432	73	16	,	,	PUNCT
ajlm-1432	73	17	cameroon	cameroon	PROPN
ajlm-1432	73	18	,	,	PUNCT
ajlm-1432	73	19	june	june	PROPN
ajlm-1432	73	20	2020	2020	NUM
ajlm-1432	73	21	–	–	PUNCT
ajlm-1432	73	22	september	september	PROPN
ajlm-1432	73	23	2020	2020	NUM
ajlm-1432	73	24	.	.	PUNCT
ajlm-1432	74	1	participants	participant	NOUN
ajlm-1432	74	2	were	be	AUX
ajlm-1432	74	3	aged	age	VERB
ajlm-1432	74	4	between	between	ADP
ajlm-1432	74	5	18	18	NUM
ajlm-1432	74	6	years	year	NOUN
ajlm-1432	74	7	and	and	CCONJ
ajlm-1432	74	8	55	55	NUM
ajlm-1432	74	9	years	year	NOUN
ajlm-1432	74	10	and	and	CCONJ
ajlm-1432	74	11	comprised	comprise	VERB
ajlm-1432	74	12	383	383	NUM
ajlm-1432	74	13	(	(	PUNCT
ajlm-1432	74	14	79.8	79.8	NUM
ajlm-1432	74	15	%	%	NOUN
ajlm-1432	74	16	)	)	PUNCT
ajlm-1432	74	17	men	man	NOUN
ajlm-1432	74	18	and	and	CCONJ
ajlm-1432	74	19	97	97	NUM
ajlm-1432	74	20	(	(	PUNCT
ajlm-1432	74	21	20.2	20.2	NUM
ajlm-1432	74	22	%	%	NOUN
ajlm-1432	74	23	)	)	PUNCT
ajlm-1432	75	1	women	woman	NOUN
ajlm-1432	75	2	(	(	PUNCT
ajlm-1432	75	3	table	table	NOUN
ajlm-1432	75	4	1	1	NUM
ajlm-1432	75	5	)	)	PUNCT
ajlm-1432	75	6	.	.	PUNCT
ajlm-1432	76	1	four	four	NUM
ajlm-1432	76	2	hundred	hundred	NUM
ajlm-1432	76	3	and	and	CCONJ
ajlm-1432	76	4	sixty	sixty	NUM
ajlm-1432	76	5	-	-	PUNCT
ajlm-1432	76	6	three	three	NUM
ajlm-1432	76	7	(	(	PUNCT
ajlm-1432	76	8	96.5	96.5	NUM
ajlm-1432	76	9	%	%	NOUN
ajlm-1432	76	10	)	)	PUNCT
ajlm-1432	76	11	of	of	ADP
ajlm-1432	76	12	the	the	DET
ajlm-1432	76	13	participants	participant	NOUN
ajlm-1432	76	14	were	be	AUX
ajlm-1432	76	15	rhesus	rhesus	ADJ
ajlm-1432	76	16	d	d	PROPN
ajlm-1432	76	17	positive	positive	ADJ
ajlm-1432	76	18	and	and	CCONJ
ajlm-1432	76	19	17	17	NUM
ajlm-1432	76	20	(	(	PUNCT
ajlm-1432	76	21	3.5	3.5	NUM
ajlm-1432	76	22	%	%	NOUN
ajlm-1432	76	23	)	)	PUNCT
ajlm-1432	76	24	were	be	AUX
ajlm-1432	76	25	rhesus	rhesus	NOUN
ajlm-1432	76	26	d	d	X
ajlm-1432	76	27	negative	negative	ADJ
ajlm-1432	76	28	.	.	PUNCT
ajlm-1432	77	1	of	of	ADP
ajlm-1432	77	2	the	the	DET
ajlm-1432	77	3	480	480	NUM
ajlm-1432	77	4	blood	blood	NOUN
ajlm-1432	77	5	group	group	NOUN
ajlm-1432	77	6	o	o	NOUN
ajlm-1432	77	7	donors	donor	NOUN
ajlm-1432	77	8	tested	test	VERB
ajlm-1432	77	9	for	for	ADP
ajlm-1432	77	10	haemolysins	haemolysin	NOUN
ajlm-1432	77	11	,	,	PUNCT
ajlm-1432	77	12	230	230	NUM
ajlm-1432	77	13	were	be	AUX
ajlm-1432	77	14	negative	negative	ADJ
ajlm-1432	77	15	while	while	SCONJ
ajlm-1432	77	16	250	250	NUM
ajlm-1432	77	17	were	be	AUX
ajlm-1432	77	18	positive	positive	ADJ
ajlm-1432	77	19	,	,	PUNCT
ajlm-1432	77	20	giving	give	VERB
ajlm-1432	77	21	a	a	DET
ajlm-1432	77	22	haemolysin	haemolysin	NOUN
ajlm-1432	77	23	prevalence	prevalence	NOUN
ajlm-1432	77	24	of	of	ADP
ajlm-1432	77	25	52.1	52.1	NUM
ajlm-1432	77	26	%	%	NOUN
ajlm-1432	77	27	.	.	PUNCT
ajlm-1432	78	1	haemolysins	haemolysin	NOUN
ajlm-1432	78	2	were	be	AUX
ajlm-1432	78	3	detected	detect	VERB
ajlm-1432	78	4	in	in	ADP
ajlm-1432	78	5	204	204	NUM
ajlm-1432	78	6	(	(	PUNCT
ajlm-1432	78	7	53.3	53.3	NUM
ajlm-1432	78	8	%	%	NOUN
ajlm-1432	78	9	)	)	PUNCT
ajlm-1432	78	10	men	man	NOUN
ajlm-1432	78	11	and	and	CCONJ
ajlm-1432	78	12	46	46	NUM
ajlm-1432	78	13	(	(	PUNCT
ajlm-1432	78	14	47.4	47.4	NUM
ajlm-1432	78	15	%	%	NOUN
ajlm-1432	78	16	)	)	PUNCT
ajlm-1432	78	17	women	woman	NOUN
ajlm-1432	78	18	.	.	PUNCT
ajlm-1432	79	1	the	the	DET
ajlm-1432	79	2	single	single	ADJ
ajlm-1432	79	3	participant	participant	NOUN
ajlm-1432	79	4	aged	age	VERB
ajlm-1432	79	5	≥	≥	NUM
ajlm-1432	79	6	55	55	NUM
ajlm-1432	79	7	years	year	NOUN
ajlm-1432	79	8	was	be	AUX
ajlm-1432	79	9	positive	positive	ADJ
ajlm-1432	79	10	for	for	ADP
ajlm-1432	79	11	haemolysin	haemolysin	NOUN
ajlm-1432	79	12	.	.	PUNCT
ajlm-1432	80	1	in	in	ADP
ajlm-1432	80	2	the	the	DET
ajlm-1432	80	3	other	other	ADJ
ajlm-1432	80	4	age	age	NOUN
ajlm-1432	80	5	groups	group	NOUN
ajlm-1432	80	6	,	,	PUNCT
ajlm-1432	80	7	haemolysin	haemolysin	NOUN
ajlm-1432	80	8	prevalence	prevalence	NOUN
ajlm-1432	80	9	was	be	AUX
ajlm-1432	80	10	highest	high	ADJ
ajlm-1432	80	11	among	among	ADP
ajlm-1432	80	12	participants	participant	NOUN
ajlm-1432	80	13	aged	age	VERB
ajlm-1432	80	14	between	between	ADP
ajlm-1432	80	15	45	45	NUM
ajlm-1432	80	16	and	and	CCONJ
ajlm-1432	80	17	54	54	NUM
ajlm-1432	80	18	years	year	NOUN
ajlm-1432	80	19	(	(	PUNCT
ajlm-1432	80	20	28/48	28/48	NUM
ajlm-1432	80	21	;	;	PUNCT
ajlm-1432	80	22	58.3	58.3	NUM
ajlm-1432	80	23	%	%	NOUN
ajlm-1432	80	24	)	)	PUNCT
ajlm-1432	80	25	,	,	PUNCT
ajlm-1432	80	26	followed	follow	VERB
ajlm-1432	80	27	by	by	ADP
ajlm-1432	80	28	participants	participant	NOUN
ajlm-1432	80	29	aged	age	VERB
ajlm-1432	80	30	18–24	18–24	NUM
ajlm-1432	80	31	years	year	NOUN
ajlm-1432	80	32	(	(	PUNCT
ajlm-1432	80	33	86/156	86/156	NUM
ajlm-1432	80	34	;	;	PUNCT
ajlm-1432	80	35	55.1	55.1	NUM
ajlm-1432	80	36	%	%	NOUN
ajlm-1432	80	37	)	)	PUNCT
ajlm-1432	80	38	,	,	PUNCT
ajlm-1432	80	39	35–44	35–44	NUM
ajlm-1432	80	40	years	year	NOUN
ajlm-1432	80	41	(	(	PUNCT
ajlm-1432	80	42	44/87	44/87	NUM
ajlm-1432	80	43	;	;	PUNCT
ajlm-1432	80	44	50.6	50.6	NUM
ajlm-1432	80	45	%	%	NOUN
ajlm-1432	80	46	)	)	PUNCT
ajlm-1432	80	47	and	and	CCONJ
ajlm-1432	80	48	25–34	25–34	NUM
ajlm-1432	80	49	years	year	NOUN
ajlm-1432	80	50	(	(	PUNCT
ajlm-1432	80	51	91/188	91/188	NUM
ajlm-1432	80	52	;	;	PUNCT
ajlm-1432	80	53	48.4	48.4	NUM
ajlm-1432	80	54	%	%	NOUN
ajlm-1432	80	55	)	)	PUNCT
ajlm-1432	80	56	.	.	PUNCT
ajlm-1432	81	1	there	there	PRON
ajlm-1432	81	2	was	be	VERB
ajlm-1432	81	3	no	no	DET
ajlm-1432	81	4	association	association	NOUN
ajlm-1432	81	5	between	between	ADP
ajlm-1432	81	6	haemolysin	haemolysin	NOUN
ajlm-1432	81	7	production	production	NOUN
ajlm-1432	81	8	and	and	CCONJ
ajlm-1432	81	9	gender	gender	NOUN
ajlm-1432	81	10	(	(	PUNCT
ajlm-1432	81	11	p	p	X
ajlm-1432	81	12	=	=	NOUN
ajlm-1432	81	13	0.304	0.304	NUM
ajlm-1432	81	14	)	)	PUNCT
ajlm-1432	81	15	,	,	PUNCT
ajlm-1432	81	16	age	age	NOUN
ajlm-1432	81	17	group	group	NOUN
ajlm-1432	81	18	(	(	PUNCT
ajlm-1432	81	19	p	p	X
ajlm-1432	81	20	=	=	NOUN
ajlm-1432	81	21	0.501	0.501	NUM
ajlm-1432	81	22	)	)	PUNCT
ajlm-1432	81	23	or	or	CCONJ
ajlm-1432	81	24	rhesus	rhesus	NOUN
ajlm-1432	81	25	d	d	NOUN
ajlm-1432	81	26	positivity	positivity	NOUN
ajlm-1432	81	27	(	(	PUNCT
ajlm-1432	81	28	p	p	X
ajlm-1432	81	29	=	=	NOUN
ajlm-1432	81	30	0.628	0.628	NUM
ajlm-1432	81	31	)	)	PUNCT
ajlm-1432	81	32	.	.	PUNCT
ajlm-1432	82	1	two	two	NUM
ajlm-1432	82	2	hundred	hundred	NUM
ajlm-1432	82	3	and	and	CCONJ
ajlm-1432	82	4	forty	forty	NUM
ajlm-1432	82	5	(	(	PUNCT
ajlm-1432	82	6	240	240	NUM
ajlm-1432	82	7	)	)	PUNCT
ajlm-1432	82	8	of	of	ADP
ajlm-1432	82	9	the	the	DET
ajlm-1432	82	10	463	463	NUM
ajlm-1432	82	11	rhesus	rhesus	NOUN
ajlm-1432	82	12	d	d	ADJ
ajlm-1432	82	13	-	-	ADJ
ajlm-1432	82	14	positive	positive	ADJ
ajlm-1432	82	15	participants	participant	NOUN
ajlm-1432	82	16	(	(	PUNCT
ajlm-1432	82	17	51.8	51.8	NUM
ajlm-1432	82	18	%	%	NOUN
ajlm-1432	82	19	)	)	PUNCT
ajlm-1432	82	20	were	be	AUX
ajlm-1432	82	21	positive	positive	ADJ
ajlm-1432	82	22	for	for	ADP
ajlm-1432	82	23	haemolysin	haemolysin	NOUN
ajlm-1432	82	24	while	while	SCONJ
ajlm-1432	82	25	10	10	NUM
ajlm-1432	82	26	(	(	PUNCT
ajlm-1432	82	27	58.8	58.8	NUM
ajlm-1432	82	28	%	%	NOUN
ajlm-1432	82	29	)	)	PUNCT
ajlm-1432	82	30	of	of	ADP
ajlm-1432	82	31	the	the	DET
ajlm-1432	82	32	17	17	NUM
ajlm-1432	82	33	rhesus	rhesus	NOUN
ajlm-1432	82	34	d	d	ADJ
ajlm-1432	82	35	-	-	ADJ
ajlm-1432	82	36	negative	negative	ADJ
ajlm-1432	82	37	participants	participant	NOUN
ajlm-1432	82	38	were	be	AUX
ajlm-1432	82	39	positive	positive	ADJ
ajlm-1432	82	40	for	for	ADP
ajlm-1432	82	41	haemolysin	haemolysin	NOUN
ajlm-1432	82	42	.	.	PUNCT
ajlm-1432	83	1	table	table	NOUN
ajlm-1432	83	2	1	1	NUM
ajlm-1432	83	3	:	:	PUNCT
ajlm-1432	83	4	 	 	SPACE
ajlm-1432	83	5	association	association	NOUN
ajlm-1432	83	6	between	between	ADP
ajlm-1432	83	7	haemolysin	haemolysin	NOUN
ajlm-1432	83	8	production	production	NOUN
ajlm-1432	83	9	and	and	CCONJ
ajlm-1432	83	10	gender	gender	NOUN
ajlm-1432	83	11	,	,	PUNCT
ajlm-1432	83	12	age	age	NOUN
ajlm-1432	83	13	group	group	NOUN
ajlm-1432	83	14	or	or	CCONJ
ajlm-1432	83	15	rhesus	rhesus	NOUN
ajlm-1432	83	16	d	d	NOUN
ajlm-1432	83	17	positivity	positivity	NOUN
ajlm-1432	83	18	of	of	ADP
ajlm-1432	83	19	blood	blood	NOUN
ajlm-1432	83	20	group	group	NOUN
ajlm-1432	83	21	o	o	NOUN
ajlm-1432	83	22	donors	donor	NOUN
ajlm-1432	83	23	at	at	ADP
ajlm-1432	83	24	the	the	DET
ajlm-1432	83	25	rhbbb	rhbbb	NOUN
ajlm-1432	83	26	,	,	PUNCT
ajlm-1432	83	27	cameroon	cameroon	PROPN
ajlm-1432	83	28	,	,	PUNCT
ajlm-1432	83	29	june	june	PROPN
ajlm-1432	83	30	2020	2020	NUM
ajlm-1432	83	31	–	–	PUNCT
ajlm-1432	83	32	september	september	PROPN
ajlm-1432	83	33	2020	2020	NUM
ajlm-1432	83	34	.	.	PUNCT
ajlm-1432	84	1	of	of	ADP
ajlm-1432	84	2	the	the	DET
ajlm-1432	84	3	250	250	NUM
ajlm-1432	84	4	participants	participant	NOUN
ajlm-1432	84	5	positive	positive	ADJ
ajlm-1432	84	6	for	for	ADP
ajlm-1432	84	7	haemolysin	haemolysin	NOUN
ajlm-1432	84	8	(	(	PUNCT
ajlm-1432	84	9	alpha	alpha	NOUN
ajlm-1432	84	10	,	,	PUNCT
ajlm-1432	84	11	beta	beta	NOUN
ajlm-1432	84	12	or	or	CCONJ
ajlm-1432	84	13	both	both	PRON
ajlm-1432	84	14	)	)	PUNCT
ajlm-1432	84	15	,	,	PUNCT
ajlm-1432	84	16	105	105	NUM
ajlm-1432	84	17	(	(	PUNCT
ajlm-1432	84	18	42.0	42.0	NUM
ajlm-1432	84	19	%	%	NOUN
ajlm-1432	84	20	)	)	PUNCT
ajlm-1432	84	21	were	be	AUX
ajlm-1432	84	22	positive	positive	ADJ
ajlm-1432	84	23	for	for	ADP
ajlm-1432	84	24	only	only	ADJ
ajlm-1432	84	25	alpha	alpha	NOUN
ajlm-1432	84	26	haemolysin	haemolysin	NOUN
ajlm-1432	84	27	,	,	PUNCT
ajlm-1432	84	28	69	69	NUM
ajlm-1432	84	29	(	(	PUNCT
ajlm-1432	84	30	27.6	27.6	NUM
ajlm-1432	84	31	%	%	NOUN
ajlm-1432	84	32	)	)	PUNCT
ajlm-1432	84	33	were	be	AUX
ajlm-1432	84	34	positive	positive	ADJ
ajlm-1432	84	35	for	for	ADP
ajlm-1432	84	36	only	only	ADV
ajlm-1432	84	37	beta	beta	ADJ
ajlm-1432	84	38	haemolysin	haemolysin	NOUN
ajlm-1432	84	39	,	,	PUNCT
ajlm-1432	84	40	and	and	CCONJ
ajlm-1432	84	41	76	76	NUM
ajlm-1432	84	42	(	(	PUNCT
ajlm-1432	84	43	30.4	30.4	NUM
ajlm-1432	84	44	%	%	NOUN
ajlm-1432	84	45	)	)	PUNCT
ajlm-1432	84	46	were	be	AUX
ajlm-1432	84	47	positive	positive	ADJ
ajlm-1432	84	48	for	for	ADP
ajlm-1432	84	49	both	both	CCONJ
ajlm-1432	84	50	alpha	alpha	NOUN
ajlm-1432	84	51	and	and	CCONJ
ajlm-1432	84	52	beta	beta	NOUN
ajlm-1432	84	53	haemolysins	haemolysin	NOUN
ajlm-1432	84	54	(	(	PUNCT
ajlm-1432	84	55	figure	figure	NOUN
ajlm-1432	84	56	2	2	NUM
ajlm-1432	84	57	)	)	PUNCT
ajlm-1432	84	58	.	.	PUNCT
ajlm-1432	85	1	haemolysins	haemolysin	NOUN
ajlm-1432	85	2	from	from	ADP
ajlm-1432	85	3	the	the	DET
ajlm-1432	85	4	181	181	NUM
ajlm-1432	85	5	participants	participant	NOUN
ajlm-1432	85	6	positive	positive	ADJ
ajlm-1432	85	7	for	for	ADP
ajlm-1432	85	8	alpha	alpha	NOUN
ajlm-1432	85	9	haemolysin	haemolysin	NOUN
ajlm-1432	85	10	showed	show	VERB
ajlm-1432	85	11	trace	trace	NOUN
ajlm-1432	85	12	haemolysis	haemolysis	NOUN
ajlm-1432	85	13	(	(	PUNCT
ajlm-1432	85	14	47	47	NUM
ajlm-1432	85	15	;	;	PUNCT
ajlm-1432	85	16	26.0	26.0	NUM
ajlm-1432	85	17	%	%	NOUN
ajlm-1432	85	18	)	)	PUNCT
ajlm-1432	85	19	,	,	PUNCT
ajlm-1432	85	20	partial	partial	ADJ
ajlm-1432	85	21	haemolysis	haemolysis	NOUN
ajlm-1432	85	22	(	(	PUNCT
ajlm-1432	85	23	95	95	NUM
ajlm-1432	85	24	;	;	PUNCT
ajlm-1432	85	25	52.5	52.5	NUM
ajlm-1432	85	26	%	%	NOUN
ajlm-1432	85	27	)	)	PUNCT
ajlm-1432	85	28	and	and	CCONJ
ajlm-1432	85	29	complete	complete	ADJ
ajlm-1432	85	30	haemolysis	haemolysis	NOUN
ajlm-1432	85	31	(	(	PUNCT
ajlm-1432	85	32	39	39	NUM
ajlm-1432	85	33	;	;	PUNCT
ajlm-1432	85	34	21.5	21.5	NUM
ajlm-1432	85	35	%	%	NOUN
ajlm-1432	85	36	)	)	PUNCT
ajlm-1432	85	37	(	(	PUNCT
ajlm-1432	85	38	table	table	NOUN
ajlm-1432	85	39	2	2	NUM
ajlm-1432	85	40	)	)	PUNCT
ajlm-1432	85	41	.	.	PUNCT
ajlm-1432	86	1	of	of	ADP
ajlm-1432	86	2	the	the	DET
ajlm-1432	86	3	haemolysins	haemolysin	NOUN
ajlm-1432	86	4	from	from	ADP
ajlm-1432	86	5	the	the	DET
ajlm-1432	86	6	145	145	NUM
ajlm-1432	86	7	participants	participant	NOUN
ajlm-1432	86	8	positive	positive	ADJ
ajlm-1432	86	9	for	for	ADP
ajlm-1432	86	10	beta	beta	ADJ
ajlm-1432	86	11	haemolysin	haemolysin	NOUN
ajlm-1432	86	12	,	,	PUNCT
ajlm-1432	86	13	58	58	NUM
ajlm-1432	86	14	(	(	PUNCT
ajlm-1432	86	15	40.0	40.0	NUM
ajlm-1432	86	16	%	%	NOUN
ajlm-1432	86	17	)	)	PUNCT
ajlm-1432	86	18	showed	show	VERB
ajlm-1432	86	19	trace	trace	NOUN
ajlm-1432	86	20	haemolysis	haemolysis	NOUN
ajlm-1432	86	21	,	,	PUNCT
ajlm-1432	86	22	58	58	NUM
ajlm-1432	86	23	(	(	PUNCT
ajlm-1432	86	24	40.0	40.0	NUM
ajlm-1432	86	25	%	%	NOUN
ajlm-1432	86	26	)	)	PUNCT
ajlm-1432	86	27	showed	show	VERB
ajlm-1432	86	28	partial	partial	ADJ
ajlm-1432	86	29	haemolysis	haemolysis	NOUN
ajlm-1432	86	30	,	,	PUNCT
ajlm-1432	86	31	and	and	CCONJ
ajlm-1432	86	32	29	29	NUM
ajlm-1432	86	33	(	(	PUNCT
ajlm-1432	86	34	20.0	20.0	NUM
ajlm-1432	86	35	%	%	NOUN
ajlm-1432	86	36	)	)	PUNCT
ajlm-1432	86	37	showed	show	VERB
ajlm-1432	86	38	complete	complete	ADJ
ajlm-1432	86	39	haemolysis	haemolysis	NOUN
ajlm-1432	86	40	.	.	PUNCT
ajlm-1432	87	1	the	the	DET
ajlm-1432	87	2	highest	highest	ADV
ajlm-1432	87	3	observed	observe	VERB
ajlm-1432	87	4	haemolysin	haemolysin	NOUN
ajlm-1432	87	5	titre	titre	NOUN
ajlm-1432	87	6	was	be	AUX
ajlm-1432	87	7	32	32	NUM
ajlm-1432	87	8	and	and	CCONJ
ajlm-1432	87	9	was	be	AUX
ajlm-1432	87	10	detected	detect	VERB
ajlm-1432	87	11	in	in	ADP
ajlm-1432	87	12	five	five	NUM
ajlm-1432	87	13	(	(	PUNCT
ajlm-1432	87	14	2.8	2.8	NUM
ajlm-1432	87	15	%	%	NOUN
ajlm-1432	87	16	)	)	PUNCT
ajlm-1432	87	17	alpha	alpha	PROPN
ajlm-1432	87	18	haemolysin	haemolysin	NOUN
ajlm-1432	87	19	-	-	PUNCT
ajlm-1432	87	20	positive	positive	ADJ
ajlm-1432	87	21	participants	participant	NOUN
ajlm-1432	87	22	and	and	CCONJ
ajlm-1432	87	23	three	three	NUM
ajlm-1432	87	24	(	(	PUNCT
ajlm-1432	87	25	2.1	2.1	NUM
ajlm-1432	87	26	%	%	NOUN
ajlm-1432	87	27	)	)	PUNCT
ajlm-1432	87	28	beta	beta	NOUN
ajlm-1432	87	29	haemolysin	haemolysin	NOUN
ajlm-1432	87	30	-	-	PUNCT
ajlm-1432	87	31	positive	positive	ADJ
ajlm-1432	87	32	participants	participant	NOUN
ajlm-1432	87	33	.	.	PUNCT
ajlm-1432	88	1	eighty	eighty	NUM
ajlm-1432	88	2	-	-	PUNCT
ajlm-1432	88	3	nine	nine	NUM
ajlm-1432	88	4	(	(	PUNCT
ajlm-1432	88	5	89	89	NUM
ajlm-1432	88	6	;	;	PUNCT
ajlm-1432	88	7	18.5	18.5	NUM
ajlm-1432	88	8	%	%	NOUN
ajlm-1432	88	9	)	)	PUNCT
ajlm-1432	88	10	participants	participant	NOUN
ajlm-1432	88	11	presented	present	VERB
ajlm-1432	88	12	with	with	ADP
ajlm-1432	88	13	significant	significant	ADJ
ajlm-1432	88	14	haemolysin	haemolysin	NOUN
ajlm-1432	88	15	titres	titre	NOUN
ajlm-1432	88	16	(	(	PUNCT
ajlm-1432	88	17	table	table	NOUN
ajlm-1432	88	18	3	3	NUM
ajlm-1432	88	19	)	)	PUNCT
ajlm-1432	88	20	,	,	PUNCT
ajlm-1432	88	21	of	of	ADP
ajlm-1432	88	22	which	which	PRON
ajlm-1432	88	23	45	45	NUM
ajlm-1432	88	24	(	(	PUNCT
ajlm-1432	88	25	50.6	50.6	NUM
ajlm-1432	88	26	%	%	NOUN
ajlm-1432	88	27	)	)	PUNCT
ajlm-1432	88	28	were	be	AUX
ajlm-1432	88	29	alpha	alpha	ADJ
ajlm-1432	88	30	haemolysin	haemolysin	NOUN
ajlm-1432	88	31	-	-	PUNCT
ajlm-1432	88	32	positive	positive	ADJ
ajlm-1432	88	33	only	only	ADV
ajlm-1432	88	34	,	,	PUNCT
ajlm-1432	88	35	16	16	NUM
ajlm-1432	88	36	(	(	PUNCT
ajlm-1432	88	37	18.0	18.0	NUM
ajlm-1432	88	38	%	%	NOUN
ajlm-1432	88	39	)	)	PUNCT
ajlm-1432	88	40	were	be	AUX
ajlm-1432	88	41	beta	beta	ADJ
ajlm-1432	88	42	haemolysin	haemolysin	NOUN
ajlm-1432	88	43	-	-	PUNCT
ajlm-1432	88	44	positive	positive	ADJ
ajlm-1432	88	45	only	only	ADV
ajlm-1432	88	46	,	,	PUNCT
ajlm-1432	88	47	and	and	CCONJ
ajlm-1432	88	48	14	14	NUM
ajlm-1432	88	49	(	(	PUNCT
ajlm-1432	88	50	15.7	15.7	NUM
ajlm-1432	88	51	%	%	NOUN
ajlm-1432	88	52	)	)	PUNCT
ajlm-1432	88	53	were	be	AUX
ajlm-1432	88	54	positive	positive	ADJ
ajlm-1432	88	55	for	for	ADP
ajlm-1432	88	56	both	both	CCONJ
ajlm-1432	88	57	alpha	alpha	NOUN
ajlm-1432	88	58	and	and	CCONJ
ajlm-1432	88	59	beta	beta	NOUN
ajlm-1432	88	60	haemolysin	haemolysin	NOUN
ajlm-1432	88	61	(	(	PUNCT
ajlm-1432	88	62	figure	figure	NOUN
ajlm-1432	88	63	3	3	NUM
ajlm-1432	88	64	)	)	PUNCT
ajlm-1432	88	65	.	.	PUNCT
ajlm-1432	89	1	figure	figure	VERB
ajlm-1432	89	2	2	2	NUM
ajlm-1432	89	3	:	:	PUNCT
ajlm-1432	89	4	the	the	DET
ajlm-1432	89	5	prevalence	prevalence	NOUN
ajlm-1432	89	6	of	of	ADP
ajlm-1432	89	7	alpha	alpha	NOUN
ajlm-1432	89	8	and	and	CCONJ
ajlm-1432	89	9	beta	beta	ADJ
ajlm-1432	89	10	haemolysins	haemolysin	NOUN
ajlm-1432	89	11	among	among	ADP
ajlm-1432	89	12	haemolysin	haemolysin	NOUN
ajlm-1432	89	13	-	-	PUNCT
ajlm-1432	89	14	positive	positive	ADJ
ajlm-1432	89	15	blood	blood	NOUN
ajlm-1432	89	16	group	group	NOUN
ajlm-1432	89	17	o	o	NOUN
ajlm-1432	89	18	donors	donor	NOUN
ajlm-1432	89	19	at	at	ADP
ajlm-1432	89	20	the	the	DET
ajlm-1432	89	21	rhbbb	rhbbb	NOUN
ajlm-1432	89	22	,	,	PUNCT
ajlm-1432	89	23	cameroon	cameroon	PROPN
ajlm-1432	89	24	,	,	PUNCT
ajlm-1432	89	25	june	june	PROPN
ajlm-1432	89	26	2020	2020	NUM
ajlm-1432	89	27	–	–	PUNCT
ajlm-1432	89	28	september	september	PROPN
ajlm-1432	89	29	2020	2020	NUM
ajlm-1432	89	30	.	.	PUNCT
ajlm-1432	90	1	figure	figure	VERB
ajlm-1432	90	2	3	3	NUM
ajlm-1432	90	3	:	:	PUNCT
ajlm-1432	90	4	prevalence	prevalence	NOUN
ajlm-1432	90	5	of	of	ADP
ajlm-1432	90	6	significant	significant	ADJ
ajlm-1432	90	7	titres	titre	NOUN
ajlm-1432	90	8	of	of	ADP
ajlm-1432	90	9	alpha	alpha	NOUN
ajlm-1432	90	10	and	and	CCONJ
ajlm-1432	90	11	beta	beta	NOUN
ajlm-1432	90	12	haemolysins	haemolysin	NOUN
ajlm-1432	90	13	among	among	ADP
ajlm-1432	90	14	blood	blood	NOUN
ajlm-1432	90	15	group	group	NOUN
ajlm-1432	90	16	o	o	NOUN
ajlm-1432	90	17	donors	donor	NOUN
ajlm-1432	90	18	at	at	ADP
ajlm-1432	90	19	the	the	DET
ajlm-1432	90	20	rhbbb	rhbbb	NOUN
ajlm-1432	90	21	,	,	PUNCT
ajlm-1432	90	22	cameroon	cameroon	PROPN
ajlm-1432	90	23	,	,	PUNCT
ajlm-1432	90	24	june	june	PROPN
ajlm-1432	90	25	2020	2020	NUM
ajlm-1432	90	26	–	–	PUNCT
ajlm-1432	90	27	september	september	PROPN
ajlm-1432	90	28	2020	2020	NUM
ajlm-1432	90	29	.	.	PUNCT
ajlm-1432	91	1	table	table	NOUN
ajlm-1432	91	2	2	2	NUM
ajlm-1432	91	3	:	:	PUNCT
ajlm-1432	91	4	 	 	SPACE
ajlm-1432	91	5	degree	degree	NOUN
ajlm-1432	91	6	of	of	ADP
ajlm-1432	91	7	haemolysis	haemolysis	NOUN
ajlm-1432	91	8	of	of	ADP
ajlm-1432	91	9	alpha	alpha	NOUN
ajlm-1432	91	10	and	and	CCONJ
ajlm-1432	91	11	beta	beta	NOUN
ajlm-1432	91	12	haemolysins	haemolysin	NOUN
ajlm-1432	91	13	from	from	ADP
ajlm-1432	91	14	blood	blood	NOUN
ajlm-1432	91	15	group	group	NOUN
ajlm-1432	91	16	o	o	NOUN
ajlm-1432	91	17	donors	donor	NOUN
ajlm-1432	91	18	at	at	ADP
ajlm-1432	91	19	the	the	DET
ajlm-1432	91	20	rhbbb	rhbbb	NOUN
ajlm-1432	91	21	,	,	PUNCT
ajlm-1432	91	22	cameroon	cameroon	PROPN
ajlm-1432	91	23	,	,	PUNCT
ajlm-1432	91	24	june	june	PROPN
ajlm-1432	91	25	2020	2020	NUM
ajlm-1432	91	26	–	–	PUNCT
ajlm-1432	91	27	september	september	PROPN
ajlm-1432	91	28	2020	2020	NUM
ajlm-1432	91	29	.	.	PUNCT
ajlm-1432	92	1	table	table	NOUN
ajlm-1432	92	2	3	3	NUM
ajlm-1432	92	3	:	:	PUNCT
ajlm-1432	92	4	 	 	SPACE
ajlm-1432	92	5	titres	titre	NOUN
ajlm-1432	92	6	of	of	ADP
ajlm-1432	92	7	alpha	alpha	NOUN
ajlm-1432	92	8	and	and	CCONJ
ajlm-1432	92	9	beta	beta	NOUN
ajlm-1432	92	10	haemolysins	haemolysin	NOUN
ajlm-1432	92	11	among	among	ADP
ajlm-1432	92	12	blood	blood	NOUN
ajlm-1432	92	13	group	group	NOUN
ajlm-1432	92	14	o	o	NOUN
ajlm-1432	92	15	donors	donor	NOUN
ajlm-1432	92	16	at	at	ADP
ajlm-1432	92	17	the	the	DET
ajlm-1432	92	18	rhbbb	rhbbb	NOUN
ajlm-1432	92	19	,	,	PUNCT
ajlm-1432	92	20	cameroon	cameroon	PROPN
ajlm-1432	92	21	,	,	PUNCT
ajlm-1432	92	22	june	june	PROPN
ajlm-1432	92	23	2020	2020	NUM
ajlm-1432	92	24	–	–	PUNCT
ajlm-1432	92	25	september	september	PROPN
ajlm-1432	92	26	2020	2020	NUM
ajlm-1432	92	27	.	.	PUNCT
ajlm-1432	93	1	discussion	discussion	NOUN
ajlm-1432	93	2	this	this	DET
ajlm-1432	93	3	study	study	NOUN
ajlm-1432	93	4	was	be	AUX
ajlm-1432	93	5	carried	carry	VERB
ajlm-1432	93	6	out	out	ADP
ajlm-1432	93	7	to	to	PART
ajlm-1432	93	8	determine	determine	VERB
ajlm-1432	93	9	the	the	DET
ajlm-1432	93	10	prevalence	prevalence	NOUN
ajlm-1432	93	11	and	and	CCONJ
ajlm-1432	93	12	titres	titre	NOUN
ajlm-1432	93	13	of	of	ADP
ajlm-1432	93	14	haemolysin	haemolysin	NOUN
ajlm-1432	93	15	among	among	ADP
ajlm-1432	93	16	blood	blood	NOUN
ajlm-1432	93	17	group	group	NOUN
ajlm-1432	93	18	o	o	NOUN
ajlm-1432	93	19	donors	donor	NOUN
ajlm-1432	93	20	at	at	ADP
ajlm-1432	93	21	the	the	DET
ajlm-1432	93	22	rhbbb	rhbbb	NOUN
ajlm-1432	93	23	.	.	PUNCT
ajlm-1432	94	1	our	our	PRON
ajlm-1432	94	2	study	study	NOUN
ajlm-1432	94	3	found	find	VERB
ajlm-1432	94	4	a	a	DET
ajlm-1432	94	5	high	high	ADJ
ajlm-1432	94	6	haemolysin	haemolysin	NOUN
ajlm-1432	94	7	prevalence	prevalence	NOUN
ajlm-1432	94	8	of	of	ADP
ajlm-1432	94	9	52.1	52.1	NUM
ajlm-1432	94	10	%	%	NOUN
ajlm-1432	94	11	among	among	ADP
ajlm-1432	94	12	the	the	DET
ajlm-1432	94	13	study	study	NOUN
ajlm-1432	94	14	population	population	NOUN
ajlm-1432	94	15	.	.	PUNCT
ajlm-1432	95	1	significant	significant	ADJ
ajlm-1432	95	2	haemolysin	haemolysin	NOUN
ajlm-1432	95	3	titres	titre	NOUN
ajlm-1432	95	4	(	(	PUNCT
ajlm-1432	95	5	defined	define	VERB
ajlm-1432	95	6	as	as	ADP
ajlm-1432	95	7	titres	titre	NOUN
ajlm-1432	95	8	≥	≥	NUM
ajlm-1432	95	9	8)	8)	NUM
ajlm-1432	95	10	were	be	AUX
ajlm-1432	95	11	also	also	ADV
ajlm-1432	95	12	detected	detect	VERB
ajlm-1432	95	13	in	in	ADP
ajlm-1432	95	14	a	a	DET
ajlm-1432	95	15	high	high	ADJ
ajlm-1432	95	16	proportion	proportion	NOUN
ajlm-1432	95	17	(	(	PUNCT
ajlm-1432	95	18	18.5	18.5	NUM
ajlm-1432	95	19	%	%	NOUN
ajlm-1432	95	20	)	)	PUNCT
ajlm-1432	95	21	of	of	ADP
ajlm-1432	95	22	participants	participant	NOUN
ajlm-1432	95	23	.	.	PUNCT
ajlm-1432	96	1	this	this	DET
ajlm-1432	96	2	high	high	ADJ
ajlm-1432	96	3	prevalence	prevalence	NOUN
ajlm-1432	96	4	may	may	AUX
ajlm-1432	96	5	be	be	AUX
ajlm-1432	96	6	attributed	attribute	VERB
ajlm-1432	96	7	to	to	ADP
ajlm-1432	96	8	immunisation	immunisation	NOUN
ajlm-1432	96	9	arising	arise	VERB
ajlm-1432	96	10	from	from	ADP
ajlm-1432	96	11	exposure	exposure	NOUN
ajlm-1432	96	12	to	to	ADP
ajlm-1432	96	13	mosquito	mosquito	ADJ
ajlm-1432	96	14	bites	bite	NOUN
ajlm-1432	96	15	and	and	CCONJ
ajlm-1432	96	16	parasitic	parasitic	ADJ
ajlm-1432	96	17	infections	infection	NOUN
ajlm-1432	96	18	of	of	ADP
ajlm-1432	96	19	the	the	DET
ajlm-1432	96	20	gastrointestinal	gastrointestinal	ADJ
ajlm-1432	96	21	system.22	system.22	NOUN
ajlm-1432	96	22	high	high	ADJ
ajlm-1432	96	23	prevalence	prevalence	NOUN
ajlm-1432	96	24	rates	rate	NOUN
ajlm-1432	96	25	of	of	ADP
ajlm-1432	96	26	malaria23	malaria23	NOUN
ajlm-1432	96	27	and	and	CCONJ
ajlm-1432	96	28	gastrointestinal	gastrointestinal	ADJ
ajlm-1432	96	29	parasites24	parasites24	NOUN
ajlm-1432	96	30	have	have	AUX
ajlm-1432	96	31	been	be	AUX
ajlm-1432	96	32	reported	report	VERB
ajlm-1432	96	33	in	in	ADP
ajlm-1432	96	34	bamenda	bamenda	NOUN
ajlm-1432	96	35	,	,	PUNCT
ajlm-1432	96	36	north	north	NOUN
ajlm-1432	96	37	-	-	PUNCT
ajlm-1432	96	38	west	west	NOUN
ajlm-1432	96	39	region	region	NOUN
ajlm-1432	96	40	,	,	PUNCT
ajlm-1432	96	41	cameroon.25	cameroon.25	VERB
ajlm-1432	96	42	the	the	DET
ajlm-1432	96	43	high	high	ADJ
ajlm-1432	96	44	prevalence	prevalence	NOUN
ajlm-1432	96	45	of	of	ADP
ajlm-1432	96	46	haemolysin	haemolysin	NOUN
ajlm-1432	96	47	in	in	ADP
ajlm-1432	96	48	this	this	DET
ajlm-1432	96	49	study	study	NOUN
ajlm-1432	96	50	is	be	AUX
ajlm-1432	96	51	comparable	comparable	ADJ
ajlm-1432	96	52	to	to	ADP
ajlm-1432	96	53	that	that	PRON
ajlm-1432	96	54	(	(	PUNCT
ajlm-1432	96	55	52.8	52.8	NUM
ajlm-1432	96	56	%	%	NOUN
ajlm-1432	96	57	)	)	PUNCT
ajlm-1432	96	58	reported	report	VERB
ajlm-1432	96	59	by	by	ADP
ajlm-1432	96	60	a	a	DET
ajlm-1432	96	61	study	study	NOUN
ajlm-1432	96	62	in	in	ADP
ajlm-1432	96	63	abakaliki	abakaliki	ADJ
ajlm-1432	96	64	,	,	PUNCT
ajlm-1432	96	65	nigeria	nigeria	PROPN
ajlm-1432	96	66	,	,	PUNCT
ajlm-1432	96	67	in	in	ADP
ajlm-1432	96	68	2014.25	2014.25	NUM
ajlm-1432	96	69	lower	low	ADJ
ajlm-1432	96	70	haemolysin	haemolysin	NOUN
ajlm-1432	96	71	prevalence	prevalence	NOUN
ajlm-1432	96	72	rates	rate	NOUN
ajlm-1432	96	73	have	have	AUX
ajlm-1432	96	74	been	be	AUX
ajlm-1432	96	75	reported	report	VERB
ajlm-1432	96	76	by	by	ADP
ajlm-1432	96	77	studies	study	NOUN
ajlm-1432	96	78	among	among	ADP
ajlm-1432	96	79	healthy	healthy	ADJ
ajlm-1432	96	80	blood	blood	NOUN
ajlm-1432	96	81	donors	donor	NOUN
ajlm-1432	96	82	in	in	ADP
ajlm-1432	96	83	south	south	PROPN
ajlm-1432	96	84	india	india	PROPN
ajlm-1432	96	85	(	(	PUNCT
ajlm-1432	96	86	10.8	10.8	NUM
ajlm-1432	96	87	%	%	NOUN
ajlm-1432	96	88	in	in	ADP
ajlm-1432	96	89	2019),26	2019),26	PROPN
ajlm-1432	96	90	abidjan	abidjan	PROPN
ajlm-1432	96	91	,	,	PUNCT
ajlm-1432	96	92	côte	côte	NOUN
ajlm-1432	96	93	d’lvoire18	d’lvoire18	NOUN
ajlm-1432	96	94	(	(	PUNCT
ajlm-1432	96	95	35.1	35.1	NUM
ajlm-1432	96	96	%	%	NOUN
ajlm-1432	96	97	in	in	ADP
ajlm-1432	96	98	2016	2016	NUM
ajlm-1432	96	99	)	)	PUNCT
ajlm-1432	96	100	,	,	PUNCT
ajlm-1432	96	101	lagos	lago	NOUN
ajlm-1432	96	102	,	,	PUNCT
ajlm-1432	96	103	nigeria10	nigeria10	NOUN
ajlm-1432	96	104	(	(	PUNCT
ajlm-1432	96	105	30.3	30.3	NUM
ajlm-1432	96	106	%	%	NOUN
ajlm-1432	96	107	in	in	ADP
ajlm-1432	96	108	2015	2015	NUM
ajlm-1432	96	109	)	)	PUNCT
ajlm-1432	96	110	,	,	PUNCT
ajlm-1432	96	111	bauchi	bauchi	ADJ
ajlm-1432	96	112	,	,	PUNCT
ajlm-1432	96	113	nigeria27	nigeria27	NOUN
ajlm-1432	96	114	(	(	PUNCT
ajlm-1432	96	115	22.2	22.2	NUM
ajlm-1432	96	116	%	%	NOUN
ajlm-1432	96	117	in	in	ADP
ajlm-1432	96	118	2015	2015	NUM
ajlm-1432	96	119	)	)	PUNCT
ajlm-1432	96	120	,	,	PUNCT
ajlm-1432	96	121	anambra	anambra	PROPN
ajlm-1432	96	122	,	,	PUNCT
ajlm-1432	96	123	nigeria28	nigeria28	PROPN
ajlm-1432	96	124	(	(	PUNCT
ajlm-1432	96	125	16.06	16.06	NUM
ajlm-1432	96	126	%	%	NOUN
ajlm-1432	96	127	in	in	ADP
ajlm-1432	96	128	2015	2015	NUM
ajlm-1432	96	129	)	)	PUNCT
ajlm-1432	96	130	,	,	PUNCT
ajlm-1432	96	131	tunisia14	tunisia14	NOUN
ajlm-1432	96	132	(	(	PUNCT
ajlm-1432	96	133	6.6	6.6	NUM
ajlm-1432	96	134	%	%	NOUN
ajlm-1432	96	135	in	in	ADP
ajlm-1432	96	136	2008	2008	NUM
ajlm-1432	96	137	)	)	PUNCT
ajlm-1432	96	138	,	,	PUNCT
ajlm-1432	96	139	ilorin	ilorin	NOUN
ajlm-1432	96	140	,	,	PUNCT
ajlm-1432	96	141	nigeria11	nigeria11	NOUN
ajlm-1432	96	142	(	(	PUNCT
ajlm-1432	96	143	23.2	23.2	NUM
ajlm-1432	96	144	%	%	NOUN
ajlm-1432	96	145	in	in	ADP
ajlm-1432	96	146	2001	2001	NUM
ajlm-1432	96	147	)	)	PUNCT
ajlm-1432	96	148	,	,	PUNCT
ajlm-1432	96	149	and	and	CCONJ
ajlm-1432	96	150	nigeria12	nigeria12	NOUN
ajlm-1432	96	151	(	(	PUNCT
ajlm-1432	96	152	30.6	30.6	NUM
ajlm-1432	96	153	%	%	NOUN
ajlm-1432	96	154	in	in	ADP
ajlm-1432	96	155	1990	1990	NUM
ajlm-1432	96	156	)	)	PUNCT
ajlm-1432	96	157	.	.	PUNCT
ajlm-1432	97	1	a	a	DET
ajlm-1432	97	2	higher	high	ADJ
ajlm-1432	97	3	prevalence	prevalence	NOUN
ajlm-1432	97	4	of	of	ADP
ajlm-1432	97	5	69.0	69.0	NUM
ajlm-1432	97	6	%	%	NOUN
ajlm-1432	97	7	was	be	AUX
ajlm-1432	97	8	reported	report	VERB
ajlm-1432	97	9	in	in	ADP
ajlm-1432	97	10	a	a	DET
ajlm-1432	97	11	2012	2012	NUM
ajlm-1432	97	12	study	study	NOUN
ajlm-1432	97	13	on	on	ADP
ajlm-1432	97	14	healthy	healthy	ADJ
ajlm-1432	97	15	blood	blood	NOUN
ajlm-1432	97	16	donors	donor	NOUN
ajlm-1432	97	17	in	in	ADP
ajlm-1432	97	18	bangkok	bangkok	PROPN
ajlm-1432	97	19	,	,	PUNCT
ajlm-1432	97	20	thailand.29	thailand.29	VERB
ajlm-1432	97	21	these	these	DET
ajlm-1432	97	22	differences	difference	NOUN
ajlm-1432	97	23	in	in	ADP
ajlm-1432	97	24	prevalence	prevalence	NOUN
ajlm-1432	97	25	rates	rate	NOUN
ajlm-1432	97	26	may	may	AUX
ajlm-1432	97	27	be	be	AUX
ajlm-1432	97	28	due	due	ADJ
ajlm-1432	97	29	to	to	ADP
ajlm-1432	97	30	the	the	DET
ajlm-1432	97	31	admixture	admixture	NOUN
ajlm-1432	97	32	of	of	ADP
ajlm-1432	97	33	blood	blood	NOUN
ajlm-1432	97	34	of	of	ADP
ajlm-1432	97	35	immigrants	immigrant	NOUN
ajlm-1432	97	36	as	as	ADP
ajlm-1432	97	37	a	a	DET
ajlm-1432	97	38	result	result	NOUN
ajlm-1432	97	39	of	of	ADP
ajlm-1432	97	40	intermarriages,20	intermarriages,20	ADJ
ajlm-1432	97	41	variations	variation	NOUN
ajlm-1432	97	42	in	in	ADP
ajlm-1432	97	43	serum	serum	NOUN
ajlm-1432	97	44	-	-	PUNCT
ajlm-1432	97	45	cell	cell	NOUN
ajlm-1432	97	46	ratios,30	ratios,30	NOUN
ajlm-1432	97	47	or	or	CCONJ
ajlm-1432	97	48	differences	difference	NOUN
ajlm-1432	97	49	in	in	ADP
ajlm-1432	97	50	geographical	geographical	ADJ
ajlm-1432	97	51	location,26	location,26	NOUN
ajlm-1432	97	52	particularly	particularly	ADV
ajlm-1432	97	53	due	due	ADJ
ajlm-1432	97	54	to	to	ADP
ajlm-1432	97	55	the	the	DET
ajlm-1432	97	56	differences	difference	NOUN
ajlm-1432	97	57	in	in	ADP
ajlm-1432	97	58	the	the	DET
ajlm-1432	97	59	degree	degree	NOUN
ajlm-1432	97	60	of	of	ADP
ajlm-1432	97	61	exposure	exposure	NOUN
ajlm-1432	97	62	to	to	ADP
ajlm-1432	97	63	gastrointestinal	gastrointestinal	ADJ
ajlm-1432	97	64	parasites22	parasites22	NOUN
ajlm-1432	97	65	and	and	CCONJ
ajlm-1432	97	66	mosquitoes.13,14,15	mosquitoes.13,14,15	SYM
ajlm-1432	97	67	it	it	PRON
ajlm-1432	97	68	has	have	AUX
ajlm-1432	97	69	been	be	AUX
ajlm-1432	97	70	reported	report	VERB
ajlm-1432	97	71	that	that	SCONJ
ajlm-1432	97	72	higher	high	ADJ
ajlm-1432	97	73	serum	serum	NOUN
ajlm-1432	97	74	-	-	PUNCT
ajlm-1432	97	75	cell	cell	NOUN
ajlm-1432	97	76	ratios	ratio	NOUN
ajlm-1432	97	77	increase	increase	VERB
ajlm-1432	97	78	the	the	DET
ajlm-1432	97	79	tendency	tendency	NOUN
ajlm-1432	97	80	for	for	ADP
ajlm-1432	97	81	red	red	ADJ
ajlm-1432	97	82	cell	cell	NOUN
ajlm-1432	97	83	lysis.30	lysis.30	PROPN
ajlm-1432	97	84	the	the	DET
ajlm-1432	97	85	alpha	alpha	PROPN
ajlm-1432	97	86	haemolysin	haemolysin	PROPN
ajlm-1432	97	87	prevalence	prevalence	NOUN
ajlm-1432	97	88	in	in	ADP
ajlm-1432	97	89	this	this	DET
ajlm-1432	97	90	study	study	NOUN
ajlm-1432	97	91	(	(	PUNCT
ajlm-1432	97	92	53.6	53.6	NUM
ajlm-1432	97	93	%	%	NOUN
ajlm-1432	97	94	)	)	PUNCT
ajlm-1432	97	95	was	be	AUX
ajlm-1432	97	96	higher	high	ADJ
ajlm-1432	97	97	than	than	ADP
ajlm-1432	97	98	that	that	PRON
ajlm-1432	97	99	reported	report	VERB
ajlm-1432	97	100	in	in	ADP
ajlm-1432	97	101	a	a	DET
ajlm-1432	97	102	study	study	NOUN
ajlm-1432	97	103	conducted	conduct	VERB
ajlm-1432	97	104	in	in	ADP
ajlm-1432	97	105	2010	2010	NUM
ajlm-1432	97	106	in	in	ADP
ajlm-1432	97	107	southeast	southeast	PROPN
ajlm-1432	97	108	nigeria	nigeria	PROPN
ajlm-1432	97	109	that	that	PRON
ajlm-1432	97	110	reported	report	VERB
ajlm-1432	97	111	a	a	DET
ajlm-1432	97	112	prevalence	prevalence	NOUN
ajlm-1432	97	113	of	of	ADP
ajlm-1432	97	114	10.3	10.3	NUM
ajlm-1432	97	115	%	%	NOUN
ajlm-1432	97	116	for	for	ADP
ajlm-1432	97	117	alpha	alpha	PROPN
ajlm-1432	97	118	haemolysin.20	haemolysin.20	PROPN
ajlm-1432	97	119	in	in	ADP
ajlm-1432	97	120	contrast	contrast	NOUN
ajlm-1432	97	121	,	,	PUNCT
ajlm-1432	97	122	the	the	DET
ajlm-1432	97	123	observed	observe	VERB
ajlm-1432	97	124	prevalence	prevalence	NOUN
ajlm-1432	97	125	rates	rate	NOUN
ajlm-1432	97	126	of	of	ADP
ajlm-1432	97	127	beta	beta	ADJ
ajlm-1432	97	128	haemolysin	haemolysin	NOUN
ajlm-1432	97	129	,	,	PUNCT
ajlm-1432	97	130	and	and	CCONJ
ajlm-1432	97	131	both	both	PRON
ajlm-1432	97	132	alpha	alpha	NOUN
ajlm-1432	97	133	and	and	CCONJ
ajlm-1432	97	134	beta	beta	NOUN
ajlm-1432	97	135	haemolysins	haemolysin	NOUN
ajlm-1432	97	136	in	in	ADP
ajlm-1432	97	137	this	this	DET
ajlm-1432	97	138	study	study	NOUN
ajlm-1432	97	139	were	be	AUX
ajlm-1432	97	140	lower	low	ADJ
ajlm-1432	97	141	than	than	ADP
ajlm-1432	97	142	that	that	PRON
ajlm-1432	97	143	reported	report	VERB
ajlm-1432	97	144	in	in	ADP
ajlm-1432	97	145	the	the	DET
ajlm-1432	97	146	same	same	ADJ
ajlm-1432	97	147	study	study	NOUN
ajlm-1432	97	148	(	(	PUNCT
ajlm-1432	97	149	8.3	8.3	NUM
ajlm-1432	97	150	%	%	NOUN
ajlm-1432	97	151	vs	vs	ADP
ajlm-1432	97	152	12.6	12.6	NUM
ajlm-1432	97	153	%	%	NOUN
ajlm-1432	97	154	for	for	ADP
ajlm-1432	97	155	beta	beta	NOUN
ajlm-1432	97	156	haemolysin	haemolysin	NOUN
ajlm-1432	97	157	,	,	PUNCT
ajlm-1432	97	158	and	and	CCONJ
ajlm-1432	97	159	15.8	15.8	NUM
ajlm-1432	97	160	%	%	NOUN
ajlm-1432	97	161	vs	vs	ADP
ajlm-1432	97	162	32.5	32.5	NUM
ajlm-1432	97	163	%	%	NOUN
ajlm-1432	97	164	for	for	ADP
ajlm-1432	97	165	both	both	CCONJ
ajlm-1432	97	166	alpha	alpha	NOUN
ajlm-1432	97	167	and	and	CCONJ
ajlm-1432	97	168	beta	beta	ADJ
ajlm-1432	97	169	haemolysins).20	haemolysins).20	NOUN
ajlm-1432	97	170	alpha	alpha	NOUN
ajlm-1432	97	171	haemolysins	haemolysin	NOUN
ajlm-1432	97	172	were	be	AUX
ajlm-1432	97	173	more	more	ADV
ajlm-1432	97	174	prevalent	prevalent	ADJ
ajlm-1432	97	175	in	in	ADP
ajlm-1432	97	176	our	our	PRON
ajlm-1432	97	177	study	study	NOUN
ajlm-1432	97	178	compared	compare	VERB
ajlm-1432	97	179	to	to	ADP
ajlm-1432	97	180	beta	beta	PROPN
ajlm-1432	97	181	haemolysin	haemolysin	NOUN
ajlm-1432	97	182	,	,	PUNCT
ajlm-1432	97	183	which	which	PRON
ajlm-1432	97	184	is	be	AUX
ajlm-1432	97	185	consistent	consistent	ADJ
ajlm-1432	97	186	with	with	ADP
ajlm-1432	97	187	the	the	DET
ajlm-1432	97	188	findings	finding	NOUN
ajlm-1432	97	189	of	of	ADP
ajlm-1432	97	190	a	a	DET
ajlm-1432	97	191	study	study	NOUN
ajlm-1432	97	192	conducted	conduct	VERB
ajlm-1432	97	193	in	in	ADP
ajlm-1432	97	194	201511	201511	NUM
ajlm-1432	97	195	in	in	ADP
ajlm-1432	97	196	lagos	lagos	PROPN
ajlm-1432	97	197	,	,	PUNCT
ajlm-1432	97	198	nigeria	nigeria	PROPN
ajlm-1432	97	199	,	,	PUNCT
ajlm-1432	97	200	but	but	CCONJ
ajlm-1432	97	201	different	different	ADJ
ajlm-1432	97	202	from	from	ADP
ajlm-1432	97	203	the	the	DET
ajlm-1432	97	204	findings	finding	NOUN
ajlm-1432	97	205	of	of	ADP
ajlm-1432	97	206	another	another	DET
ajlm-1432	97	207	study	study	NOUN
ajlm-1432	97	208	conducted	conduct	VERB
ajlm-1432	97	209	in	in	ADP
ajlm-1432	97	210	2001	2001	NUM
ajlm-1432	97	211	in	in	ADP
ajlm-1432	97	212	ilorin	ilorin	NOUN
ajlm-1432	97	213	,	,	PUNCT
ajlm-1432	97	214	nigeria	nigeria	PROPN
ajlm-1432	97	215	,	,	PUNCT
ajlm-1432	97	216	that	that	PRON
ajlm-1432	97	217	observed	observe	VERB
ajlm-1432	97	218	a	a	DET
ajlm-1432	97	219	higher	high	ADJ
ajlm-1432	97	220	prevalence	prevalence	NOUN
ajlm-1432	97	221	of	of	ADP
ajlm-1432	97	222	beta	beta	NOUN
ajlm-1432	97	223	haemolysin	haemolysin	NOUN
ajlm-1432	97	224	compared	compare	VERB
ajlm-1432	97	225	to	to	ADP
ajlm-1432	97	226	alpha	alpha	NOUN
ajlm-1432	97	227	haemolysin.11	haemolysin.11	VERB
ajlm-1432	97	228	the	the	DET
ajlm-1432	97	229	reasons	reason	NOUN
ajlm-1432	97	230	for	for	ADP
ajlm-1432	97	231	these	these	DET
ajlm-1432	97	232	variations	variation	NOUN
ajlm-1432	97	233	may	may	AUX
ajlm-1432	97	234	either	either	CCONJ
ajlm-1432	97	235	be	be	AUX
ajlm-1432	97	236	genetic	genetic	ADJ
ajlm-1432	97	237	or	or	CCONJ
ajlm-1432	97	238	environment	environment	NOUN
ajlm-1432	97	239	-	-	PUNCT
ajlm-1432	97	240	induced.31	induced.31	NOUN
ajlm-1432	97	241	the	the	DET
ajlm-1432	97	242	absence	absence	NOUN
ajlm-1432	97	243	of	of	ADP
ajlm-1432	97	244	associations	association	NOUN
ajlm-1432	97	245	between	between	ADP
ajlm-1432	97	246	haemolysin	haemolysin	NOUN
ajlm-1432	97	247	production	production	NOUN
ajlm-1432	97	248	and	and	CCONJ
ajlm-1432	97	249	gender	gender	NOUN
ajlm-1432	97	250	,	,	PUNCT
ajlm-1432	97	251	age	age	NOUN
ajlm-1432	97	252	group	group	NOUN
ajlm-1432	97	253	or	or	CCONJ
ajlm-1432	97	254	rhesus	rhesus	NOUN
ajlm-1432	97	255	d	d	NOUN
ajlm-1432	97	256	blood	blood	NOUN
ajlm-1432	97	257	group	group	NOUN
ajlm-1432	97	258	of	of	ADP
ajlm-1432	97	259	blood	blood	NOUN
ajlm-1432	97	260	group	group	NOUN
ajlm-1432	97	261	o	o	NOUN
ajlm-1432	97	262	donors	donor	NOUN
ajlm-1432	97	263	in	in	ADP
ajlm-1432	97	264	our	our	PRON
ajlm-1432	97	265	study	study	NOUN
ajlm-1432	97	266	is	be	AUX
ajlm-1432	97	267	consistent	consistent	ADJ
ajlm-1432	97	268	with	with	ADP
ajlm-1432	97	269	the	the	DET
ajlm-1432	97	270	findings	finding	NOUN
ajlm-1432	97	271	from	from	ADP
ajlm-1432	97	272	previous	previous	ADJ
ajlm-1432	97	273	studies.4,10,11,14,18,31,32	studies.4,10,11,14,18,31,32	NUM
ajlm-1432	97	274	the	the	DET
ajlm-1432	97	275	prevalence	prevalence	NOUN
ajlm-1432	97	276	of	of	ADP
ajlm-1432	97	277	significant	significant	ADJ
ajlm-1432	97	278	haemolysin	haemolysin	NOUN
ajlm-1432	97	279	titres	titre	NOUN
ajlm-1432	97	280	(	(	PUNCT
ajlm-1432	97	281	titres	titre	NOUN
ajlm-1432	97	282	≥	≥	NUM
ajlm-1432	97	283	8)	8)	NUM
ajlm-1432	97	284	in	in	ADP
ajlm-1432	97	285	our	our	PRON
ajlm-1432	97	286	study	study	NOUN
ajlm-1432	97	287	is	be	AUX
ajlm-1432	97	288	noteworthy	noteworthy	ADJ
ajlm-1432	97	289	,	,	PUNCT
ajlm-1432	97	290	considering	consider	VERB
ajlm-1432	97	291	the	the	DET
ajlm-1432	97	292	evidence	evidence	NOUN
ajlm-1432	97	293	that	that	SCONJ
ajlm-1432	97	294	titres	titre	NOUN
ajlm-1432	97	295	above	above	ADP
ajlm-1432	97	296	this	this	DET
ajlm-1432	97	297	threshold	threshold	NOUN
ajlm-1432	97	298	can	can	AUX
ajlm-1432	97	299	significantly	significantly	ADV
ajlm-1432	97	300	cause	cause	VERB
ajlm-1432	97	301	haemolysis	haemolysis	NOUN
ajlm-1432	97	302	in	in	ADP
ajlm-1432	97	303	vivo.33	vivo.33	PROPN
ajlm-1432	97	304	this	this	PRON
ajlm-1432	97	305	may	may	AUX
ajlm-1432	97	306	be	be	AUX
ajlm-1432	97	307	because	because	SCONJ
ajlm-1432	97	308	parasitic	parasitic	ADJ
ajlm-1432	97	309	infections	infection	NOUN
ajlm-1432	97	310	such	such	ADJ
ajlm-1432	97	311	as	as	ADP
ajlm-1432	97	312	malaria	malaria	NOUN
ajlm-1432	97	313	are	be	AUX
ajlm-1432	97	314	endemic	endemic	ADJ
ajlm-1432	97	315	in	in	ADP
ajlm-1432	97	316	the	the	DET
ajlm-1432	97	317	study	study	NOUN
ajlm-1432	97	318	area	area	NOUN
ajlm-1432	97	319	.	.	PUNCT
ajlm-1432	98	1	there	there	PRON
ajlm-1432	98	2	is	be	VERB
ajlm-1432	98	3	evidence	evidence	NOUN
ajlm-1432	98	4	that	that	SCONJ
ajlm-1432	98	5	the	the	DET
ajlm-1432	98	6	malaria	malaria	NOUN
ajlm-1432	98	7	parasite	parasite	NOUN
ajlm-1432	98	8	can	can	AUX
ajlm-1432	98	9	stimulate	stimulate	VERB
ajlm-1432	98	10	the	the	DET
ajlm-1432	98	11	production	production	NOUN
ajlm-1432	98	12	of	of	ADP
ajlm-1432	98	13	haemolysin.22	haemolysin.22	PRON
ajlm-1432	98	14	our	our	PRON
ajlm-1432	98	15	observation	observation	NOUN
ajlm-1432	98	16	is	be	AUX
ajlm-1432	98	17	lower	low	ADJ
ajlm-1432	98	18	than	than	ADP
ajlm-1432	98	19	those	those	PRON
ajlm-1432	98	20	reported	report	VERB
ajlm-1432	98	21	by	by	ADP
ajlm-1432	98	22	studies	study	NOUN
ajlm-1432	98	23	conducted	conduct	VERB
ajlm-1432	98	24	among	among	ADP
ajlm-1432	98	25	blood	blood	NOUN
ajlm-1432	98	26	group	group	NOUN
ajlm-1432	98	27	o	o	NOUN
ajlm-1432	98	28	donors	donor	NOUN
ajlm-1432	98	29	in	in	ADP
ajlm-1432	98	30	lagos	lago	NOUN
ajlm-1432	98	31	,	,	PUNCT
ajlm-1432	98	32	nigeria	nigeria	PROPN
ajlm-1432	98	33	,	,	PUNCT
ajlm-1432	98	34	in	in	ADP
ajlm-1432	98	35	2015	2015	NUM
ajlm-1432	98	36	(	(	PUNCT
ajlm-1432	98	37	18.6%)10	18.6%)10	NUM
ajlm-1432	98	38	and	and	CCONJ
ajlm-1432	98	39	ilorin	ilorin	NOUN
ajlm-1432	98	40	,	,	PUNCT
ajlm-1432	98	41	nigeria	nigeria	PROPN
ajlm-1432	98	42	,	,	PUNCT
ajlm-1432	98	43	in	in	ADP
ajlm-1432	98	44	2021	2021	NUM
ajlm-1432	98	45	(	(	PUNCT
ajlm-1432	98	46	31.7%).11	31.7%).11	NUM
ajlm-1432	98	47	this	this	PRON
ajlm-1432	98	48	may	may	AUX
ajlm-1432	98	49	be	be	AUX
ajlm-1432	98	50	due	due	ADJ
ajlm-1432	98	51	to	to	ADP
ajlm-1432	98	52	differences	difference	NOUN
ajlm-1432	98	53	in	in	ADP
ajlm-1432	98	54	geographical	geographical	ADJ
ajlm-1432	98	55	location26	location26	NOUN
ajlm-1432	98	56	and	and	CCONJ
ajlm-1432	98	57	the	the	DET
ajlm-1432	98	58	degree	degree	NOUN
ajlm-1432	98	59	of	of	ADP
ajlm-1432	98	60	exposure	exposure	NOUN
ajlm-1432	98	61	to	to	ADP
ajlm-1432	98	62	gastrointestinal	gastrointestinal	ADJ
ajlm-1432	98	63	parasites22	parasites22	NOUN
ajlm-1432	98	64	and	and	CCONJ
ajlm-1432	98	65	mosquitoes.13,14,15	mosquitoes.13,14,15	PROPN
ajlm-1432	98	66	group	group	NOUN
ajlm-1432	98	67	o	o	NOUN
ajlm-1432	98	68	blood	blood	NOUN
ajlm-1432	98	69	should	should	AUX
ajlm-1432	98	70	not	not	PART
ajlm-1432	98	71	be	be	AUX
ajlm-1432	98	72	transfused	transfuse	VERB
ajlm-1432	98	73	to	to	ADP
ajlm-1432	98	74	blood	blood	NOUN
ajlm-1432	98	75	group	group	NOUN
ajlm-1432	98	76	a	a	PROPN
ajlm-1432	98	77	,	,	PUNCT
ajlm-1432	98	78	b	b	NOUN
ajlm-1432	98	79	,	,	PUNCT
ajlm-1432	98	80	or	or	CCONJ
ajlm-1432	98	81	ab	ab	PROPN
ajlm-1432	98	82	recipients	recipient	NOUN
ajlm-1432	98	83	except	except	SCONJ
ajlm-1432	98	84	when	when	SCONJ
ajlm-1432	98	85	such	such	ADJ
ajlm-1432	98	86	blood	blood	NOUN
ajlm-1432	98	87	is	be	AUX
ajlm-1432	98	88	tested	test	VERB
ajlm-1432	98	89	and	and	CCONJ
ajlm-1432	98	90	determined	determine	VERB
ajlm-1432	98	91	to	to	PART
ajlm-1432	98	92	be	be	AUX
ajlm-1432	98	93	free	free	ADJ
ajlm-1432	98	94	of	of	ADP
ajlm-1432	98	95	haemolysins	haemolysin	NOUN
ajlm-1432	98	96	.	.	PUNCT
ajlm-1432	99	1	the	the	DET
ajlm-1432	99	2	haemolysin	haemolysin	NOUN
ajlm-1432	99	3	test	test	NOUN
ajlm-1432	99	4	should	should	AUX
ajlm-1432	99	5	be	be	AUX
ajlm-1432	99	6	included	include	VERB
ajlm-1432	99	7	in	in	ADP
ajlm-1432	99	8	the	the	DET
ajlm-1432	99	9	protocol	protocol	NOUN
ajlm-1432	99	10	for	for	ADP
ajlm-1432	99	11	screening	screening	NOUN
ajlm-1432	99	12	and	and	CCONJ
ajlm-1432	99	13	compatibility	compatibility	NOUN
ajlm-1432	99	14	testing	testing	NOUN
ajlm-1432	99	15	of	of	ADP
ajlm-1432	99	16	blood	blood	NOUN
ajlm-1432	99	17	donors	donor	NOUN
ajlm-1432	99	18	in	in	ADP
ajlm-1432	99	19	the	the	DET
ajlm-1432	99	20	national	national	ADJ
ajlm-1432	99	21	blood	blood	NOUN
ajlm-1432	99	22	transfusion	transfusion	NOUN
ajlm-1432	99	23	programme	programme	NOUN
ajlm-1432	99	24	of	of	ADP
ajlm-1432	99	25	cameroon	cameroon	NOUN
ajlm-1432	99	26	.	.	PUNCT
ajlm-1432	100	1	this	this	PRON
ajlm-1432	100	2	can	can	AUX
ajlm-1432	100	3	be	be	AUX
ajlm-1432	100	4	achieved	achieve	VERB
ajlm-1432	100	5	through	through	ADP
ajlm-1432	100	6	the	the	DET
ajlm-1432	100	7	collaborative	collaborative	ADJ
ajlm-1432	100	8	efforts	effort	NOUN
ajlm-1432	100	9	of	of	ADP
ajlm-1432	100	10	the	the	DET
ajlm-1432	100	11	government	government	NOUN
ajlm-1432	100	12	,	,	PUNCT
ajlm-1432	100	13	the	the	DET
ajlm-1432	100	14	ministry	ministry	PROPN
ajlm-1432	100	15	of	of	ADP
ajlm-1432	100	16	public	public	ADJ
ajlm-1432	100	17	health	health	NOUN
ajlm-1432	100	18	of	of	ADP
ajlm-1432	100	19	cameroon	cameroon	PROPN
ajlm-1432	100	20	,	,	PUNCT
ajlm-1432	100	21	the	the	DET
ajlm-1432	100	22	national	national	ADJ
ajlm-1432	100	23	blood	blood	NOUN
ajlm-1432	100	24	transfusion	transfusion	NOUN
ajlm-1432	100	25	programme	programme	NOUN
ajlm-1432	100	26	of	of	ADP
ajlm-1432	100	27	cameroon	cameroon	NOUN
ajlm-1432	100	28	,	,	PUNCT
ajlm-1432	100	29	as	as	ADV
ajlm-1432	100	30	well	well	ADV
ajlm-1432	100	31	as	as	ADP
ajlm-1432	100	32	staff	staff	NOUN
ajlm-1432	100	33	of	of	ADP
ajlm-1432	100	34	the	the	DET
ajlm-1432	100	35	rhb	rhb	NOUN
ajlm-1432	100	36	and	and	CCONJ
ajlm-1432	100	37	rhbbb	rhbbb	NOUN
ajlm-1432	100	38	.	.	PUNCT
ajlm-1432	101	1	training	training	NOUN
ajlm-1432	101	2	for	for	ADP
ajlm-1432	101	3	haemolysin	haemolysin	NOUN
ajlm-1432	101	4	testing	testing	NOUN
ajlm-1432	101	5	should	should	AUX
ajlm-1432	101	6	be	be	AUX
ajlm-1432	101	7	conducted	conduct	VERB
ajlm-1432	101	8	at	at	ADP
ajlm-1432	101	9	the	the	DET
ajlm-1432	101	10	national	national	ADJ
ajlm-1432	101	11	level	level	NOUN
ajlm-1432	101	12	.	.	PUNCT
ajlm-1432	102	1	furthermore	furthermore	ADV
ajlm-1432	102	2	,	,	PUNCT
ajlm-1432	102	3	more	more	ADJ
ajlm-1432	102	4	studies	study	NOUN
ajlm-1432	102	5	should	should	AUX
ajlm-1432	102	6	be	be	AUX
ajlm-1432	102	7	carried	carry	VERB
ajlm-1432	102	8	out	out	ADP
ajlm-1432	102	9	in	in	ADP
ajlm-1432	102	10	other	other	ADJ
ajlm-1432	102	11	localities	locality	NOUN
ajlm-1432	102	12	in	in	ADP
ajlm-1432	102	13	cameroon	cameroon	PROPN
ajlm-1432	102	14	to	to	PART
ajlm-1432	102	15	determine	determine	VERB
ajlm-1432	102	16	the	the	DET
ajlm-1432	102	17	haemolysin	haemolysin	NOUN
ajlm-1432	102	18	prevalence	prevalence	NOUN
ajlm-1432	102	19	or	or	CCONJ
ajlm-1432	102	20	presence	presence	NOUN
ajlm-1432	102	21	of	of	ADP
ajlm-1432	102	22	significant	significant	ADJ
ajlm-1432	102	23	titres	titre	NOUN
ajlm-1432	102	24	of	of	ADP
ajlm-1432	102	25	haemolysin	haemolysin	NOUN
ajlm-1432	102	26	among	among	ADP
ajlm-1432	102	27	blood	blood	NOUN
ajlm-1432	102	28	group	group	NOUN
ajlm-1432	102	29	o	o	NOUN
ajlm-1432	102	30	donors	donor	NOUN
ajlm-1432	102	31	.	.	PUNCT
ajlm-1432	103	1	limitations	limitation	NOUN
ajlm-1432	103	2	due	due	ADP
ajlm-1432	103	3	to	to	ADP
ajlm-1432	103	4	limited	limited	ADJ
ajlm-1432	103	5	resources	resource	NOUN
ajlm-1432	103	6	,	,	PUNCT
ajlm-1432	103	7	we	we	PRON
ajlm-1432	103	8	only	only	ADV
ajlm-1432	103	9	used	use	VERB
ajlm-1432	103	10	the	the	DET
ajlm-1432	103	11	visual	visual	ADJ
ajlm-1432	103	12	titration	titration	NOUN
ajlm-1432	103	13	method	method	NOUN
ajlm-1432	103	14	and	and	CCONJ
ajlm-1432	103	15	could	could	AUX
ajlm-1432	103	16	not	not	PART
ajlm-1432	103	17	carry	carry	VERB
ajlm-1432	103	18	out	out	ADP
ajlm-1432	103	19	the	the	DET
ajlm-1432	103	20	spectrophotometric	spectrophotometric	ADJ
ajlm-1432	103	21	or	or	CCONJ
ajlm-1432	103	22	gel	gel	NOUN
ajlm-1432	103	23	methods	method	NOUN
ajlm-1432	103	24	for	for	ADP
ajlm-1432	103	25	the	the	DET
ajlm-1432	103	26	quantification	quantification	NOUN
ajlm-1432	103	27	of	of	ADP
ajlm-1432	103	28	red	red	ADJ
ajlm-1432	103	29	blood	blood	NOUN
ajlm-1432	103	30	cell	cell	NOUN
ajlm-1432	103	31	lysis	lysis	NOUN
ajlm-1432	103	32	;	;	PUNCT
ajlm-1432	103	33	this	this	PRON
ajlm-1432	103	34	could	could	AUX
ajlm-1432	103	35	have	have	AUX
ajlm-1432	103	36	influenced	influence	VERB
ajlm-1432	103	37	the	the	DET
ajlm-1432	103	38	detection	detection	NOUN
ajlm-1432	103	39	of	of	ADP
ajlm-1432	103	40	lysis	lysis	NOUN
ajlm-1432	103	41	.	.	PUNCT
ajlm-1432	104	1	however	however	ADV
ajlm-1432	104	2	,	,	PUNCT
ajlm-1432	104	3	our	our	PRON
ajlm-1432	104	4	findings	finding	NOUN
ajlm-1432	104	5	were	be	AUX
ajlm-1432	104	6	compared	compare	VERB
ajlm-1432	104	7	only	only	ADV
ajlm-1432	104	8	with	with	ADP
ajlm-1432	104	9	studies	study	NOUN
ajlm-1432	104	10	that	that	PRON
ajlm-1432	104	11	used	use	VERB
ajlm-1432	104	12	the	the	DET
ajlm-1432	104	13	visual	visual	ADJ
ajlm-1432	104	14	method	method	NOUN
ajlm-1432	104	15	.	.	PUNCT
ajlm-1432	105	1	conclusion	conclusion	NOUN
ajlm-1432	105	2	alpha	alpha	NOUN
ajlm-1432	105	3	and	and	CCONJ
ajlm-1432	105	4	beta	beta	NOUN
ajlm-1432	105	5	haemolysins	haemolysin	NOUN
ajlm-1432	105	6	are	be	AUX
ajlm-1432	105	7	prevalent	prevalent	ADJ
ajlm-1432	105	8	and	and	CCONJ
ajlm-1432	105	9	exist	exist	VERB
ajlm-1432	105	10	in	in	ADP
ajlm-1432	105	11	significant	significant	ADJ
ajlm-1432	105	12	titres	titre	NOUN
ajlm-1432	105	13	among	among	ADP
ajlm-1432	105	14	blood	blood	NOUN
ajlm-1432	105	15	group	group	NOUN
ajlm-1432	105	16	o	o	NOUN
ajlm-1432	105	17	donors	donor	NOUN
ajlm-1432	105	18	in	in	ADP
ajlm-1432	105	19	bamenda	bamenda	NOUN
ajlm-1432	105	20	,	,	PUNCT
ajlm-1432	105	21	cameroon	cameroon	NOUN
ajlm-1432	105	22	.	.	PUNCT
ajlm-1432	106	1	thus	thus	ADV
ajlm-1432	106	2	,	,	PUNCT
ajlm-1432	106	3	there	there	PRON
ajlm-1432	106	4	is	be	VERB
ajlm-1432	106	5	an	an	DET
ajlm-1432	106	6	urgent	urgent	ADJ
ajlm-1432	106	7	need	need	NOUN
ajlm-1432	106	8	for	for	ADP
ajlm-1432	106	9	public	public	ADJ
ajlm-1432	106	10	health	health	NOUN
ajlm-1432	106	11	intervention	intervention	NOUN
ajlm-1432	106	12	.	.	PUNCT
ajlm-1432	107	1	considering	consider	VERB
ajlm-1432	107	2	the	the	DET
ajlm-1432	107	3	frequent	frequent	ADJ
ajlm-1432	107	4	practice	practice	NOUN
ajlm-1432	107	5	of	of	ADP
ajlm-1432	107	6	non	non	ADJ
ajlm-1432	107	7	-	-	ADJ
ajlm-1432	107	8	iso	iso	ADJ
ajlm-1432	107	9	group	group	NOUN
ajlm-1432	107	10	-	-	PUNCT
ajlm-1432	107	11	compatible	compatible	ADJ
ajlm-1432	107	12	abo	abo	NOUN
ajlm-1432	107	13	transfusion	transfusion	NOUN
ajlm-1432	107	14	,	,	PUNCT
ajlm-1432	107	15	there	there	PRON
ajlm-1432	107	16	is	be	VERB
ajlm-1432	107	17	a	a	DET
ajlm-1432	107	18	need	need	NOUN
ajlm-1432	107	19	to	to	PART
ajlm-1432	107	20	routinely	routinely	ADV
ajlm-1432	107	21	test	test	VERB
ajlm-1432	107	22	for	for	ADP
ajlm-1432	107	23	the	the	DET
ajlm-1432	107	24	presence	presence	NOUN
ajlm-1432	107	25	of	of	ADP
ajlm-1432	107	26	haemolysins	haemolysin	NOUN
ajlm-1432	107	27	in	in	ADP
ajlm-1432	107	28	blood	blood	NOUN
ajlm-1432	107	29	donors	donor	NOUN
ajlm-1432	107	30	to	to	PART
ajlm-1432	107	31	prevent	prevent	VERB
ajlm-1432	107	32	the	the	DET
ajlm-1432	107	33	potential	potential	ADJ
ajlm-1432	107	34	risk	risk	NOUN
ajlm-1432	107	35	to	to	ADP
ajlm-1432	107	36	recipients	recipient	NOUN
ajlm-1432	107	37	and	and	CCONJ
ajlm-1432	107	38	to	to	PART
ajlm-1432	107	39	provide	provide	VERB
ajlm-1432	107	40	safer	safe	ADJ
ajlm-1432	107	41	blood	blood	NOUN
ajlm-1432	107	42	for	for	ADP
ajlm-1432	107	43	maximum	maximum	ADJ
ajlm-1432	107	44	benefits	benefit	NOUN
ajlm-1432	107	45	to	to	ADP
ajlm-1432	107	46	the	the	DET
ajlm-1432	107	47	recipient	recipient	NOUN
ajlm-1432	107	48	.	.	PUNCT
ajlm-1432	108	1	acknowledgements	acknowledgement	NOUN
ajlm-1432	108	2	we	we	PRON
ajlm-1432	108	3	acknowledge	acknowledge	VERB
ajlm-1432	108	4	all	all	DET
ajlm-1432	108	5	the	the	DET
ajlm-1432	108	6	participants	participant	NOUN
ajlm-1432	108	7	who	who	PRON
ajlm-1432	108	8	gave	give	VERB
ajlm-1432	108	9	their	their	PRON
ajlm-1432	108	10	blood	blood	NOUN
ajlm-1432	108	11	for	for	ADP
ajlm-1432	108	12	this	this	DET
ajlm-1432	108	13	study	study	NOUN
ajlm-1432	108	14	.	.	PUNCT
ajlm-1432	109	1	thanks	thank	NOUN
ajlm-1432	109	2	to	to	ADP
ajlm-1432	109	3	the	the	DET
ajlm-1432	109	4	management	management	NOUN
ajlm-1432	109	5	of	of	ADP
ajlm-1432	109	6	the	the	DET
ajlm-1432	109	7	department	department	PROPN
ajlm-1432	109	8	of	of	ADP
ajlm-1432	109	9	medical	medical	ADJ
ajlm-1432	109	10	laboratory	laboratory	NOUN
ajlm-1432	109	11	science	science	NOUN
ajlm-1432	109	12	,	,	PUNCT
ajlm-1432	109	13	faculty	faculty	NOUN
ajlm-1432	109	14	of	of	ADP
ajlm-1432	109	15	health	health	NOUN
ajlm-1432	109	16	and	and	CCONJ
ajlm-1432	109	17	medical	medical	ADJ
ajlm-1432	109	18	science	science	NOUN
ajlm-1432	109	19	,	,	PUNCT
ajlm-1432	109	20	and	and	CCONJ
ajlm-1432	109	21	the	the	DET
ajlm-1432	109	22	department	department	PROPN
ajlm-1432	109	23	of	of	ADP
ajlm-1432	109	24	health	health	NOUN
ajlm-1432	109	25	economics	economic	NOUN
ajlm-1432	109	26	,	,	PUNCT
ajlm-1432	109	27	policy	policy	NOUN
ajlm-1432	109	28	and	and	CCONJ
ajlm-1432	109	29	management	management	NOUN
ajlm-1432	109	30	,	,	PUNCT
ajlm-1432	109	31	faculty	faculty	NOUN
ajlm-1432	109	32	of	of	ADP
ajlm-1432	109	33	business	business	NOUN
ajlm-1432	109	34	management	management	NOUN
ajlm-1432	109	35	–	–	PUNCT
ajlm-1432	109	36	catholic	catholic	PROPN
ajlm-1432	109	37	university	university	PROPN
ajlm-1432	109	38	of	of	ADP
ajlm-1432	109	39	cameroon	cameroon	NOUN
ajlm-1432	109	40	-	-	PUNCT
ajlm-1432	109	41	bamenda	bamenda	NOUN
ajlm-1432	109	42	for	for	ADP
ajlm-1432	109	43	academic	academic	ADJ
ajlm-1432	109	44	support	support	NOUN
ajlm-1432	109	45	during	during	ADP
ajlm-1432	109	46	this	this	DET
ajlm-1432	109	47	study	study	NOUN
ajlm-1432	109	48	.	.	PUNCT
ajlm-1432	110	1	lastly	lastly	ADV
ajlm-1432	110	2	,	,	PUNCT
ajlm-1432	110	3	we	we	PRON
ajlm-1432	110	4	appreciate	appreciate	VERB
ajlm-1432	110	5	the	the	DET
ajlm-1432	110	6	management	management	NOUN
ajlm-1432	110	7	and	and	CCONJ
ajlm-1432	110	8	staff	staff	NOUN
ajlm-1432	110	9	of	of	ADP
ajlm-1432	110	10	the	the	DET
ajlm-1432	110	11	rhbbb	rhbbb	NOUN
ajlm-1432	110	12	for	for	ADP
ajlm-1432	110	13	their	their	PRON
ajlm-1432	110	14	wonderful	wonderful	ADJ
ajlm-1432	110	15	support	support	NOUN
ajlm-1432	110	16	during	during	ADP
ajlm-1432	110	17	the	the	DET
ajlm-1432	110	18	study	study	NOUN
ajlm-1432	110	19	.	.	PUNCT
ajlm-1432	111	1	competing	compete	VERB
ajlm-1432	111	2	interests	interest	NOUN
ajlm-1432	111	3	the	the	DET
ajlm-1432	111	4	authors	author	NOUN
ajlm-1432	111	5	declare	declare	VERB
ajlm-1432	111	6	that	that	SCONJ
ajlm-1432	111	7	they	they	PRON
ajlm-1432	111	8	have	have	VERB
ajlm-1432	111	9	no	no	DET
ajlm-1432	111	10	financial	financial	ADJ
ajlm-1432	111	11	or	or	CCONJ
ajlm-1432	111	12	personal	personal	ADJ
ajlm-1432	111	13	relationships	relationship	NOUN
ajlm-1432	111	14	that	that	PRON
ajlm-1432	111	15	may	may	AUX
ajlm-1432	111	16	have	have	AUX
ajlm-1432	111	17	inappropriately	inappropriately	ADV
ajlm-1432	111	18	influenced	influence	VERB
ajlm-1432	111	19	them	they	PRON
ajlm-1432	111	20	in	in	ADP
ajlm-1432	111	21	writing	write	VERB
ajlm-1432	111	22	this	this	DET
ajlm-1432	111	23	article	article	NOUN
ajlm-1432	111	24	.	.	PUNCT
ajlm-1432	112	1	authors	author	NOUN
ajlm-1432	112	2	’	’	PART
ajlm-1432	112	3	contributions	contribution	NOUN
ajlm-1432	112	4	v.n.f	v.n.f	ADJ
ajlm-1432	112	5	.	.	PUNCT
ajlm-1432	113	1	(	(	PUNCT
ajlm-1432	113	2	study	study	NOUN
ajlm-1432	113	3	lead	lead	NOUN
ajlm-1432	113	4	)	)	PUNCT
ajlm-1432	113	5	designed	design	VERB
ajlm-1432	113	6	the	the	DET
ajlm-1432	113	7	model	model	NOUN
ajlm-1432	113	8	and	and	CCONJ
ajlm-1432	113	9	the	the	DET
ajlm-1432	113	10	computational	computational	ADJ
ajlm-1432	113	11	framework	framework	NOUN
ajlm-1432	113	12	,	,	PUNCT
ajlm-1432	113	13	conceived	conceive	VERB
ajlm-1432	113	14	,	,	PUNCT
ajlm-1432	113	15	and	and	CCONJ
ajlm-1432	113	16	planned	plan	VERB
ajlm-1432	113	17	the	the	DET
ajlm-1432	113	18	experiments	experiment	NOUN
ajlm-1432	113	19	and	and	CCONJ
ajlm-1432	113	20	finalised	finalise	VERB
ajlm-1432	113	21	the	the	DET
ajlm-1432	113	22	writing	writing	NOUN
ajlm-1432	113	23	of	of	ADP
ajlm-1432	113	24	the	the	DET
ajlm-1432	113	25	manuscript	manuscript	NOUN
ajlm-1432	113	26	.	.	PUNCT
ajlm-1432	114	1	t.s	t.s	PROPN
ajlm-1432	114	2	.	.	PROPN
ajlm-1432	114	3	and	and	CCONJ
ajlm-1432	114	4	v.n.f	v.n.f	VERB
ajlm-1432	114	5	.	.	PUNCT
ajlm-1432	115	1	were	be	AUX
ajlm-1432	115	2	responsible	responsible	ADJ
ajlm-1432	115	3	for	for	ADP
ajlm-1432	115	4	supervision	supervision	NOUN
ajlm-1432	115	5	of	of	ADP
ajlm-1432	115	6	the	the	DET
ajlm-1432	115	7	findings	finding	NOUN
ajlm-1432	115	8	.	.	PUNCT
ajlm-1432	116	1	v.n.f	v.n.f	ADJ
ajlm-1432	116	2	.	.	PROPN
ajlm-1432	116	3	,	,	PUNCT
ajlm-1432	116	4	r.m.f	r.m.f	ADJ
ajlm-1432	116	5	and	and	CCONJ
ajlm-1432	116	6	c.n.a	c.n.a	PROPN
ajlm-1432	116	7	.	.	PROPN
ajlm-1432	116	8	were	be	AUX
ajlm-1432	116	9	responsible	responsible	ADJ
ajlm-1432	116	10	for	for	ADP
ajlm-1432	116	11	statistical	statistical	ADJ
ajlm-1432	116	12	analysis	analysis	NOUN
ajlm-1432	116	13	.	.	PUNCT
ajlm-1432	117	1	v.n.f	v.n.f	X
ajlm-1432	117	2	.	.	PUNCT
ajlm-1432	118	1	and	and	CCONJ
ajlm-1432	118	2	n.n	n.n	PROPN
ajlm-1432	118	3	.	.	PROPN
ajlm-1432	118	4	were	be	AUX
ajlm-1432	118	5	responsible	responsible	ADJ
ajlm-1432	118	6	for	for	ADP
ajlm-1432	118	7	specimen	speciman	NOUN
ajlm-1432	118	8	collection	collection	NOUN
ajlm-1432	118	9	,	,	PUNCT
ajlm-1432	118	10	performing	perform	VERB
ajlm-1432	118	11	the	the	DET
ajlm-1432	118	12	experiments	experiment	NOUN
ajlm-1432	118	13	and	and	CCONJ
ajlm-1432	118	14	data	datum	NOUN
ajlm-1432	118	15	collection	collection	NOUN
ajlm-1432	118	16	.	.	PUNCT
ajlm-1432	119	1	t.s	t.s	PROPN
ajlm-1432	119	2	.	.	PROPN
ajlm-1432	119	3	,	,	PUNCT
ajlm-1432	119	4	n.n	n.n	PROPN
ajlm-1432	119	5	.	.	PROPN
ajlm-1432	119	6	,	,	PUNCT
ajlm-1432	119	7	r.m.f	r.m.f	ADJ
ajlm-1432	119	8	.	.	PUNCT
ajlm-1432	119	9	c.n.a	c.n.a	PROPN
ajlm-1432	119	10	.	.	PROPN
ajlm-1432	119	11	,	,	PUNCT
ajlm-1432	119	12	r.e	r.e	PROPN
ajlm-1432	119	13	-	-	PUNCT
ajlm-1432	119	14	t.	t.	PROPN
ajlm-1432	119	15	,	,	PUNCT
ajlm-1432	119	16	e.p.e	e.p.e	PROPN
ajlm-1432	119	17	.	.	PROPN
ajlm-1432	119	18	,	,	PUNCT
ajlm-1432	119	19	r.l	r.l	PROPN
ajlm-1432	119	20	,	,	PUNCT
ajlm-1432	119	21	n.f.n.r	n.f.n.r	PROPN
ajlm-1432	119	22	.	.	PROPN
ajlm-1432	120	1	and	and	CCONJ
ajlm-1432	120	2	d.n	d.n	PROPN
ajlm-1432	120	3	.	.	PROPN
ajlm-1432	120	4	reviewed	review	VERB
ajlm-1432	120	5	and	and	CCONJ
ajlm-1432	120	6	edited	edit	VERB
ajlm-1432	120	7	the	the	DET
ajlm-1432	120	8	manuscript	manuscript	NOUN
ajlm-1432	120	9	.	.	PUNCT
ajlm-1432	121	1	sources	source	NOUN
ajlm-1432	121	2	of	of	ADP
ajlm-1432	121	3	support	support	NOUN
ajlm-1432	121	4	this	this	DET
ajlm-1432	121	5	research	research	NOUN
ajlm-1432	121	6	received	receive	VERB
ajlm-1432	121	7	no	no	DET
ajlm-1432	121	8	specific	specific	ADJ
ajlm-1432	121	9	grant	grant	NOUN
ajlm-1432	121	10	from	from	ADP
ajlm-1432	121	11	any	any	DET
ajlm-1432	121	12	funding	funding	NOUN
ajlm-1432	121	13	agency	agency	NOUN
ajlm-1432	121	14	in	in	ADP
ajlm-1432	121	15	the	the	DET
ajlm-1432	121	16	public	public	ADJ
ajlm-1432	121	17	,	,	PUNCT
ajlm-1432	121	18	commercial	commercial	ADJ
ajlm-1432	121	19	or	or	CCONJ
ajlm-1432	121	20	not	not	PART
ajlm-1432	121	21	-	-	PUNCT
ajlm-1432	121	22	for	for	ADP
ajlm-1432	121	23	-	-	PUNCT
ajlm-1432	121	24	profit	profit	NOUN
ajlm-1432	121	25	sectors	sector	NOUN
ajlm-1432	121	26	.	.	PUNCT
ajlm-1432	122	1	data	datum	NOUN
ajlm-1432	122	2	availability	availability	NOUN
ajlm-1432	122	3	the	the	DET
ajlm-1432	122	4	data	datum	NOUN
ajlm-1432	122	5	supporting	support	VERB
ajlm-1432	122	6	the	the	DET
ajlm-1432	122	7	findings	finding	NOUN
ajlm-1432	122	8	of	of	ADP
ajlm-1432	122	9	this	this	DET
ajlm-1432	122	10	study	study	NOUN
ajlm-1432	122	11	are	be	AUX
ajlm-1432	122	12	available	available	ADJ
ajlm-1432	122	13	within	within	ADP
ajlm-1432	122	14	the	the	DET
ajlm-1432	122	15	article	article	NOUN
ajlm-1432	122	16	.	.	PUNCT
ajlm-1432	123	1	data	datum	NOUN
ajlm-1432	123	2	are	be	AUX
ajlm-1432	123	3	also	also	ADV
ajlm-1432	123	4	available	available	ADJ
ajlm-1432	123	5	on	on	ADP
ajlm-1432	123	6	request	request	NOUN
ajlm-1432	123	7	from	from	ADP
ajlm-1432	123	8	the	the	DET
ajlm-1432	123	9	corresponding	corresponding	ADJ
ajlm-1432	123	10	author	author	NOUN
ajlm-1432	123	11	,	,	PUNCT
ajlm-1432	123	12	v.n.f	v.n.f	ADJ
ajlm-1432	123	13	.	.	PUNCT
ajlm-1432	123	14	disclaimer	disclaimer	VERB
ajlm-1432	123	15	the	the	DET
ajlm-1432	123	16	views	view	NOUN
ajlm-1432	123	17	and	and	CCONJ
ajlm-1432	123	18	opinions	opinion	NOUN
ajlm-1432	123	19	expressed	express	VERB
ajlm-1432	123	20	in	in	ADP
ajlm-1432	123	21	this	this	DET
ajlm-1432	123	22	article	article	NOUN
ajlm-1432	123	23	are	be	AUX
ajlm-1432	123	24	those	those	PRON
ajlm-1432	123	25	of	of	ADP
ajlm-1432	123	26	the	the	DET
ajlm-1432	123	27	authors	author	NOUN
ajlm-1432	123	28	and	and	CCONJ
ajlm-1432	123	29	do	do	AUX
ajlm-1432	123	30	not	not	PART
ajlm-1432	123	31	necessarily	necessarily	ADV
ajlm-1432	123	32	reflect	reflect	VERB
ajlm-1432	123	33	the	the	DET
ajlm-1432	123	34	official	official	ADJ
ajlm-1432	123	35	policy	policy	NOUN
ajlm-1432	123	36	or	or	CCONJ
ajlm-1432	123	37	position	position	NOUN
ajlm-1432	123	38	of	of	ADP
ajlm-1432	123	39	any	any	DET
ajlm-1432	123	40	affiliated	affiliated	ADJ
ajlm-1432	123	41	agency	agency	NOUN
ajlm-1432	123	42	of	of	ADP
ajlm-1432	123	43	the	the	DET
ajlm-1432	123	44	authors	author	NOUN
ajlm-1432	123	45	.	.	PUNCT
ajlm-1432	124	1	references	reference	NOUN
ajlm-1432	124	2	boorman	boorman	PROPN
ajlm-1432	124	3	ke	ke	PROPN
ajlm-1432	124	4	,	,	PUNCT
ajlm-1432	124	5	dodd	dodd	PROPN
ajlm-1432	124	6	be	be	VERB
ajlm-1432	124	7	,	,	PUNCT
ajlm-1432	124	8	lincoln	lincoln	PROPN
ajlm-1432	124	9	pj	pj	PROPN
ajlm-1432	124	10	.	.	PUNCT
ajlm-1432	124	11	blood	blood	NOUN
ajlm-1432	124	12	group	group	NOUN
ajlm-1432	124	13	serology	serology	NOUN
ajlm-1432	124	14	:	:	PUNCT
ajlm-1432	124	15	theory	theory	NOUN
ajlm-1432	124	16	,	,	PUNCT
ajlm-1432	124	17	techniques	technique	NOUN
ajlm-1432	124	18	,	,	PUNCT
ajlm-1432	124	19	practical	practical	ADJ
ajlm-1432	124	20	applications	application	NOUN
ajlm-1432	124	21	.	.	PUNCT
ajlm-1432	125	1	london	london	PROPN
ajlm-1432	125	2	:	:	PUNCT
ajlm-1432	125	3	churchill	churchill	PROPN
ajlm-1432	125	4	livingstone	livingstone	PROPN
ajlm-1432	125	5	;	;	PUNCT
ajlm-1432	125	6	1977	1977	NUM
ajlm-1432	125	7	.	.	PUNCT
ajlm-1432	126	1	waters	water	VERB
ajlm-1432	126	2	a	a	PRON
ajlm-1432	126	3	,	,	PUNCT
ajlm-1432	126	4	lloyd	lloyd	PROPN
ajlm-1432	126	5	e.	e.	PROPN
ajlm-1432	126	6	laboratory	laboratory	PROPN
ajlm-1432	126	7	aspects	aspect	NOUN
ajlm-1432	126	8	of	of	ADP
ajlm-1432	126	9	blood	blood	NOUN
ajlm-1432	126	10	transfusion	transfusion	NOUN
ajlm-1432	126	11	.	.	PUNCT
ajlm-1432	127	1	practical	practical	ADJ
ajlm-1432	127	2	haematology	haematology	NOUN
ajlm-1432	127	3	.	.	PUNCT
ajlm-1432	128	1	7th	7th	ADJ
ajlm-1432	128	2	ed	ed	NOUN
ajlm-1432	128	3	.	.	PUNCT
ajlm-1432	128	4	edinburgh	edinburgh	PROPN
ajlm-1432	128	5	:	:	PUNCT
ajlm-1432	128	6	churchill	churchill	PROPN
ajlm-1432	128	7	livingstone	livingstone	PROPN
ajlm-1432	128	8	;	;	PUNCT
ajlm-1432	128	9	1991	1991	NUM
ajlm-1432	128	10	,	,	PUNCT
ajlm-1432	128	11	p.	p.	NOUN
ajlm-1432	128	12	115–124	115–124	NUM
ajlm-1432	128	13	.	.	PUNCT
ajlm-1432	129	1	berséus	berséus	PROPN
ajlm-1432	129	2	o	o	PROPN
ajlm-1432	129	3	,	,	PUNCT
ajlm-1432	129	4	boman	boman	PROPN
ajlm-1432	129	5	o	o	PROPN
ajlm-1432	129	6	,	,	PUNCT
ajlm-1432	129	7	nessen	nessen	PROPN
ajlm-1432	129	8	sc	sc	PROPN
ajlm-1432	129	9	,	,	PUNCT
ajlm-1432	129	10	et	et	PROPN
ajlm-1432	129	11	al	al	PROPN
ajlm-1432	129	12	.	.	PUNCT
ajlm-1432	129	13	risks	risk	NOUN
ajlm-1432	129	14	of	of	ADP
ajlm-1432	129	15	hemolysis	hemolysis	NOUN
ajlm-1432	129	16	due	due	ADJ
ajlm-1432	129	17	to	to	ADP
ajlm-1432	129	18	anti	anti	ADJ
ajlm-1432	129	19	-	-	ADJ
ajlm-1432	129	20	a	a	PRON
ajlm-1432	129	21	and	and	CCONJ
ajlm-1432	129	22	anti	anti	ADJ
ajlm-1432	129	23	-	-	ADJ
ajlm-1432	129	24	b	b	ADJ
ajlm-1432	129	25	caused	cause	VERB
ajlm-1432	129	26	by	by	ADP
ajlm-1432	129	27	the	the	DET
ajlm-1432	129	28	transfusion	transfusion	NOUN
ajlm-1432	129	29	of	of	ADP
ajlm-1432	129	30	blood	blood	NOUN
ajlm-1432	129	31	or	or	CCONJ
ajlm-1432	129	32	blood	blood	NOUN
ajlm-1432	129	33	components	component	NOUN
ajlm-1432	129	34	containing	contain	VERB
ajlm-1432	129	35	abo	abo	NOUN
ajlm-1432	129	36	-	-	PUNCT
ajlm-1432	129	37	incompatible	incompatible	ADJ
ajlm-1432	129	38	plasma	plasma	NOUN
ajlm-1432	129	39	.	.	PUNCT
ajlm-1432	130	1	transfusion	transfusion	NOUN
ajlm-1432	130	2	.	.	PUNCT
ajlm-1432	131	1	2013;53(s1):114s–123s	2013;53(s1):114s–123	NOUN
ajlm-1432	131	2	.	.	PUNCT
ajlm-1432	132	1	https://doi.org/10.1111/trf.12045	https://doi.org/10.1111/trf.12045	PROPN
ajlm-1432	132	2	angiolillo	angiolillo	PROPN
ajlm-1432	132	3	,	,	PUNCT
ajlm-1432	132	4	anne	anne	PROPN
ajlm-1432	132	5	et	et	PROPN
ajlm-1432	132	6	luban	luban	PROPN
ajlm-1432	132	7	,	,	PUNCT
ajlm-1432	132	8	naomi	naomi	NOUN
ajlm-1432	132	9	lc	lc	PROPN
ajlm-1432	132	10	.	.	PUNCT
ajlm-1432	133	1	hemolysis	hemolysis	PROPN
ajlm-1432	133	2	following	follow	VERB
ajlm-1432	133	3	an	an	DET
ajlm-1432	133	4	out	out	ADV
ajlm-1432	133	5	-	-	PUNCT
ajlm-1432	133	6	of	of	ADP
ajlm-1432	133	7	-	-	PUNCT
ajlm-1432	133	8	group	group	NOUN
ajlm-1432	133	9	platelet	platelet	NOUN
ajlm-1432	133	10	transfusion	transfusion	NOUN
ajlm-1432	133	11	in	in	ADP
ajlm-1432	133	12	an	an	DET
ajlm-1432	133	13	8	8	NUM
ajlm-1432	133	14	-	-	PUNCT
ajlm-1432	133	15	month	month	NOUN
ajlm-1432	133	16	-	-	PUNCT
ajlm-1432	133	17	old	old	ADJ
ajlm-1432	133	18	with	with	ADP
ajlm-1432	133	19	langerhans	langerhan	NOUN
ajlm-1432	133	20	cell	cell	NOUN
ajlm-1432	133	21	histiocytosis	histiocytosis	NOUN
ajlm-1432	133	22	.	.	PUNCT
ajlm-1432	134	1	j	j	PROPN
ajlm-1432	134	2	pediatr	pediatr	PROPN
ajlm-1432	134	3	hematol	hematol	PROPN
ajlm-1432	134	4	oncol	oncol	ADJ
ajlm-1432	134	5	.	.	PUNCT
ajlm-1432	135	1	2004;26(4):267–269	2004;26(4):267–269	X
ajlm-1432	135	2	.	.	PUNCT
ajlm-1432	135	3	https://doi.org/10.1097/00043426-200404000-00012	https://doi.org/10.1097/00043426-200404000-00012	PROPN
ajlm-1432	135	4	sapatnekar	sapatnekar	PROPN
ajlm-1432	135	5	s	s	PROPN
ajlm-1432	135	6	,	,	PUNCT
ajlm-1432	135	7	girish	girish	PROPN
ajlm-1432	135	8	s	s	PROPN
ajlm-1432	135	9	,	,	PUNCT
ajlm-1432	135	10	downes	downes	PROPN
ajlm-1432	135	11	ka	ka	PROPN
ajlm-1432	135	12	,	,	PUNCT
ajlm-1432	135	13	et	et	PROPN
ajlm-1432	135	14	al	al	PROPN
ajlm-1432	135	15	.	.	PROPN
ajlm-1432	135	16	acute	acute	PROPN
ajlm-1432	135	17	hemolytic	hemolytic	ADJ
ajlm-1432	135	18	transfusion	transfusion	NOUN
ajlm-1432	135	19	reaction	reaction	NOUN
ajlm-1432	135	20	in	in	ADP
ajlm-1432	135	21	a	a	DET
ajlm-1432	135	22	pediatric	pediatric	ADJ
ajlm-1432	135	23	patient	patient	NOUN
ajlm-1432	135	24	following	follow	VERB
ajlm-1432	135	25	transfusion	transfusion	NOUN
ajlm-1432	135	26	of	of	ADP
ajlm-1432	135	27	apheresis	apheresis	NOUN
ajlm-1432	135	28	platelets	platelet	NOUN
ajlm-1432	135	29	.	.	PUNCT
ajlm-1432	136	1	j	j	PROPN
ajlm-1432	136	2	clin	clin	PROPN
ajlm-1432	136	3	apheresis	apheresis	NOUN
ajlm-1432	136	4	.	.	PUNCT
ajlm-1432	137	1	2005;20(4):225–229	2005;20(4):225–229	X
ajlm-1432	137	2	.	.	PUNCT
ajlm-1432	138	1	https://doi.org/10.1002/jca.20072	https://doi.org/10.1002/jca.20072	PROPN
ajlm-1432	138	2	suleiman	suleiman	PROPN
ajlm-1432	138	3	am	be	AUX
ajlm-1432	138	4	,	,	PUNCT
ajlm-1432	138	5	aisha	aisha	PROPN
ajlm-1432	138	6	i	i	PROPN
ajlm-1432	138	7	,	,	PUNCT
ajlm-1432	138	8	mamman	mamman	PROPN
ajlm-1432	138	9	et	et	PROPN
ajlm-1432	138	10	,	,	PUNCT
ajlm-1432	138	11	akanmu	akanmu	VERB
ajlm-1432	138	12	as	as	ADP
ajlm-1432	138	13	.	.	PUNCT
ajlm-1432	139	1	transfusion	transfusion	NOUN
ajlm-1432	139	2	of	of	ADP
ajlm-1432	139	3	the	the	DET
ajlm-1432	139	4	dangerous	dangerous	ADJ
ajlm-1432	139	5	universal	universal	ADJ
ajlm-1432	139	6	donor	donor	NOUN
ajlm-1432	139	7	blood	blood	NOUN
ajlm-1432	139	8	leading	lead	VERB
ajlm-1432	139	9	to	to	ADP
ajlm-1432	139	10	maternal	maternal	ADJ
ajlm-1432	139	11	mortality	mortality	NOUN
ajlm-1432	139	12	:	:	PUNCT
ajlm-1432	139	13	a	a	DET
ajlm-1432	139	14	case	case	NOUN
ajlm-1432	139	15	report	report	NOUN
ajlm-1432	139	16	.	.	PUNCT
ajlm-1432	140	1	afr	afr	PROPN
ajlm-1432	140	2	sanguine	sanguine	PROPN
ajlm-1432	140	3	.	.	PUNCT
ajlm-1432	141	1	2016;18(2):1–3	2016;18(2):1–3	NUM
ajlm-1432	141	2	.	.	PUNCT
ajlm-1432	142	1	shittu	shittu	PROPN
ajlm-1432	142	2	ao	ao	PROPN
ajlm-1432	142	3	.	.	PUNCT
ajlm-1432	143	1	incidence	incidence	NOUN
ajlm-1432	143	2	of	of	ADP
ajlm-1432	143	3	acute	acute	ADJ
ajlm-1432	143	4	haemolytic	haemolytic	ADJ
ajlm-1432	143	5	transfusion	transfusion	NOUN
ajlm-1432	143	6	reactions	reaction	NOUN
ajlm-1432	143	7	in	in	ADP
ajlm-1432	143	8	abo	abo	NOUN
ajlm-1432	143	9	group	group	NOUN
ajlm-1432	143	10	compatible	compatible	ADJ
ajlm-1432	143	11	compared	compare	VERB
ajlm-1432	143	12	with	with	ADP
ajlm-1432	143	13	group	group	NOUN
ajlm-1432	143	14	identical	identical	ADJ
ajlm-1432	143	15	adult	adult	NOUN
ajlm-1432	143	16	blood	blood	NOUN
ajlm-1432	143	17	recipients	recipient	NOUN
ajlm-1432	143	18	in	in	ADP
ajlm-1432	143	19	ilorin	ilorin	NOUN
ajlm-1432	143	20	.	.	PUNCT
ajlm-1432	144	1	fmcpath	fmcpath	ADJ
ajlm-1432	144	2	dissertation	dissertation	NOUN
ajlm-1432	144	3	.	.	PUNCT
ajlm-1432	145	1	ibadan	ibadan	PROPN
ajlm-1432	145	2	:	:	PUNCT
ajlm-1432	145	3	faculty	faculty	NOUN
ajlm-1432	145	4	of	of	ADP
ajlm-1432	145	5	laboratory	laboratory	NOUN
ajlm-1432	145	6	medicine	medicine	NOUN
ajlm-1432	145	7	,	,	PUNCT
ajlm-1432	145	8	medical	medical	ADJ
ajlm-1432	145	9	college	college	PROPN
ajlm-1432	145	10	of	of	ADP
ajlm-1432	145	11	nigeria	nigeria	PROPN
ajlm-1432	145	12	.	.	PUNCT
ajlm-1432	146	1	2005	2005	NUM
ajlm-1432	146	2	.	.	PUNCT
ajlm-1432	147	1	available	available	ADJ
ajlm-1432	147	2	from	from	ADP
ajlm-1432	147	3	:	:	PUNCT
ajlm-1432	147	4	https://www.dissertation.npmcn.edu.ng/index.php/fmcpath/article/download/1349/1242	https://www.dissertation.npmcn.edu.ng/index.php/fmcpath/article/download/1349/1242	PROPN
ajlm-1432	147	5	aubert	aubert	NOUN
ajlm-1432	147	6	ef	ef	PROPN
ajlm-1432	147	7	,	,	PUNCT
ajlm-1432	147	8	boorman	boorman	PROPN
ajlm-1432	147	9	ke	ke	PROPN
ajlm-1432	147	10	,	,	PUNCT
ajlm-1432	147	11	dodd	dodd	PROPN
ajlm-1432	147	12	be	be	VERB
ajlm-1432	147	13	,	,	PUNCT
ajlm-1432	147	14	et	et	PROPN
ajlm-1432	147	15	al	al	PROPN
ajlm-1432	147	16	.	.	PUNCT
ajlm-1432	148	1	the	the	DET
ajlm-1432	148	2	universal	universal	ADJ
ajlm-1432	148	3	donor	donor	NOUN
ajlm-1432	148	4	with	with	ADP
ajlm-1432	148	5	high	high	ADJ
ajlm-1432	148	6	titre	titre	NOUN
ajlm-1432	148	7	iso	iso	NOUN
ajlm-1432	148	8	-	-	PUNCT
ajlm-1432	148	9	agglutinins	agglutinin	NOUN
ajlm-1432	148	10	.	.	PUNCT
ajlm-1432	149	1	br	br	PROPN
ajlm-1432	149	2	med	med	PROPN
ajlm-1432	149	3	j.	j.	PROPN
ajlm-1432	149	4	1942;1(4247	1942;1(4247	PROPN
ajlm-1432	149	5	):	):	PUNCT
ajlm-1432	149	6	659	659	NUM
ajlm-1432	149	7	.	.	PUNCT
ajlm-1432	150	1	https://doi.org/10.1136/bmj.1.4247.659	https://doi.org/10.1136/bmj.1.4247.659	NOUN
ajlm-1432	150	2	tisdall	tisdall	PROPN
ajlm-1432	150	3	ml	ml	ADP
ajlm-1432	150	4	,	,	PUNCT
ajlm-1432	150	5	garland	garland	PROPN
ajlm-1432	150	6	cd	cd	PROPN
ajlm-1432	150	7	,	,	PUNCT
ajlm-1432	150	8	szanto	szanto	ADP
ajlm-1432	150	9	lb	lb	NUM
ajlm-1432	150	10	,	,	PUNCT
ajlm-1432	150	11	et	et	PROPN
ajlm-1432	150	12	al	al	PROPN
ajlm-1432	150	13	.	.	PUNCT
ajlm-1432	151	1	the	the	DET
ajlm-1432	151	2	effects	effect	NOUN
ajlm-1432	151	3	of	of	ADP
ajlm-1432	151	4	the	the	DET
ajlm-1432	151	5	transfusion	transfusion	NOUN
ajlm-1432	151	6	of	of	ADP
ajlm-1432	151	7	group	group	NOUN
ajlm-1432	151	8	o	o	NOUN
ajlm-1432	151	9	blood	blood	NOUN
ajlm-1432	151	10	of	of	ADP
ajlm-1432	151	11	high	high	ADJ
ajlm-1432	151	12	iso	iso	NOUN
ajlm-1432	151	13	-	-	PUNCT
ajlm-1432	151	14	agglutinin	agglutinin	NOUN
ajlm-1432	151	15	titer	titer	NOUN
ajlm-1432	151	16	into	into	ADP
ajlm-1432	151	17	recipients	recipient	NOUN
ajlm-1432	151	18	of	of	ADP
ajlm-1432	151	19	other	other	ADJ
ajlm-1432	151	20	blood	blood	NOUN
ajlm-1432	151	21	groups	group	NOUN
ajlm-1432	151	22	.	.	PUNCT
ajlm-1432	152	1	am	be	AUX
ajlm-1432	152	2	j	j	PROPN
ajlm-1432	152	3	clin	clin	PROPN
ajlm-1432	152	4	pathol	pathol	PROPN
ajlm-1432	152	5	.	.	PUNCT
ajlm-1432	153	1	1946;16(3):193–206	1946;16(3):193–206	X
ajlm-1432	153	2	.	.	PUNCT
ajlm-1432	154	1	https://doi.org/10.1093/ajcp/16.3.193	https://doi.org/10.1093/ajcp/16.3.193	NOUN
ajlm-1432	154	2	oyedeyi	oyedeyi	VERB
ajlm-1432	154	3	o	o	PROPN
ajlm-1432	154	4	,	,	PUNCT
ajlm-1432	154	5	adeyemo	adeyemo	PROPN
ajlm-1432	154	6	t	t	PROPN
ajlm-1432	154	7	,	,	PUNCT
ajlm-1432	154	8	ogbenna	ogbenna	X
ajlm-1432	154	9	a	a	PRON
ajlm-1432	154	10	,	,	PUNCT
ajlm-1432	154	11	et	et	PROPN
ajlm-1432	154	12	al	al	PROPN
ajlm-1432	154	13	.	.	PUNCT
ajlm-1432	154	14	prevalence	prevalence	NOUN
ajlm-1432	154	15	of	of	ADP
ajlm-1432	154	16	anti‑a	anti‑a	PROPN
ajlm-1432	154	17	and	and	CCONJ
ajlm-1432	154	18	anti‑b	anti‑b	NOUN
ajlm-1432	154	19	hemolysis	hemolysis	NOUN
ajlm-1432	154	20	among	among	ADP
ajlm-1432	154	21	blood	blood	NOUN
ajlm-1432	154	22	group	group	NOUN
ajlm-1432	154	23	o	o	NOUN
ajlm-1432	154	24	donors	donor	NOUN
ajlm-1432	154	25	in	in	ADP
ajlm-1432	154	26	lagos	lago	NOUN
ajlm-1432	154	27	.	.	PUNCT
ajlm-1432	155	1	niger	niger	PROPN
ajlm-1432	155	2	j	j	PROPN
ajlm-1432	155	3	clin	clin	PROPN
ajlm-1432	155	4	pract	pract	PROPN
ajlm-1432	155	5	.	.	PUNCT
ajlm-1432	156	1	2015;18(3):328–332	2015;18(3):328–332	X
ajlm-1432	156	2	.	.	PUNCT
ajlm-1432	157	1	https://doi.org/10.4103/1119-3077.151760	https://doi.org/10.4103/1119-3077.151760	PROPN
ajlm-1432	157	2	olawumi	olawumi	ADJ
ajlm-1432	157	3	h	h	NOUN
ajlm-1432	157	4	,	,	PUNCT
ajlm-1432	157	5	olatunji	olatunji	NOUN
ajlm-1432	157	6	p.	p.	NOUN
ajlm-1432	157	7	prevalence	prevalence	NOUN
ajlm-1432	157	8	and	and	CCONJ
ajlm-1432	157	9	titre	titre	NOUN
ajlm-1432	157	10	of	of	ADP
ajlm-1432	157	11	alpha	alpha	NOUN
ajlm-1432	157	12	and	and	CCONJ
ajlm-1432	157	13	beta	beta	NOUN
ajlm-1432	157	14	haemolysins	haemolysin	NOUN
ajlm-1432	157	15	in	in	ADP
ajlm-1432	157	16	blood	blood	NOUN
ajlm-1432	157	17	group	group	NOUN
ajlm-1432	157	18	‘	'	PUNCT
ajlm-1432	157	19	o	o	NOUN
ajlm-1432	157	20	’	'	PUNCT
ajlm-1432	157	21	donors	donor	NOUN
ajlm-1432	157	22	in	in	ADP
ajlm-1432	157	23	ilorin	ilorin	NOUN
ajlm-1432	157	24	.	.	PUNCT
ajlm-1432	158	1	afr	afr	PROPN
ajlm-1432	158	2	j	j	PROPN
ajlm-1432	158	3	med	med	PROPN
ajlm-1432	158	4	med	med	PROPN
ajlm-1432	158	5	sci	sci	PROPN
ajlm-1432	158	6	.	.	PUNCT
ajlm-1432	158	7	2001;30(4):319–321	2001;30(4):319–321	NUM
ajlm-1432	158	8	.	.	PUNCT
ajlm-1432	159	1	emeribe	emeribe	PROPN
ajlm-1432	159	2	a.	a.	PROPN
ajlm-1432	159	3	the	the	DET
ajlm-1432	159	4	status	status	NOUN
ajlm-1432	159	5	of	of	ADP
ajlm-1432	159	6	alpha	alpha	NOUN
ajlm-1432	159	7	and	and	CCONJ
ajlm-1432	159	8	beta	beta	NOUN
ajlm-1432	159	9	haemolysins	haemolysin	NOUN
ajlm-1432	159	10	in	in	ADP
ajlm-1432	159	11	nigerian	nigerian	ADJ
ajlm-1432	159	12	blood	blood	NOUN
ajlm-1432	159	13	donors	donor	NOUN
ajlm-1432	159	14	.	.	PUNCT
ajlm-1432	160	1	east	east	PROPN
ajlm-1432	160	2	afr	afr	PROPN
ajlm-1432	160	3	med	med	PROPN
ajlm-1432	160	4	j.	j.	PROPN
ajlm-1432	160	5	1990;67(3):205–208	1990;67(3):205–208	PROPN
ajlm-1432	160	6	.	.	PROPN
ajlm-1432	160	7	uko	uko	PROPN
ajlm-1432	160	8	e	e	PROPN
ajlm-1432	160	9	,	,	PUNCT
ajlm-1432	160	10	erhabor	erhabor	PROPN
ajlm-1432	160	11	o	o	PROPN
ajlm-1432	160	12	,	,	PUNCT
ajlm-1432	160	13	ahmed	ahmed	PROPN
ajlm-1432	160	14	h	h	PROPN
ajlm-1432	160	15	,	,	PUNCT
ajlm-1432	160	16	et	et	PROPN
ajlm-1432	160	17	al	al	PROPN
ajlm-1432	160	18	.	.	PUNCT
ajlm-1432	161	1	prevalence	prevalence	NOUN
ajlm-1432	161	2	of	of	ADP
ajlm-1432	161	3	high	high	ADJ
ajlm-1432	161	4	titre	titre	NOUN
ajlm-1432	161	5	alpha	alpha	NOUN
ajlm-1432	161	6	and	and	CCONJ
ajlm-1432	161	7	beta	beta	NOUN
ajlm-1432	161	8	haemolysins	haemolysin	NOUN
ajlm-1432	161	9	among	among	ADP
ajlm-1432	161	10	blood	blood	NOUN
ajlm-1432	161	11	donors	donor	NOUN
ajlm-1432	161	12	in	in	ADP
ajlm-1432	161	13	sokoto	sokoto	PROPN
ajlm-1432	161	14	,	,	PUNCT
ajlm-1432	161	15	north	north	NOUN
ajlm-1432	161	16	western	western	PROPN
ajlm-1432	161	17	nigeria	nigeria	PROPN
ajlm-1432	161	18	.	.	PUNCT
ajlm-1432	162	1	int	int	PROPN
ajlm-1432	162	2	j	j	PROPN
ajlm-1432	162	3	med	med	PROPN
ajlm-1432	162	4	sci	sci	PROPN
ajlm-1432	162	5	health	health	NOUN
ajlm-1432	162	6	care	care	NOUN
ajlm-1432	162	7	.	.	PUNCT
ajlm-1432	163	1	2013;1:1–8	2013;1:1–8	NOUN
ajlm-1432	163	2	.	.	PUNCT
ajlm-1432	163	3	louati	louati	PROPN
ajlm-1432	163	4	n	n	CCONJ
ajlm-1432	163	5	,	,	PUNCT
ajlm-1432	163	6	cherif	cherif	PROPN
ajlm-1432	163	7	j	j	PROPN
ajlm-1432	163	8	,	,	PUNCT
ajlm-1432	163	9	ben	ben	PROPN
ajlm-1432	163	10	amor	amor	PROPN
ajlm-1432	163	11	i	i	PROPN
ajlm-1432	163	12	,	,	PUNCT
ajlm-1432	163	13	rekik	rekik	PROPN
ajlm-1432	163	14	h	h	NOUN
ajlm-1432	163	15	,	,	PUNCT
ajlm-1432	163	16	gargouri	gargouri	PROPN
ajlm-1432	163	17	j.	j.	PROPN
ajlm-1432	163	18	recherche	recherche	PROPN
ajlm-1432	163	19	des	des	PROPN
ajlm-1432	163	20	hémolysines	hémolysines	PROPN
ajlm-1432	163	21	chez	chez	PROPN
ajlm-1432	163	22	les	les	X
ajlm-1432	163	23	donneurs	donneurs	X
ajlm-1432	163	24	de	de	X
ajlm-1432	163	25	sang	sang	PROPN
ajlm-1432	163	26	.	.	PUNCT
ajlm-1432	164	1	tinisia	tinisia	PROPN
ajlm-1432	164	2	.	.	PUNCT
ajlm-1432	165	1	j	j	PROPN
ajlm-1432	165	2	inform	inform	VERB
ajlm-1432	165	3	méd	méd	NOUN
ajlm-1432	165	4	sfax	sfax	NOUN
ajlm-1432	165	5	.	.	PUNCT
ajlm-1432	166	1	2008;15(16):17–19	2008;15(16):17–19	X
ajlm-1432	166	2	.	.	PUNCT
ajlm-1432	167	1	ukaejiofor	ukaejiofor	PROPN
ajlm-1432	167	2	e.	e.	PROPN
ajlm-1432	168	1	the	the	DET
ajlm-1432	168	2	blood	blood	NOUN
ajlm-1432	168	3	groups	group	NOUN
ajlm-1432	168	4	antigen	antigen	NOUN
ajlm-1432	168	5	-	-	PUNCT
ajlm-1432	168	6	antibody	antibody	NOUN
ajlm-1432	168	7	reactions	reaction	NOUN
ajlm-1432	168	8	.	.	PUNCT
ajlm-1432	169	1	blood	blood	NOUN
ajlm-1432	169	2	transfus	transfus	PROPN
ajlm-1432	169	3	trop	trop	PROPN
ajlm-1432	169	4	.	.	PUNCT
ajlm-1432	170	1	1996;1:13–23	1996;1:13–23	X
ajlm-1432	170	2	.	.	PUNCT
ajlm-1432	171	1	kagu	kagu	PROPN
ajlm-1432	171	2	m	m	PROPN
ajlm-1432	171	3	,	,	PUNCT
ajlm-1432	171	4	ahmed	ahmed	PROPN
ajlm-1432	171	5	s	s	PROPN
ajlm-1432	171	6	,	,	PUNCT
ajlm-1432	171	7	askira	askira	PROPN
ajlm-1432	171	8	b.	b.	PROPN
ajlm-1432	171	9	utilisation	utilisation	NOUN
ajlm-1432	171	10	of	of	ADP
ajlm-1432	171	11	blood	blood	NOUN
ajlm-1432	171	12	transfusion	transfusion	NOUN
ajlm-1432	171	13	service	service	NOUN
ajlm-1432	171	14	in	in	ADP
ajlm-1432	171	15	north	north	PROPN
ajlm-1432	171	16	eastern	eastern	PROPN
ajlm-1432	171	17	nigeria	nigeria	PROPN
ajlm-1432	171	18	.	.	PUNCT
ajlm-1432	172	1	highland	highland	PROPN
ajlm-1432	172	2	med	med	PROPN
ajlm-1432	172	3	res	res	PROPN
ajlm-1432	172	4	j.	j.	PROPN
ajlm-1432	172	5	2007;5(2):27–30	2007;5(2):27–30	PROPN
ajlm-1432	172	6	.	.	PUNCT
ajlm-1432	173	1	bamou	bamou	PROPN
ajlm-1432	173	2	r	r	PROPN
ajlm-1432	173	3	,	,	PUNCT
ajlm-1432	173	4	sevidzem	sevidzem	NOUN
ajlm-1432	173	5	sl	sl	PROPN
ajlm-1432	173	6	.	.	PUNCT
ajlm-1432	173	7	abo	abo	PROPN
ajlm-1432	173	8	/	/	SYM
ajlm-1432	173	9	rhesus	rhesus	NOUN
ajlm-1432	173	10	blood	blood	NOUN
ajlm-1432	173	11	group	group	NOUN
ajlm-1432	173	12	systems	system	NOUN
ajlm-1432	173	13	and	and	CCONJ
ajlm-1432	173	14	malaria	malaria	NOUN
ajlm-1432	173	15	prevalence	prevalence	NOUN
ajlm-1432	173	16	among	among	ADP
ajlm-1432	173	17	students	student	NOUN
ajlm-1432	173	18	of	of	ADP
ajlm-1432	173	19	the	the	DET
ajlm-1432	173	20	university	university	PROPN
ajlm-1432	173	21	of	of	ADP
ajlm-1432	173	22	dschang	dschang	PROPN
ajlm-1432	173	23	,	,	PUNCT
ajlm-1432	173	24	cameroon	cameroon	PROPN
ajlm-1432	173	25	.	.	PUNCT
ajlm-1432	174	1	microwave	microwave	PROPN
ajlm-1432	174	2	j.	j.	PROPN
ajlm-1432	174	3	2016;7(4	2016;7(4	PROPN
ajlm-1432	174	4	)	)	PUNCT
ajlm-1432	174	5	.	.	PUNCT
ajlm-1432	175	1	victorine	victorine	PROPN
ajlm-1432	175	2	g	g	PROPN
ajlm-1432	175	3	-	-	PUNCT
ajlm-1432	175	4	kap	kap	PROPN
ajlm-1432	175	5	,	,	PUNCT
ajlm-1432	175	6	liliane	liliane	PROPN
ajlm-1432	175	7	sk	sk	PROPN
ajlm-1432	175	8	,	,	PUNCT
ajlm-1432	175	9	honoré	honoré	NOUN
ajlm-1432	175	10	aa	aa	PROPN
ajlm-1432	175	11	,	,	PUNCT
ajlm-1432	175	12	et	et	PROPN
ajlm-1432	175	13	al	al	PROPN
ajlm-1432	175	14	.	.	PUNCT
ajlm-1432	176	1	prevalence	prevalence	NOUN
ajlm-1432	176	2	of	of	ADP
ajlm-1432	176	3	anti	anti	ADJ
ajlm-1432	176	4	-	-	ADJ
ajlm-1432	176	5	a	a	PRON
ajlm-1432	176	6	and	and	CCONJ
ajlm-1432	176	7	anti	anti	ADJ
ajlm-1432	176	8	-	-	ADJ
ajlm-1432	176	9	b	b	ADJ
ajlm-1432	176	10	haemolysins	haemolysin	NOUN
ajlm-1432	176	11	in	in	ADP
ajlm-1432	176	12	group	group	NOUN
ajlm-1432	176	13	o	o	NOUN
ajlm-1432	176	14	blood	blood	NOUN
ajlm-1432	176	15	donors	donor	NOUN
ajlm-1432	176	16	at	at	ADP
ajlm-1432	176	17	the	the	DET
ajlm-1432	176	18	national	national	ADJ
ajlm-1432	176	19	blood	blood	NOUN
ajlm-1432	176	20	transfusion	transfusion	NOUN
ajlm-1432	176	21	center	center	NOUN
ajlm-1432	176	22	of	of	ADP
ajlm-1432	176	23	abidjan	abidjan	PROPN
ajlm-1432	176	24	,	,	PUNCT
ajlm-1432	176	25	côte	côte	PROPN
ajlm-1432	176	26	d’ivoire	d’ivoire	PROPN
ajlm-1432	176	27	.	.	PUNCT
ajlm-1432	177	1	int	int	PROPN
ajlm-1432	177	2	j	j	PROPN
ajlm-1432	177	3	immunol	immunol	NOUN
ajlm-1432	177	4	.	.	PUNCT
ajlm-1432	178	1	2016;4(6):68–72	2016;4(6):68–72	NUM
ajlm-1432	178	2	.	.	PUNCT
ajlm-1432	179	1	https://doi.org/10.11648/j.iji.20160406.14	https://doi.org/10.11648/j.iji.20160406.14	PROPN
ajlm-1432	179	2	cheesbrough	cheesbrough	PROPN
ajlm-1432	179	3	m.	m.	NOUN
ajlm-1432	179	4	district	district	PROPN
ajlm-1432	179	5	laboratory	laboratory	NOUN
ajlm-1432	179	6	practice	practice	NOUN
ajlm-1432	179	7	in	in	ADP
ajlm-1432	179	8	tropical	tropical	ADJ
ajlm-1432	179	9	countries	country	NOUN
ajlm-1432	179	10	,	,	PUNCT
ajlm-1432	179	11	part	part	NOUN
ajlm-1432	179	12	2	2	NUM
ajlm-1432	179	13	.	.	PUNCT
ajlm-1432	180	1	cambridge	cambridge	PROPN
ajlm-1432	180	2	:	:	PUNCT
ajlm-1432	180	3	cambridge	cambridge	PROPN
ajlm-1432	180	4	university	university	PROPN
ajlm-1432	180	5	press	press	NOUN
ajlm-1432	180	6	;	;	PUNCT
ajlm-1432	180	7	2006	2006	NUM
ajlm-1432	180	8	.	.	PUNCT
ajlm-1432	181	1	kagu	kagu	PROPN
ajlm-1432	181	2	m	m	PROPN
ajlm-1432	181	3	,	,	PUNCT
ajlm-1432	181	4	ahmed	ahmed	PROPN
ajlm-1432	181	5	sg	sg	PROPN
ajlm-1432	181	6	,	,	PUNCT
ajlm-1432	181	7	mohammed	mohammed	PROPN
ajlm-1432	181	8	aa	aa	PROPN
ajlm-1432	181	9	,	,	PUNCT
ajlm-1432	181	10	moshood	moshood	NOUN
ajlm-1432	181	11	wk	wk	PROPN
ajlm-1432	181	12	,	,	PUNCT
ajlm-1432	181	13	malah	malah	PROPN
ajlm-1432	181	14	mb	mb	PROPN
ajlm-1432	181	15	,	,	PUNCT
ajlm-1432	181	16	kehinde	kehinde	PROPN
ajlm-1432	181	17	jm	jm	PROPN
ajlm-1432	181	18	.	.	PROPN
ajlm-1432	181	19	anti	anti	PROPN
ajlm-1432	181	20	-	-	ADJ
ajlm-1432	181	21	a	a	PRON
ajlm-1432	181	22	and	and	CCONJ
ajlm-1432	181	23	anti	anti	ADJ
ajlm-1432	181	24	-	-	ADJ
ajlm-1432	181	25	b	b	ADJ
ajlm-1432	181	26	haemolysins	haemolysin	NOUN
ajlm-1432	181	27	amongst	amongst	ADP
ajlm-1432	181	28	group	group	NOUN
ajlm-1432	181	29	‘	'	PUNCT
ajlm-1432	181	30	o	o	NOUN
ajlm-1432	181	31	’	'	PUNCT
ajlm-1432	181	32	voluntary	voluntary	ADJ
ajlm-1432	181	33	blood	blood	NOUN
ajlm-1432	181	34	donors	donor	NOUN
ajlm-1432	181	35	in	in	ADP
ajlm-1432	181	36	northeastern	northeastern	ADJ
ajlm-1432	181	37	nigeria	nigeria	PROPN
ajlm-1432	181	38	.	.	PUNCT
ajlm-1432	182	1	j	j	PROPN
ajlm-1432	182	2	blood	blood	NOUN
ajlm-1432	182	3	transfus	transfus	PROPN
ajlm-1432	182	4	.	.	PUNCT
ajlm-1432	183	1	2011;2011:302406	2011;2011:302406	NUM
ajlm-1432	183	2	.	.	PUNCT
ajlm-1432	183	3	https://doi.org/10.4061/2011/302406	https://doi.org/10.4061/2011/302406	PROPN
ajlm-1432	183	4	edinoton	edinoton	PROPN
ajlm-1432	183	5	g	g	PROPN
ajlm-1432	183	6	,	,	PUNCT
ajlm-1432	183	7	gilles	gilles	PROPN
ajlm-1432	183	8	hm	hm	INTJ
ajlm-1432	183	9	.	.	PUNCT
ajlm-1432	183	10	pathology	pathology	PROPN
ajlm-1432	183	11	in	in	ADP
ajlm-1432	183	12	the	the	DET
ajlm-1432	183	13	tropics	tropic	NOUN
ajlm-1432	183	14	,	,	PUNCT
ajlm-1432	183	15	2nd	2nd	PROPN
ajlm-1432	183	16	edition	edition	NOUN
ajlm-1432	183	17	.	.	PUNCT
ajlm-1432	184	1	london	london	PROPN
ajlm-1432	184	2	:	:	PUNCT
ajlm-1432	184	3	edward	edward	PROPN
ajlm-1432	184	4	arnold	arnold	PROPN
ajlm-1432	184	5	(	(	PUNCT
ajlm-1432	184	6	publishers	publishers	PROPN
ajlm-1432	184	7	)	)	PUNCT
ajlm-1432	184	8	ltd	ltd	PROPN
ajlm-1432	184	9	;	;	PUNCT
ajlm-1432	184	10	1979	1979	NUM
ajlm-1432	184	11	.	.	PUNCT
ajlm-1432	185	1	shanbhag	shanbhag	NOUN
ajlm-1432	185	2	s	s	PROPN
ajlm-1432	185	3	,	,	PUNCT
ajlm-1432	185	4	joshi	joshi	PROPN
ajlm-1432	185	5	s	s	PROPN
ajlm-1432	185	6	,	,	PUNCT
ajlm-1432	185	7	bhatia	bhatia	PROPN
ajlm-1432	185	8	h.	h.	PROPN
ajlm-1432	185	9	evaluation	evaluation	NOUN
ajlm-1432	185	10	of	of	ADP
ajlm-1432	185	11	the	the	DET
ajlm-1432	185	12	two	two	NUM
ajlm-1432	185	13	screening	screen	VERB
ajlm-1432	185	14	techniques	technique	NOUN
ajlm-1432	185	15	in	in	ADP
ajlm-1432	185	16	the	the	DET
ajlm-1432	185	17	detection	detection	NOUN
ajlm-1432	185	18	of	of	ADP
ajlm-1432	185	19	high	high	ADJ
ajlm-1432	185	20	titre	titre	NOUN
ajlm-1432	185	21	anti	anti	NOUN
ajlm-1432	185	22	-	-	ADJ
ajlm-1432	185	23	a	a	PRON
ajlm-1432	185	24	and	and	CCONJ
ajlm-1432	185	25	anti	anti	ADJ
ajlm-1432	185	26	-	-	ADJ
ajlm-1432	185	27	b.	b.	ADJ
ajlm-1432	185	28	ind	ind	PROPN
ajlm-1432	185	29	j	j	PROPN
ajlm-1432	185	30	med	med	PROPN
ajlm-1432	185	31	res	re	NOUN
ajlm-1432	185	32	.	.	PUNCT
ajlm-1432	186	1	1973;61(12):1824–1830	1973;61(12):1824–1830	NUM
ajlm-1432	186	2	.	.	PUNCT
ajlm-1432	187	1	ntonifor	ntonifor	ADP
ajlm-1432	187	2	nh	nh	PROPN
ajlm-1432	187	3	,	,	PUNCT
ajlm-1432	187	4	veyufambom	veyufambom	PROPN
ajlm-1432	187	5	s.	s.	PROPN
ajlm-1432	187	6	assessing	assess	VERB
ajlm-1432	187	7	the	the	DET
ajlm-1432	187	8	effective	effective	ADJ
ajlm-1432	187	9	use	use	NOUN
ajlm-1432	187	10	of	of	ADP
ajlm-1432	187	11	mosquito	mosquito	ADJ
ajlm-1432	187	12	nets	net	NOUN
ajlm-1432	187	13	in	in	ADP
ajlm-1432	187	14	the	the	DET
ajlm-1432	187	15	prevention	prevention	NOUN
ajlm-1432	187	16	of	of	ADP
ajlm-1432	187	17	malaria	malaria	NOUN
ajlm-1432	187	18	in	in	ADP
ajlm-1432	187	19	some	some	DET
ajlm-1432	187	20	parts	part	NOUN
ajlm-1432	187	21	of	of	ADP
ajlm-1432	187	22	mezam	mezam	NOUN
ajlm-1432	187	23	division	division	NOUN
ajlm-1432	187	24	,	,	PUNCT
ajlm-1432	187	25	northwest	northwest	PROPN
ajlm-1432	187	26	region	region	PROPN
ajlm-1432	187	27	cameroon	cameroon	PROPN
ajlm-1432	187	28	.	.	PUNCT
ajlm-1432	188	1	malar	malar	ADJ
ajlm-1432	188	2	j.	j.	PROPN
ajlm-1432	188	3	2016;15(1):390	2016;15(1):390	PROPN
ajlm-1432	188	4	.	.	PUNCT
ajlm-1432	189	1	https://doi.org/10.1186/s12936-016-1419-y	https://doi.org/10.1186/s12936-016-1419-y	PROPN
ajlm-1432	189	2	bissong	bissong	PROPN
ajlm-1432	189	3	m	m	PROPN
ajlm-1432	189	4	,	,	PUNCT
ajlm-1432	189	5	nguemain	nguemain	PROPN
ajlm-1432	189	6	n	n	CCONJ
ajlm-1432	189	7	,	,	PUNCT
ajlm-1432	189	8	ng’awono	ng’awono	PROPN
ajlm-1432	189	9	t	t	PROPN
ajlm-1432	189	10	,	,	PUNCT
ajlm-1432	189	11	kamga	kamga	PROPN
ajlm-1432	189	12	f.	f.	PROPN
ajlm-1432	189	13	burden	burden	PROPN
ajlm-1432	189	14	of	of	ADP
ajlm-1432	189	15	intestinal	intestinal	ADJ
ajlm-1432	189	16	parasites	parasite	NOUN
ajlm-1432	189	17	amongst	amongst	ADP
ajlm-1432	189	18	hiv	hiv	PROPN
ajlm-1432	189	19	/	/	SYM
ajlm-1432	189	20	aids	aids	PROPN
ajlm-1432	189	21	patients	patient	NOUN
ajlm-1432	189	22	attending	attend	VERB
ajlm-1432	189	23	bamenda	bamenda	ADJ
ajlm-1432	189	24	regional	regional	ADJ
ajlm-1432	189	25	hospital	hospital	NOUN
ajlm-1432	189	26	in	in	ADP
ajlm-1432	189	27	cameroon	cameroon	PROPN
ajlm-1432	189	28	.	.	PUNCT
ajlm-1432	190	1	afr	afr	PROPN
ajlm-1432	190	2	j	j	PROPN
ajlm-1432	190	3	clin	clin	PROPN
ajlm-1432	190	4	exp	exp	PROPN
ajlm-1432	190	5	microbiol	microbiol	PROPN
ajlm-1432	190	6	.	.	PUNCT
ajlm-1432	191	1	2015;16(3):97–103	2015;16(3):97–103	X
ajlm-1432	191	2	.	.	PUNCT
ajlm-1432	191	3	https://doi.org/10.4314/ajcem.v16i3.3	https://doi.org/10.4314/ajcem.v16i3.3	PROPN
ajlm-1432	191	4	ugah	ugah	PROPN
ajlm-1432	191	5	u	u	NOUN
ajlm-1432	191	6	,	,	PUNCT
ajlm-1432	191	7	ibekailo	ibekailo	PROPN
ajlm-1432	191	8	s	s	PROPN
ajlm-1432	191	9	,	,	PUNCT
ajlm-1432	191	10	mbamagu	mbamagu	ADJ
ajlm-1432	191	11	d.	d.	PROPN
ajlm-1432	191	12	rate	rate	NOUN
ajlm-1432	191	13	of	of	ADP
ajlm-1432	191	14	haemolysins	haemolysin	NOUN
ajlm-1432	191	15	among	among	ADP
ajlm-1432	191	16	blood	blood	NOUN
ajlm-1432	191	17	donors	donor	NOUN
ajlm-1432	191	18	in	in	ADP
ajlm-1432	191	19	abakaliki	abakaliki	ADJ
ajlm-1432	191	20	,	,	PUNCT
ajlm-1432	191	21	ebonyi	ebonyi	PROPN
ajlm-1432	191	22	state	state	PROPN
ajlm-1432	191	23	,	,	PUNCT
ajlm-1432	191	24	nigeria	nigeria	PROPN
ajlm-1432	191	25	.	.	PUNCT
ajlm-1432	192	1	gjmr	gjmr	PROPN
ajlm-1432	192	2	stud	stud	PROPN
ajlm-1432	192	3	.	.	PUNCT
ajlm-1432	193	1	2014;1(3):61–65	2014;1(3):61–65	X
ajlm-1432	193	2	.	.	PUNCT
ajlm-1432	194	1	amita	amita	PROPN
ajlm-1432	194	2	r	r	NOUN
ajlm-1432	194	3	,	,	PUNCT
ajlm-1432	194	4	vijayalakshmi	vijayalakshmi	NOUN
ajlm-1432	194	5	k.	k.	NOUN
ajlm-1432	194	6	prevalence	prevalence	NOUN
ajlm-1432	194	7	and	and	CCONJ
ajlm-1432	194	8	haemolytic	haemolytic	ADJ
ajlm-1432	194	9	significance	significance	NOUN
ajlm-1432	194	10	of	of	ADP
ajlm-1432	194	11	red	red	ADJ
ajlm-1432	194	12	cell	cell	NOUN
ajlm-1432	194	13	antibodies	antibodie	VERB
ajlm-1432	194	14	among	among	ADP
ajlm-1432	194	15	dangerous	dangerous	ADJ
ajlm-1432	194	16	universal	universal	ADJ
ajlm-1432	194	17	donors	donor	NOUN
ajlm-1432	194	18	in	in	ADP
ajlm-1432	194	19	a	a	DET
ajlm-1432	194	20	tertiary	tertiary	ADJ
ajlm-1432	194	21	care	care	NOUN
ajlm-1432	194	22	hospital	hospital	NOUN
ajlm-1432	194	23	in	in	ADP
ajlm-1432	194	24	south	south	PROPN
ajlm-1432	194	25	india	india	PROPN
ajlm-1432	194	26	.	.	PUNCT
ajlm-1432	195	1	int	int	PROPN
ajlm-1432	195	2	j	j	PROPN
ajlm-1432	195	3	med	med	ADJ
ajlm-1432	195	4	lab	lab	NOUN
ajlm-1432	195	5	.	.	PUNCT
ajlm-1432	196	1	2019;6(4):234–240	2019;6(4):234–240	NUM
ajlm-1432	196	2	.	.	PUNCT
ajlm-1432	197	1	https://doi.org/10.18502/ijml.v6i4.1998	https://doi.org/10.18502/ijml.v6i4.1998	PROPN
ajlm-1432	197	2	obisesan	obisesan	NOUN
ajlm-1432	197	3	oa	oa	SYM
ajlm-1432	197	4	,	,	PUNCT
ajlm-1432	197	5	ogundeko	ogundeko	PROPN
ajlm-1432	197	6	to	to	PART
ajlm-1432	197	7	,	,	PUNCT
ajlm-1432	197	8	iheanacho	iheanacho	PROPN
ajlm-1432	197	9	cu	cu	PROPN
ajlm-1432	197	10	,	,	PUNCT
ajlm-1432	197	11	et	et	PROPN
ajlm-1432	197	12	al	al	PROPN
ajlm-1432	197	13	.	.	PUNCT
ajlm-1432	197	14	evaluation	evaluation	NOUN
ajlm-1432	197	15	of	of	ADP
ajlm-1432	197	16	alpha	alpha	NOUN
ajlm-1432	197	17	(	(	PUNCT
ajlm-1432	197	18	α	α	NOUN
ajlm-1432	197	19	)	)	PUNCT
ajlm-1432	197	20	and	and	CCONJ
ajlm-1432	197	21	beta	beta	NOUN
ajlm-1432	197	22	(	(	PUNCT
ajlm-1432	197	23	β	β	NOUN
ajlm-1432	197	24	)	)	PUNCT
ajlm-1432	197	25	haemolysin	haemolysin	NOUN
ajlm-1432	197	26	antibodies	antibodie	VERB
ajlm-1432	197	27	incidence	incidence	NOUN
ajlm-1432	197	28	among	among	ADP
ajlm-1432	197	29	blood	blood	NOUN
ajlm-1432	197	30	group	group	NOUN
ajlm-1432	197	31	‘	'	PUNCT
ajlm-1432	197	32	o	o	NOUN
ajlm-1432	197	33	’	'	PUNCT
ajlm-1432	197	34	donors	donor	NOUN
ajlm-1432	197	35	in	in	ADP
ajlm-1432	197	36	.	.	PUNCT
ajlm-1432	198	1	am	be	AUX
ajlm-1432	198	2	j	j	PROPN
ajlm-1432	198	3	clin	clin	PROPN
ajlm-1432	198	4	med	med	PROPN
ajlm-1432	198	5	res	re	NOUN
ajlm-1432	198	6	.	.	PUNCT
ajlm-1432	198	7	2015;3(3):42–44	2015;3(3):42–44	NUM
ajlm-1432	198	8	.	.	PUNCT
ajlm-1432	199	1	https://doi.org/10.12691/ajcmr-3-3-2	https://doi.org/10.12691/ajcmr-3-3-2	PROPN
ajlm-1432	199	2	ibeh	ibeh	PROPN
ajlm-1432	199	3	n	n	CCONJ
ajlm-1432	199	4	,	,	PUNCT
ajlm-1432	199	5	aneke	aneke	PROPN
ajlm-1432	199	6	j	j	PROPN
ajlm-1432	199	7	,	,	PUNCT
ajlm-1432	199	8	okocha	okocha	PROPN
ajlm-1432	199	9	c.	c.	PROPN
ajlm-1432	199	10	prevalence	prevalence	NOUN
ajlm-1432	199	11	of	of	ADP
ajlm-1432	199	12	haemolysins	haemolysin	NOUN
ajlm-1432	199	13	in	in	ADP
ajlm-1432	199	14	blood	blood	NOUN
ajlm-1432	199	15	donors	donor	NOUN
ajlm-1432	199	16	in	in	ADP
ajlm-1432	199	17	nnamdi	nnamdi	PROPN
ajlm-1432	199	18	azikiwe	azikiwe	PROPN
ajlm-1432	199	19	university	university	PROPN
ajlm-1432	199	20	teaching	teaching	NOUN
ajlm-1432	199	21	hospital	hospital	NOUN
ajlm-1432	199	22	,	,	PUNCT
ajlm-1432	199	23	nnewi	nnewi	PROPN
ajlm-1432	199	24	,	,	PUNCT
ajlm-1432	199	25	anambra	anambra	PROPN
ajlm-1432	199	26	state	state	PROPN
ajlm-1432	199	27	,	,	PUNCT
ajlm-1432	199	28	nigeria	nigeria	PROPN
ajlm-1432	199	29	.	.	PUNCT
ajlm-1432	200	1	orient	orient	PROPN
ajlm-1432	200	2	j	j	PROPN
ajlm-1432	200	3	med	med	PROPN
ajlm-1432	200	4	.	.	PUNCT
ajlm-1432	201	1	2015;27(1–2):34–39	2015;27(1–2):34–39	NUM
ajlm-1432	201	2	.	.	PUNCT
ajlm-1432	202	1	khampanon	khampanon	PROPN
ajlm-1432	202	2	k	k	PROPN
ajlm-1432	202	3	,	,	PUNCT
ajlm-1432	202	4	chanprakop	chanprakop	PROPN
ajlm-1432	202	5	t	t	PROPN
ajlm-1432	202	6	,	,	PUNCT
ajlm-1432	202	7	sriwanitchrak	sriwanitchrak	PROPN
ajlm-1432	202	8	p	p	NOUN
ajlm-1432	202	9	,	,	PUNCT
ajlm-1432	202	10	setthakarn	setthakarn	VERB
ajlm-1432	202	11	m	m	PROPN
ajlm-1432	202	12	,	,	PUNCT
ajlm-1432	202	13	oota	oota	PROPN
ajlm-1432	202	14	s	s	PROPN
ajlm-1432	202	15	,	,	PUNCT
ajlm-1432	202	16	nathalang	nathalang	PROPN
ajlm-1432	202	17	o.	o.	PROPN
ajlm-1432	203	1	the	the	DET
ajlm-1432	203	2	characteristics	characteristic	NOUN
ajlm-1432	203	3	of	of	ADP
ajlm-1432	203	4	abo	abo	ADJ
ajlm-1432	203	5	antibodies	antibody	NOUN
ajlm-1432	203	6	in	in	ADP
ajlm-1432	203	7	group	group	NOUN
ajlm-1432	203	8	ot	ot	PROPN
ajlm-1432	203	9	hai	hai	PROPN
ajlm-1432	203	10	blood	blood	NOUN
ajlm-1432	203	11	donors	donor	NOUN
ajlm-1432	203	12	.	.	PUNCT
ajlm-1432	204	1	j	j	PROPN
ajlm-1432	204	2	clin	clin	PROPN
ajlm-1432	204	3	lab	lab	PROPN
ajlm-1432	204	4	anal	anal	PROPN
ajlm-1432	204	5	.	.	PUNCT
ajlm-1432	205	1	2012;26(4):223–226	2012;26(4):223–226	X
ajlm-1432	205	2	.	.	PUNCT
ajlm-1432	206	1	https://doi.org/10.1002/jcla.21499	https://doi.org/10.1002/jcla.21499	PRON
ajlm-1432	206	2	polley	polley	PROPN
ajlm-1432	206	3	mj	mj	PROPN
ajlm-1432	206	4	,	,	PUNCT
ajlm-1432	206	5	adinolfi	adinolfi	NOUN
ajlm-1432	206	6	m	m	PROPN
ajlm-1432	206	7	,	,	PUNCT
ajlm-1432	206	8	mollison	mollison	PROPN
ajlm-1432	206	9	p.	p.	NOUN
ajlm-1432	206	10	serological	serological	ADJ
ajlm-1432	206	11	characteristics	characteristic	NOUN
ajlm-1432	206	12	of	of	ADP
ajlm-1432	206	13	anti	anti	ADJ
ajlm-1432	206	14	-	-	ADJ
ajlm-1432	206	15	a	a	PRON
ajlm-1432	206	16	related	relate	VERB
ajlm-1432	206	17	to	to	ADP
ajlm-1432	206	18	type	type	NOUN
ajlm-1432	206	19	of	of	ADP
ajlm-1432	206	20	antibody	antibody	NOUN
ajlm-1432	206	21	protein	protein	NOUN
ajlm-1432	206	22	(	(	PUNCT
ajlm-1432	206	23	7s	7	NOUN
ajlm-1432	206	24	γ	γ	NOUN
ajlm-1432	206	25	or	or	CCONJ
ajlm-1432	206	26	19s	19s	NUM
ajlm-1432	206	27	γ	γ	NOUN
ajlm-1432	206	28	)	)	PUNCT
ajlm-1432	206	29	.	.	PUNCT
ajlm-1432	207	1	vox	vox	PROPN
ajlm-1432	207	2	sanguinis	sanguinis	PROPN
ajlm-1432	207	3	.	.	PUNCT
ajlm-1432	208	1	1963;8(4):385–409	1963;8(4):385–409	X
ajlm-1432	208	2	.	.	PUNCT
ajlm-1432	209	1	https://doi.org/10.1111/j.1423-0410.1963.tb04159.x	https://doi.org/10.1111/j.1423-0410.1963.tb04159.x	PROPN
ajlm-1432	209	2	anyanwu	anyanwu	ADJ
ajlm-1432	209	3	r	r	NOUN
ajlm-1432	209	4	,	,	PUNCT
ajlm-1432	209	5	emeribe	emeribe	VERB
ajlm-1432	209	6	a	a	PRON
ajlm-1432	209	7	,	,	PUNCT
ajlm-1432	209	8	igwe	igwe	PROPN
ajlm-1432	209	9	c	c	NOUN
ajlm-1432	209	10	,	,	PUNCT
ajlm-1432	209	11	et	et	PROPN
ajlm-1432	209	12	al	al	PROPN
ajlm-1432	209	13	.	.	PROPN
ajlm-1432	210	1	occurrence	occurrence	NOUN
ajlm-1432	210	2	of	of	ADP
ajlm-1432	210	3	haemolysin	haemolysin	PROPN
ajlm-1432	210	4	antibodies	antibodie	VERB
ajlm-1432	210	5	among	among	ADP
ajlm-1432	210	6	sickle	sickle	NOUN
ajlm-1432	210	7	cell	cell	NOUN
ajlm-1432	210	8	anaemia	anaemia	NOUN
ajlm-1432	210	9	patients	patient	NOUN
ajlm-1432	210	10	within	within	ADP
ajlm-1432	210	11	calabar	calabar	PROPN
ajlm-1432	210	12	metropolis	metropolis	PROPN
ajlm-1432	210	13	of	of	ADP
ajlm-1432	210	14	nigeria	nigeria	PROPN
ajlm-1432	210	15	.	.	PUNCT
ajlm-1432	211	1	afr	afr	PROPN
ajlm-1432	211	2	j	j	PROPN
ajlm-1432	211	3	biotechnol	biotechnol	PROPN
ajlm-1432	211	4	.	.	PUNCT
ajlm-1432	212	1	2007;6(10):1217–1220	2007;6(10):1217–1220	NOUN
ajlm-1432	212	2	.	.	PUNCT
ajlm-1432	213	1	adewuyi	adewuyi	PROPN
ajlm-1432	213	2	j	j	PROPN
ajlm-1432	213	3	,	,	PUNCT
ajlm-1432	213	4	gwanzura	gwanzura	NOUN
ajlm-1432	213	5	c.	c.	PROPN
ajlm-1432	213	6	racial	racial	ADJ
ajlm-1432	213	7	difference	difference	NOUN
ajlm-1432	213	8	between	between	ADP
ajlm-1432	213	9	white	white	ADJ
ajlm-1432	213	10	and	and	CCONJ
ajlm-1432	213	11	black	black	ADJ
ajlm-1432	213	12	zimbabweans	zimbabwean	NOUN
ajlm-1432	213	13	in	in	ADP
ajlm-1432	213	14	the	the	DET
ajlm-1432	213	15	haemolytic	haemolytic	ADJ
ajlm-1432	213	16	activity	activity	NOUN
ajlm-1432	213	17	of	of	ADP
ajlm-1432	213	18	a	a	DET
ajlm-1432	213	19	,	,	PUNCT
ajlm-1432	213	20	b	b	NOUN
ajlm-1432	213	21	,	,	PUNCT
ajlm-1432	213	22	o	o	NOUN
ajlm-1432	213	23	antibodies	antibodie	VERB
ajlm-1432	213	24	.	.	PUNCT
ajlm-1432	214	1	afr	afr	PROPN
ajlm-1432	214	2	j	j	PROPN
ajlm-1432	214	3	med	med	PROPN
ajlm-1432	214	4	med	med	PROPN
ajlm-1432	214	5	sci	sci	PROPN
ajlm-1432	214	6	.	.	PUNCT
ajlm-1432	215	1	2001;30(1–2):71	2001;30(1–2):71	NUM
ajlm-1432	215	2	.	.	PUNCT
ajlm-1432	216	1	saphire	saphire	PROPN
ajlm-1432	216	2	d	d	PROPN
ajlm-1432	216	3	,	,	PUNCT
ajlm-1432	216	4	rudolph	rudolph	PROPN
ajlm-1432	216	5	n	n	SYM
ajlm-1432	216	6	,	,	PUNCT
ajlm-1432	216	7	hackleman	hackleman	NOUN
ajlm-1432	216	8	s	s	PROPN
ajlm-1432	216	9	,	,	PUNCT
ajlm-1432	216	10	stone	stone	PROPN
ajlm-1432	216	11	w.	w.	NOUN
ajlm-1432	217	1	the	the	DET
ajlm-1432	217	2	effect	effect	NOUN
ajlm-1432	217	3	of	of	ADP
ajlm-1432	217	4	age	age	NOUN
ajlm-1432	217	5	on	on	ADP
ajlm-1432	217	6	the	the	DET
ajlm-1432	217	7	level	level	NOUN
ajlm-1432	217	8	of	of	ADP
ajlm-1432	217	9	human	human	ADJ
ajlm-1432	217	10	abo	abo	NOUN
ajlm-1432	217	11	blood	blood	NOUN
ajlm-1432	217	12	group	group	NOUN
ajlm-1432	217	13	antibodies	antibodie	VERB
ajlm-1432	217	14	.	.	PUNCT
ajlm-1432	218	1	aging	age	VERB
ajlm-1432	218	2	clin	clin	PROPN
ajlm-1432	218	3	exp	exp	NOUN
ajlm-1432	218	4	res	re	NOUN
ajlm-1432	218	5	.	.	PUNCT
ajlm-1432	219	1	1993;5(3):177–184	1993;5(3):177–184	X
ajlm-1432	219	2	.	.	PUNCT
ajlm-1432	219	3	https://doi.org/10.1007/bf03324152	https://doi.org/10.1007/bf03324152	PROPN